September 2023
Can malignant lymphadenopathies be predicted? Analysis of clinical, ultrasonographic and laboratory data
Anar Aslanov, Burak Uçaner, Mehmet Sabri Çiftçi, Mehmet Zeki Buldanlı
Department of General Surgery, University of Health Sciences, Gülhane Training and Research Hospital, Ankara, Turkey
DOI: 10.4328/ACAM.21513 Received: 2022-11-22 Accepted: 2022-12-24 Published Online: 2022-12-30 Printed: 2023-09-01 Ann Clin Anal Med 2023;14(9):768-771
Corresponding Author: Mehmet Zeki Buldanlı, Department of General Surgery, Gülhane Training and Research Hospital, General Dr. Tevfik Sağlam Street, No:1, 06010, Etlik, Ankara, Turkey. E-mail: buldanli87@hotmail.com P: +90 312 304 51 50 F: +90 312 304 27 00 Corresponding Author ORCID ID: https://orcid.org/0000-0002-6491-7630
This study was approved by the Ethics Committee of Gulhane Training and Research Hospital (Date: 2022-07-01, No: 2022/103)
Aim: Lymphadenopathy may be result from an infectious disease or manifest an underlying hematologic disease, a metastasis of an as-yet undiagnosed malignancy, or a primary malignancy. This study aimed to investigate whether there is predictive value in malignancy by examining data from patients who underwent excisional biopsy for lymphadenopathy.
Material and Methods: Clinical data from patients who had undergone excisional lymph node biopsy at a single-center approximately six years were retrospectively reviewed. Based on the results of the histopathology report, patients were divided into two separate groups that are malignant and benign histopathology groups. Then, the malignant histopathological group was further divided into two subgroups: primary lymph node malignancy and lymph node metastatic malignancy.
Results: The mean age of patients included in the study was 47.5±17.0 years (19-87 years). It was observed that the CRP levels were higher in primary lymph node malignancies than in metastatic malignancies in lymph nodes (p=0.027). When histopathology results were accepted as a reference, the sensitivity of ultrasonography in detecting malignant lymph nodes was 77.2%, specificity was 48.1%. For malignant lymph nodes, only lymph node diameter proved to be a determinant (p=0.026). Lymph node diameter >25 mm was predictive of malignant histopathology with a sensitivity of 54.5% and a specificity of 66.7%.
Discussion: While ultrasonography is a significant predictor of lymphadenopathy, CRP levels may be important in differential diagnosis of primary lymph node malignancies from metastatic malignancies in the lymph nodes.
Keywords: Lymphadenopathy, Lymphoma, Malignant Lymph Node, Metastatic Lymph Node, Benign Lymph Node
Introduction
Lymphadenopathy may result from infectious disease or may be an expression of underlying hematologic disease, metastasis of undiagnosed malignancy, or primary malignancy [1]. Histopathologic analysis of the lymph node is necessary for the differential diagnosis of lymphadenopathy in patients [2]. Although imaging-guided fine-needle aspiration biopsy (FNAB) and tru-cut biopsy are the first-choice procedures, these techniques have some disadvantages. FNAB may provide nondiagnostic specimens, while tru-cut biopsy may not provide a diagnosis of diseases such as lymphoma [3]. The European Society of Medical Oncology (ESMO) guidelines recommend an excisional biopsy of lymph nodes to diagnose and type lymphoma [4]. According to these guidelines, the chance of early diagnosis and treatment is higher in palpable lymph nodes thanks to imaging-guided and excisional biopsies [4].
In this study, we aimed to examine in detail the preoperative, intraoperative, and postoperative data of patients who underwent excisional biopsy for lymphadenopathy approximately six years, compare the results, and investigate whether there is predictive value in terms of malignancy and whether it is a predictor that distinguishes primary lymph node malignancies.
Material and Methods
Patients older than eighteen years of age and who underwent excisional lymph node biopsy for lymphadenopathy from October 2016 to June 2022 in a single tertiary hospital were included in this retrospective study. Patients younger than 18 years, patients with a previous malignancy diagnosis, and patients who had undergone surgical procedures such as lymphadenectomy and lymph node dissection additional for main surgery were excluded from the study. In this study, patient demographics such as age and gender, American Society of Anesthesiologists scores, symptoms, comorbidities, clinical data such as length of hospital stay, intensive care unit (ICU) stay status, preoperative ultrasonography (US) and laboratory results, and Clavien-Dindo Classification System results for postoperative complications, reoperation status and histopathological report results were examined. Preoperative laboratory results of white blood cell counts (WBC, 103/µl), hemoglobin levels (Hb, g/dl), neutrophil counts (Neu, 103/µl), lymphocyte counts (Lym, 103/µl), platelet counts (Plt, 103/µl), lactate dehydrogenase levels (LDH, 103/µl), C-reactive protein levels (CRP, mg/l) and albumin levels (Alb, g/dl) were analyzed. Imaging results included lymph node size in US reports and the radiologist’s reactive or pathologic description of the lymph node.
Based on the results of the histopathology report, patients were divided into two separate groups that are malignant and benign histopathology groups. Then, the malignant histopathological group was further divided into two subgroups, namely primary lymph node malignancy and lymph node metastatic malignancy.
This study was conducted under the fundamental ethical principles for medical research involving human subjects, as stated in the guidelines of the World Medical Association Declaration of Helsinki, and was approved by the local ethics committee (01.07.2022-2022/103).
Statistical analysis
Statistical analyzes were performed using the SPSS package program version 22.0. Descriptive statistics were expressed as a number, percentage, mean and standard deviation, and median. The conformity of variables to the normal distribution was examined using visual (histogram and probability graphs) and analytical methods (“Kolmogorov–Smirnov,” “Shapiro-Wilk”). Normally distributed numerical variables were analyzed between the two groups using the “T-test in independent groups,” and numerical variables that did not have a normal distribution were analyzed between the two groups using the “Mann Whitney U test” “Chi-square” and “Fisher’s Exact test” were preferred for comparing nominal data. Analysis of predictive factors for malignant histopathology was evaluated using the “ROC (receiver operating characteristic) analysis.” The ROC Analysis was expressed as the area under the curve (AUC) with a 95% confidence interval (CI). Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for the threshold determined with the “Youden index” in the ROC analysis. In the study’s statistical analysis, comparisons with a P value less than 0.05 were considered statistically significant.
Ethical Approval
Ethics Committee approval for the study was obtained.
Results
The mean age of the 120 patients included in the study was 47.5±17.0 years (19-87 years). Sixty-three patients were female, and 57 patients were male. The female-to-male ratio was 1.1/1. In 56.7% of the patients, there was a comorbidity other than malignancy. Symptoms were present in 81.7% of patients. The most common symptoms were a palpable mass (70%) and pain (17.5%). Lymphadenopathies were most commonly observed in the axillary (65%), inguinal (21.7%), and neck (8.3%) regions. The US finding was a pathological lymph node in 65.8% of patients. The median size of the lymph nodes was 25 (5-83) mm. The median length of hospital stay was one day (0-9 days). None of the patients required reoperation. In addition, according to the Clavien-Dindo classification, no complications were observed in the patients. Only one patient required intensive care unit stay (Table 1).
The histopathologically malignant and benign lymph nodes were compared in terms of demographic and clinical features. The diameter of lymph nodes in malignant histopathology was significantly larger (p=0.029). In addition, malignant lymph nodes were more frequently reported that pathological lymph nodes on US (p=0.003) (Table 2). When histopathology results were accepted as a reference, the sensitivity of US in detecting malignant lymph nodes was 77.2%, specificity was 48.1%, PPV was 64.5%, and NPV was 63.4%.
The histopathology of malignant and benign lymph nodes was compared in terms of preoperative laboratory results, and no significant difference was found.
Malignant lymph nodes were divided into primary and lymph node metastatic malignancies, and the demographic and clinical characteristics were compared between the groups, but no significant difference was found.
The primary and metastatic lymph node groups were compared in terms of preoperative laboratory results. It was found that CRP levels were higher in primary lymph node malignancies (p=0.027) (Table 3).
Parameters potentially determinant in malignant lymph nodes were evaluated with ROC analysis. In malignant lymph nodes, only lymph node diameter proved to be a determinant (AUC = 0.616, 95% CI 0.523-0.703, p=0.026). Lymph node diameter greater than 25 mm was predictive of malignant histopathology, with a sensitivity of 54.5%, specificity of 66.7%, PPV of 66.7% and NPV of 54.5%.
Discussion
Peripheral lymphadenopathy is a secondary condition in malignant, hematologic, or infectious disease and may require excisional lymph node biopsy, a procedure generally included in the diagnostic algorithm. Because of excisional lymph node biopsy is a surgical procedure, FNAB and tru-cut biopsy, less invasive techniques, have come to the forefront. However, excisional lymph node biopsy remains highly actual due to poor diagnostic performance, reintervention, and the fact that it cannot be performed in every center [5]. In this study, all patients underwent excisional lymph node biopsy for diagnostic purposes.
It is known that there are many lymph node regions in the human body. Peripheral lymph node localizations, especially in the neck and groin area, may be painful and palpable after a rapid growth tendency due to infectious diseases. In such cases, the lymph nodes may decrease in size due to etiology-targeted treatment with anti-inflammatory, antiviral, or antibiotic agents and regression of existing pathology, symptoms may resolve, and biopsy is usually not required [6].
However, lymphadenopathies that develop secondary to malignant or hematologic pathologies may enlarge. In addition to their size, they do not regress and may be painless. Also, the risk factors for malignancy include the white race, age older than 40 years, male gender, supraclavicular lymphadenopathy, and systemic symptoms such as fever, night sweats, unexplained weight loss has been described. In these cases, the first diagnostic option in the algorithm may be needle biopsy. However, the gold standard in diagnosis is excisional biopsy [7, 8].
In the diagnosis of malignant lymph nodes, laboratory tests are performed before excisional lymph node biopsy to establish the diagnosis. Among laboratory parameters, acute phase reactants such as WBC, CRP, and erythrocyte sedimentation rate take precedence. In addition, parameters such as neutrophils, monocytes, and lymphocytes may be used for bacterial, parasitic, and viral infectious etiology. While immunoglobulins, lactate dehydrogenase, autoantibodies, and platelets can be used for hematologic and rheumatologic etiologies, biomarkers can also be used for malignancies [9-11]. No statistically significant difference was found between the benign and malignant groups in the laboratory parameters examined in this study. However, it was observed that CRP levels were significantly higher in the group with primary malignant lymph nodes.
There are differences between imaging modalities regarding diagnostic performance in recognizing lymph nodes as pathological. While the US is superior in the inguinal, cervical, and axillary regions, cross-sectional examinations such as computed tomography (CT) and magnetic resonance imaging (MRI) are more prominent in the intraabdominal, retroperitoneal, and mediastinal regions [12].
The advantages of the US, such as the fact that it is inexpensive, easily accessible, radiation-free, and simple to use, also support its usage in diagnostics. Pathologic description in the radiologist’s ultrasonography report, which can be considered a predictor of malignant histopathology, depends on certain criteria. The lobular contour structure of the lymph node, the decrease in the ratio of longitudinal to transverse size, the presence of necrosis, the absence of an echogenic hilus, and the increase in lymph node diameter are the findings support the pathologic condition. In addition, peripheral and mixed blood supply on coloured Doppler US may be significant for malignancy [13, 14]. In this study, the pathologic description of the lymph node was radiologically significant between groups in favor of the malignant histopathologic group.
The pathologic assumption of lymph node enlargement may show regional differences. When considering adult dimensions after adolescence, the histopathological diagnosis may arise with lymph nodes larger than 1 cm. In the literature, lymph nodes larger than 1.5 cm in the inguinal and mediastinal regions, 1 cm in the cervical and axillary regions, and 2 cm in the intraabdominal region are considered abnormal, and in general, lymph nodes larger than 2.5 cm are reported to have a seriously increased risk of malignancy [15, 16]. In this study, the lymph node diameter was found to be important for the malignant histopathology group. Moreover, when evaluating the parameters that could be determinant for malignant lymph nodes, it was found with ROC analysis that only the lymph node diameter was determinant.
Study limitations
This study’s limitations were the retrospective design of the study, the limited number of patients, and the inability to evaluate parameters such as biomarkers in laboratory data because of the insufficient number of patients when the data were examined. In addition, the lack of sufficient patient data on cross-sectional imaging studies such as CT and MRI was another study limitation.
Conclusion
Imaging and laboratory tests are essential to clarify the etiology after an effective anamnesis and physical examination when persistent lymphadenopathy is detected. US can provide very valuable information for predicting malignancy. High levels of CRP value can predict the differential diagnosis between a primary malignant lymph node and a metastatic lymph node. However, there is a need for randomized, prospective studies and reviews with a larger patient population on this topic.
Scientific Responsibility Statement
The authors declare that they are responsible for the article’s scientific content including study design, data collection, analysis and interpretation, writing, some of the main line, or all of the preparation and scientific review of the contents and approval of the final version of the article.
Animal and human rights statement
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. No animal or human studies were carried out by the authors for this article.
Funding: None
Conflict of interest
None of the authors received any type of financial support that could be considered potential conflict of interest regarding the manuscript or its submission.
References
1. Kiliçarslan A, Doğan M, Süngü N, Karakök E, Karabekmez L, Akyol M, et al. Can Cutting-Needle Biopsy Be an Alternative to Excisional Biopsy in Lymph Node Pathologies? Turk Patoloji Derg. 2017; 1(1): 235-9.
2. Alice J, Eva L, Wolfgang H, Wolfram K. Core needle biopsies and surgical excision biopsies in the diagnosis of lymphoma-experience at the Lymph Node Registry Kiel. Ann Hematol. 2016; 95(8): 1281-6.
3. Campanelli M, Cabry F, Marasca R, Gelmini R. Peripheral lymphadenopathy: role of excisional biopsy in differential diagnosis based on a five-year experience. Minerva Chir. 2019; 74(3): 218-23.
4. Özkan EA, Göret CC, Özdemir ZT, Yanık S, Göret NE, Doğan M, et al. Evaluation of peripheral lymphadenopathy with excisional biopsy: six-year experience. Int J Clin Exp Pathol. 2015; 8(11): 15234-9.
5. Shrestha AL, Shrestha P. Peripheral Lymph Node Excisional Biopsy: Yield, Relevance, and Outcomes in a Remote Surgical Setup. Surg Res Pract. 2018; 2018: 8120390.
6. Faraz M, Rosado FGN. Reactive Lymphadenopathies. Clin Lab Med. 2021; 41(3): 433-51.
7. Gaddey HL, Riegel AM. Unexplained Lymphadenopathy: Evaluation and Differential Diagnosis. Am Fam Physician. 2016; 94(11): 896-903.
8. Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A. Peripheral lymphadenopathy: approach and diagnostic tools. Iran J Med Sci. 2014; 39(2 Suppl): 158-70.
9. Matson DR, Yang DT. Autoimmune Lymphoproliferative Syndrome: An Overview. Arch Pathol Lab Med. 2020; 144(2): 245-51.
10. Kamiya N, Ishikawa Y, Takeshima T, Sagara Y, Yamamoto S, Naka Mieno M, et al. Usefulness of lactate dehydrogenase in differentiating abnormal cervical lymphadenopathy. J Gen Fam Med. 2020; 22(2): 75-80.
11. Hamada Y, Tanaka K, Yamamoto N. A Middle-Aged Woman with Elevated Serum CA19-9 and Lymphadenopathy. Am J Med. 2021; 134(8): e459-60.
12. Sim JK, Lee JY, Hong HS. Differentiation Between Malignant and Benign Lymph Nodes: Role of Superb Microvascular Imaging in the Evaluation of Cervical Lymph Nodes. J Ultrasound Med. 2019; 38(11): 3025-3036.
13. Yang JR, Song Y, Jia YL, Ruan LT. Application of multimodal ultrasonography for differentiating benign and malignant cervical lymphadenopathy. Jpn J Radiol. 2021; 39(10): 938-45.
14. Lee EWC, Issa A, Oliveira P, Lau M, Sangar V, Parnham A, et al. High diagnostic accuracy of inguinal ultrasonography and fine-needle aspiration followed by dynamic sentinel lymph node biopsy in men with impalpable and palpable inguinal lymph nodes. BJU Int. 2022;130(3): 331-6.
15. Chiorean L, Cui XW, Klein SA, Budjan J, Sparchez Z, Radzina M, et al. Clinical value of imaging for lymph nodes evaluation with particular emphasis on ultrasonography. Z Gastroenterol. 2016; 54(8): 774-90.
16. Ryu KH, Lee KH, Ryu J, Baek HJ, Kim SJ, Jung HK, et al. Cervical Lymph Node Imaging Reporting and Data System for Ultrasound of Cervical Lymphadenopathy: A Pilot Study. AJR Am J Roentgenol. 2016; 206(6): 1286-91.
Download attachments: 10.4328.ACAM.21513
Anar Aslanov, Burak Uçaner, Mehmet Sabri Çiftçi, Mehmet Zeki Buldanlı. Can malignant lymphadenopathies be predicted? Analysis of clinical, ultrasonographic and laboratory data. Ann Clin Anal Med 2023;14(9):768-771
Citations in Google Scholar: Google Scholar
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/
The role of platelet distribution width in the diagnosis of ischemic and hemorrhagic stroke
Mustafa Enes Demirel, Sinan Özel
Department of Emergency, Faculty of Medicine, Bolu Abant İzzet Baysal University, Bolu, Turkiye
DOI: 10.4328/ACAM.21573 Received: 2023-01-03 Accepted: 2023-03-02 Published Online: 2023-08-30 Printed: 2023-09-01 Ann Clin Anal Med 2023;14(9):772-776
Corresponding Author: Mustafa Enes Demirel, Department of Emergency, Faculty of Medicine, Bolu Abant İzzet Baysal University, 14030, Bolu, Turkiye. E-mail: mnsdmrl@hotmail.com P: +90 505 391 09 03 Corresponding Author ORCID ID: https://orcid.org/0000-0001-5187-5737
This study was approved by the Clinical Researches Ethics Committee of Bolu Abant İzzet Baysal University (Date: 2022-02-22, No: 2022/29)
Aim: Current efforts to find diagnoses using simple and widely used indices of platelet activation have focused on the platelet activation caused by morphological changes, including both pseudopodia formation and spherical shape. The aim of this study was to evaluate the effect of PDW in differentiating ischemic and hemorrhagic stroke.
Material and Methods: The study included a total of 333 patients, of which 269 had ischemic stroke and 64 had hemorrhagic stroke. Demographic data of the patients such as gender and age, National Institutes of Health Stroke Scale (NIHSS), Glasgow Coma Scale (GCS) and the modified Rankin score (mRs) were recorded. Complete blood count parameters were also recorded and compared between the patients with ischemic and hemorrhagic stroke.
Results: The mean age of the patients was found to be 72.3±12.71 years in the ischemic stroke group and 69.27±14.39 years in the hemorrhagic group. The median neutrophil count was statistically significantly higher in the hemorrhagic stroke group (p=0.041). The median level of albumin was statistically significantly higher in the patients with hemorrhagic stroke (p=0.010). The median PDW value was determined to be statistically significantly higher at 14.9 (11.9-17.8) in the ischemic stroke group compared to 12.85 (11.33-17.03) in the hemorrhagic stroke group (p=0.009).
Discussion: As the PDW level was statistically significantly lower in patients with hemorrhagic stroke than in patients with ischemic stroke, it may be of value in distinguishing these two forms of stroke. However, further comprehensive, multi-center studies are needed to better understand the role of PDW in ischemic and hemorrhagic stroke.
Keywords: Cerebral Hemorrhage, Cerebrovascular Disorders, Platelet, Stroke
Introduction
Stroke is a neurological disease characterized by blood vessel occlusion. The formation of clots in the brain interrupts blood flow, blocks arteries, and causes blood vessels to rupture, resulting in bleeding. This causes the sudden death of brain cells due to oxygen deprivation. Stroke is an important cause of disability, the prevalence of which is increasing in parallel with the growing world population. It is also the second most common cause of death worldwide [1], affecting approximately 13.7 million people per year and causing the death of approximately 5.5 million people [2].
The global burden of ischemic strokes is nearly 4-fold greater than that of hemorrhagic strokes [3]. Of all strokes, 87% are caused by ischemic infarctions [4]. In ischemic stroke, reduced blood flow to the brain causes embolism, resulting in severe stress and cell necrosis, after which the cellular contents leak into the extracellular space [5]. Hemorrhagic strokes, which have a high mortality rate, constitute 10-15% of all strokes. Blood vessels are ruptured in a hemorrhagic stroke due to brain stress and internal injury. Blood accumulates abnormally within the brain as a result of vessel rupture, and the toxic effects of a hemorrhagic stroke on the vascular system cause hemorrhage [6]. The primary causes of hemorrhagic stress are vasculature disruption, hypertension, and excessive use of anticoagulants and thrombolytic agents [2]. There are two types of hemorrhagic stroke, which are classified as intracerebral and subarachnoid. Comparison between ischemic and hemorrhagic stroke is difficult, as ischemic stroke is approximately 10 times more common [7].
Platelets are important for coagulation, atherosclerosis, immune response, and inflammation [8-10]. Platelet parameters have been extensively studied in the literature. Current efforts to find simple and widely used indices of platelet activation have focused on the platelet activation causing morphological changes in platelets, including both pseudopodia formation and spherical shape [11]. Platelet distribution width (PDW), which reflects the variation in platelets, functions as an indicator of platelet activation and function [12]. Higher PDW levels are related to cancer, type 2 diabetes, cardiovascular disease, and respiratory problems [13,14]. In addition, increased PDW values have been observed in individuals with serious illnesses [15,16]. Activated platelets release high expression levels of glycoproteins Ib and IIb/IIIa, contributing to stroke [17]. Although PDW and mean platelet volume (MPV) are both indicators of platelet activation, PDW is a more accurate indicator of platelet reactivity [18].
Generally, cortical infarctions, which can be easily diagnosed with imaging techniques, can be managed in emergency departments without any problems. However, there are still patients classified as having unspecified ischemic stroke. PDW can assist decisions about ischemic events. The aim of this study was to evaluate the value of PDW in differentiating ischemic and hemorrhagic stroke.
Material and Methods
Ethics Committee Approval
The institutional review board of our hospital approved the study protocol on February 22, 2022 (number: 2022/29). Since the study was retrospective, informed consent was not necessary. All procedures were applied in accordance with the 2013 update of the Declaration of Helsinki.
Study Design
The study included a total of 333 patients, of which 269 had ischemic stroke and 64 had a hemorrhagic stroke, who presented at the Emergency Department between August 01, 2021 and February 28, 2022. Patients <18 years old, those who received thrombolysis therapy combined with mechanical thrombectomy, patients with inflammatory disease, underlying hematological disease, autoimmune disease, pregnant women, those without complete blood count on admission, and those with incomplete data were excluded from the study.
The age and gender of the patients were recorded together with the National Institutes of Health Stroke Scale (NIHSS), the modified Rankin score (mRs), and the Glasgow Coma Scale (GCS) score. Complete blood count parameters were also recorded and compared between the patients with ischemic and hemorrhagic strokes.
Statistical analysis
Data obtained in the study were analyzed statistically using SPSS version 23.0 software (SPSS, Statistical Package for the Social Sciences, IBM Inc., Armonk, NY, USA). The Shapiro-Wilk test was used to determine the normality of the continuous variables. Comparisons of variables between the groups were made using the Mann-Whitney U-test. Continuous variables were stated as median (IQR) values and categorical variables as number (n) and percentage (%). A p-value of 0.05 was regarded as statistically significant.
Ethical Approval
Ethics Committee approval for the study was obtained.
Results
A total of 333 stroke patients who presented at the Emergency Department were examined. Of all the patients, 269 (80.78%) had ischemic stroke and 64 (19.22%) had hemorrhagic stroke. The mean age of the patients was 72.3±12.71 years in the ischemic stroke group and 69.27±14.39 years in the hemorrhagic stroke group. No statistically significant difference was determined between the groups in terms of age.
Of the patients, 163 (48.95%) patients were male and 170 (51.05%) patients were female, with no statistically significant difference between the groups in terms of gender (p=0.079) (Figure 1). The gender distribution in each group showed no statistically significant difference (p=0.308).
The median NIHSS score was 8 (4-15) in the ischemic group and 8 (4-18) in the hemorrhagic group, with no statistically significant difference determined between the groups (p=0.100). The median mRs was measured as 3 (2-5) in the ischemic group, and 4 (2-5) in the hemorrhagic stroke group. The difference between the two groups was not statistically significant (p=0.672). The median GCS score was 13 (9-5) in the patients with ischemic stroke, and 11 (5.25-14.75) in the hemorrhagic stroke group. The median GCS score was statistically significantly higher in the patients with ischemic stroke (p=0.009).
Mortality developed in 66 (19.82%) patients and 268 (80.48%) were discharged. The mortality rate was determined to be 18.22% in the ischemic stroke group and 23.44% in the hemorrhagic stroke group. There was no statistically significant difference between the groups in terms of patient outcomes (p=0.219). The distribution of patient outcomes is shown in Figure 2.
When complete blood count parameters were examined, the median neutrophil count was found to be 5.6 (4.12-8.1) in the ischemic stroke group and 6.66 (4.75-9.29) in the hemorrhagic stroke group. The median neutrophil count was statistically significantly higher in the hemorrhagic stroke group (p=0.041). The median basophil count was found to be 0.05 (0.03-0.08) in the ischemic stroke group, and 0.04 (0.02-0.06) in the hemorrhagic stroke group. There was a statistically significant difference between the ischemic and hemorrhagic stroke groups in respect of basophil count (p=0.001). The median albumin level was found to be 39.6 (36-42) in the ischemic stroke group and 41.65 (38.08-44) in the hemorrhagic stroke group. The difference between the groups in respect of the median albumin value was statistically significant (p=0.010). The median PDW value was found to be 14.9 (11.9-17.8) in the ischemic stroke group, and 12.85 (11.33-17.03) in the hemorrhagic stroke group. The median PDW value was statistically significantly higher in the ischemic stroke group (p=0.009) (Figure 3).
No statistically significant difference was found between the ischemic and hemorrhagic stroke groups in the other parameters (p>0.05 for all) (Table 1).
Discussion
The results of this study showed a statistically significant difference between the ischemic and hemorrhagic stroke groups in terms of PDW. The median PDW was statistically significantly higher in the ischemic stroke group (p=0.009).
The mean age of the patients in this study was 72.3±12.71 years in the patients with ischemic stroke, and 69.27±14.39 years in the patients with hemorrhagic stroke. Tzur et al. investigated PDW as a novel biomarker in internal medicine and reported the mean age of patients to be 66.4 ± 18 years [19]. In another study, Gao et al. evaluated the relationship between poor outcomes of acute ischemic stroke and PDW and found the mean age to be 62.1±12.6 years [20]. Salvadory et al. [6] reported a mean age of 72.9 ± 13.9 years in patients with hemorrhagic and ischemic stroke. Within this context, the current study finding was consistent with previous studies. The gender distribution in the current study was 48.95% male and 51.05% female. Salvadori et al. similarly reported that 52% of the patients were female and 48% of them were male.
Hemorrhagic stroke is associated with a significantly higher mortality, which is specifically associated with the hemorrhagic nature of the lesion [7]. In the current study, the mortality rate was higher in the hemorrhagic group, although the difference was not statistically significant (p>0.05). Similarly, in a study by Andersen et al. comparing ischemic and hemorrhagic strokes, hemorrhagic stroke was associated with a higher risk of mortality compared to ischemic stroke [7].
Included in routine blood testing, PDW is one of the platelet characteristics that shows platelet activity. An increase in PDW indicates an increase in the number of platelets of various sizes in circulation. Platelets in circulation with a low PDW level have diameters that are closer together, indicating that they are inflammatory and metabolically less active [12]. PDW and MPV are simple platelet indicators that increase during platelet activation. However, PDW is a more specific marker of platelet activation because it does not increase during simple platelet swelling [12]. In addition to other platelet parameters, PDW has been extensively studied in the literature in various diseases. Higher PDW values have been shown in patients with cancer, diabetes mellitus, cardiovascular and cerebrovascular diseases [13,14,21]. Higher PDW values have also been associated with increased morbidity and mortality in patients with coronary artery disease, pulmonary embolism, and COPD [22].
In a study by Tzur et al., higher PDW values on admission to internal medicine wards were associated with an increased risk of 90-day mortality and a more severe clinical prognosis [19]. In another study, Gao et al. reported that a lower level of PDW may be associated with a poor outcome at 3 months following intravenous thrombolysis in patients with acute ischemic stroke [20]. In a study by Al-Tameemi et al., no significant difference was found between 25 patients undergoing the first acute ischemic stroke, 25 patients undergoing more than one ischemic stroke and control groups in terms of PDW [23]. In a study by Li et al., elevated PDW was reported to be an independent indicator of poor functional outcomes in patients with acute ischemic stroke [5]. In contrast, it was reported in a meta-analysis and systematic review by Zheng et al. that PDW has insufficient value in estimating clinical results of acute ischemic stroke [24]. In another study by Sonmezler et al., PDW was reported to be associated with mortality in older patients who had acute ischemic stroke [25].
In the current study, statistically significantly higher PDW values were observed in the patients who had an ischemic stroke compared to those with hemorrhagic stroke. In addition, statistically significant differences were observed between the patients with ischemic stroke and those with hemorrhagic stroke in respect of neutrophil count, basophil count and albumin levels. These results suggest that the PDW index may be used as a novel marker for the differentiation of ischemic and hemorrhagic stroke. However, there is a need for furthermore comprehensive studies to support our findings.
Conclusion
PDW value was seen to be statistically significantly higher in patients who underwent ischemic stroke compared to those who underwent hemorrhagic stroke. PDW may be of value in distinguishing these two forms of stroke. However, further comprehensive, multi-center studies are needed to better understand the role of PDW in ischemic and hemorrhagic stroke.
Study Limitations
Major limitations of this study were that it was conducted in a single center, was retrospective in design, and there was no healthy control group without stroke. However, given the scarcity of similar studies in the literature, these findings can be considered to be of value in guiding further comprehensive studies. However, a strong aspect of the study was that it is the first to have investigated the clinical value of PDW in distinguishing ischemic stroke and hemorrhagic stroke.
Scientific Responsibility Statement
The authors declare that they are responsible for the article’s scientific content including study design, data collection, analysis and interpretation, writing, some of the main line, or all of the preparation and scientific review of the contents and approval of the final version of the article.
Animal and human rights statement
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. No animal or human studies were carried out by the authors for this article.
Funding: None
Conflict of interest
None of the authors received any type of financial support that could be considered potential conflict of interest regarding the manuscript or its submission.
References
1. Katan M, Luft A. Global Burden of Stroke. Semin Neurol. 2018;38(2):208-11.
2. Kuriakose D, Xiao Z. Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives. Int J Mol Sci. 2020;21(20):7609.
3. Kalaria RN, Akinyemi R, Ihara M. Stroke injury, cognitive impairment and vascular dementia. Biochim Biophys Acta. 2016;1862(5):915-25.
4. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Heart disease and stroke statistics. 2011 update: A report from the American Heart Association. Circulation. 2011;123(4):18-209.
5. Li Y, Li T, Zhao L, Zhang Y, Wang X, Wu Y, et al. Platelet Distribution Width: A Significant Predictor of Poor Outcome After Mechanical Thrombectomy. J Stroke Cerebrovasc Dis. 2022;31(3):106273.
6. Salvadori E, Papi G, Insalata G, Rinnoci I, Donnini I, Martini M, et al. Comparison between Ischemic and Hemorrhagic Strokes in Functional Outcome at Discharge from an Intensive Rehabilitation Hospital. Diagnostics (Basel). 2020;11(1):38.
7. Andersen KK, Olsen TS, Dehlendorff C, Kammersgaard LP. Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors. Stroke. 2009;40(6):2068-72.
8. Yilmaz E, Akbay MÖ, Yilmaz A, Ernam D. Akut Pulmoner Embolide Ortalama Trombosit Hacmi Erken Dönem Mortaliteyi Gösteren Bir Belirteç Midir? (Is Mean Platelet Volume a Marker of Early Mortality in Acute Pulmonary Embolism?). Abant Tıp Dergisi/ Abant Medical Journal. 2021;10(3):380-7.
9. Demirkol M E, Kaya M, Kocadağ D, Özsarı E. Prognostic value of complete blood count parameters in COVID-19 patients. Northwestern Medical Journal. 2022;(2): 94-102.
10. Güven H, Çilliler A, Sarikaya S, Köker C, Çomoğlu S. The etiologic and prognostic importance of high leukocyte and neutrophil counts in acute ischemic stroke. Acta neurologica belgica. 2010;27(3): 311-18.
11. Alrafiah A, Alofi E, Almohaya Y, Hamami A, Qadah T, Almagrabi S, et al. Angiogenesis biomarkers in ischemic stroke patients. J Inflamm Res. 2021;14:4893.
12. Vagdatli E, Gounari E, Lazaridou E, Katsibourlia E, Tesikopoulou F, Labrianou I. Platelet distribution width: a simple, practical and specific marker of activation of coagulation. Hippokratia. 2010;14(1):28-32.
13. Bülbül Y, Aydin Özgür E, Örem A. Platelet indices in obstructive sleep apnea: the role of mean platelet volume, platelet distribution width and plateletcrit. Tuberk Toraks. 2016;64:206-210.
14. Jindal S, Gupta S, Gupta R, Kakkar A, Singh HV, Gupta K, et al. Platelet indices in diabetes mellitus: indicators of diabetic microvascular complications. Hematology. 2011;16(2):86-89.
15. Zhang H, Liu L, Fu S, Liu YS, Wang C, Liu T, et al. Higher platelet distribution width predicts poor prognosis in laryngeal cancer. Oncotarget. 2017;8(29):48138-144.
16. Araz O, Albez FS, Ucar EY, Kerget B, Yılmaz N, Akgün M. Predictive value of mean platelet volume for pulmonary embolism recurrence. Lung. 2017;195(4):497-502.
17. Reddy SK, Shetty R, Marupuru S, Yedavalli N, Shetty K. Significance of platelet volume indices in STEMI patients: a case-control study. J Clin Diagn Res. 2017;11(4):LC05–LC07.
18. Cetin M, Bakirci EM, Baysal E, Tasolar H, Ballı M, Çakıcı M, et al. Increased platelet distribution width is associated with ST-segment elevation myocardial infarction and thrombolysis failure. Angiology. 2014;65(8):737-43.
19. Tzur I, Barchel D, Izhakian S, Swarka M, Jehoshua OG, Krutkina E, et al. Platelet distribution width: a novel prognostic marker in an internal medicine ward. J Community Hosp Intern Med Perspect. 2019;9(6):464-70.
20. Gao F, Chen C, Lyu J, Zheng J, Ma XC, Yuan XY, et al. Association between platelet distribution width and poor outcome of acute ischemic stroke after intravenous thrombolysis. Neuropsychiatr Dis Treat. 2018;14:2233-39.
21. Sevuk U, Bahadir MV, Altindag R, Baysal E, Yaylak B, Ay N, et al. Values of serial platelet indices measurements for the prediction of pulmonary embolism in patients with deep venous thrombosis. Ther Clin Risk Manag. 2015;11:1243-49.
22. Ulucan Ş, Keser A, Kaya Z, Katlandur H, Özdil H, Bilgi M, et al. Association between PDW and long term major adverse cardiac events in patients with acute coronary syndrome. Heart Lung Circ. 2016;25(1):29-34.
23. Waseem F Al-Tameemi, Ameer MM Ameen. Significance of Platelet Indices in Patients with Acute Ischemic Stroke. Iraqi J Med Sci. 2012;10(4):383-9.
24. Zheng YY, Wang L, Shi Q. Mean platelet volume (MPV) and platelet distribution width (PDW) predict clinical outcome of acute ischemic stroke: A systematic review and meta-analysis. J Clin Neurosci. 2022;101:221-7.
25. Sönmezler A, Keşkek SO. Is mean platelet volume or platelet distribution width more associated with mortality in elderly patients with acute ischemic stroke? J Clin Res Hematol. 2018;1(2):1-3.
Download attachments: 10.4328.ACAM.21573
Mustafa Enes Demirel, Sinan Özel. The role of platelet distribution width in the diagnosis of ischemic and hemorrhagic stroke. Ann Clin Anal Med 2023;14(9):772-776
Citations in Google Scholar: Google Scholar
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/
Evaluation of attitudes and knowledge of anesthesiologists about regional anesthesia methods in ophthalmic surgery: A national survey study
Birzat Emre Gölboyu 1, Bahadir Ciftci 2
1 Department of Anesthesiology and Reanimation, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, 2 Department of Anesthesiology and Reanimation, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey
DOI: 10.4328/ACAM.21647 Received: 2023-05-13 Accepted: 2023-07-03 Published Online: 2023-07-15 Printed: 2023-09-01 Ann Clin Anal Med 2023;14(9):777-781
Corresponding Author: Birzat Emre Gölboyu, Department of Anesthesiology and Reanimation, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey. E-mail: birzatemre@windowslive.com P: +90 506 734 50 82 Corresponding Author ORCID ID: https://orcid.org/0000-0002-2011-2574
This study was approved by the Ethics Committee of Istanbul Medipol University (Date: 2020-12-10, No: 886)
Aim: The use of regional techniques in ophthalmic surgery is becoming increasingly important. Worldwide, these techniques are usually performed by ophthalmologists, while the perioperative care of patients is provided by anesthesiologists. Therefore, good communication between the surgeon and the anesthesiologist is necessary for the careful management of all techniques used in ophthalmic surgery. In this study, the willingness of anesthesiologists to assume responsibility in the use of regional techniques and their knowledge of ophthalmic nerve blocks were assessed in a national survey.
Material and Methods: A total of 23 questions were asked to assess attitudes and knowledge about regional anesthesia procedures in ophthalmic surgery, and participants had three weeks to complete the Web-based questionnaire. Complete responses from 126 physicians were analyzed.
Results: 60% of participants work in university hospitals as faculty members. Although 54.8% of participants had worked in ophthalmic surgery for 3 months or more, and 76% reported that they had not attended any lectures or seminars on regional block use in ophthalmic surgery. When asked who applied blocks in ophthalmic surgery, 95% of the participants answered the surgical team.
Discussion: The lack of theoretical and practical knowledge about ophthalmic nerve blocks is striking even among the group of physicians who practice regional anesthesia. Even if regional techniques are performed by the surgeon himself, the anesthesiologist’s responsibility in perioperative patient care cannot be ignored. For this reason, the level of knowledge of anesthesiologists on this topic should be increased through various continuing education courses.
Keywords: Multimodal Pain Management, Ophthalmic Surgery, Regional Anesthesia, Retrobulbar Block, Ophthalmic Block
Introduction
Ophthalmic surgery is one of the most common surgical procedures requiring anesthesia in developed countries. Good communication between ophthalmologist and anesthesiologist is required at all times for the careful management of all techniques used in ophthalmic surgery. Anesthetic procedures and management used in ophthalmic surgery play an important role in the safety and success of surgery [1].
Since the 1980s, anesthesiologists have been increasingly involved in ophthalmic nerve blocks previously performed by surgeons. However, because there are not enough anesthesiologists in some countries, surgeons perform the nerve block themselves. In some countries, anesthesiologists are only responsible for perioperative anesthesiologic care, as the surgeon himself performs the ophthalmic nerve block. In many developed countries (e.g., France and Australia), anesthesiologists are often responsible for administering ophthalmic nerve blocks. The same is true in the United Kingdom. However, recent cost constraints have forced health care leaders to reconsider the role of the anesthesiologist in elective ophthalmic procedures that do not require general anesthesia. Currently, there are no data to support or refute the idea that it is safer for this patient population to have ophthalmic nerve block performed by an anesthesiologist instead of a surgeon, or even to involve an anesthesiologist [2].
Today, it is common practice to provide peroperative care by an anesthesiologist after the ophthalmologist has applied ophthalmic nerve blocks. This is observed because many anesthesiologists consider themselves inadequately trained in ophthalmic block techniques. Less than 25% of anesthesiology residency programs provide hands-on clinical training in ophthalmic regional anesthesia [3]. Anesthesiologists avoid performing ophthalmic blocks because of the potential risk of perforation of the eyeball and damage to muscles and optic nerves [4].
The question arises: “Who should perform ophthalmic blocks?” in the literature. The answer to this question continues to be sought. We conducted a national survey to evaluate the attitudes and knowledge of anesthesiologists involved in regional anesthesia in Turkey about the regional anesthetic procedures used in ophthalmic surgery.
Material and Methods
Ethical approval was granted by the Medipol University Faculty of Medicine Clinical Research Ethics Committee with the decision of the Ethics Committee dated 10/12/2020 and number 886.
For our survey study, questions were prepared using the technique of multiple-choice questions and a five-choice Likert-type scale. Care was taken to ensure that the response options were unbiased and did not influence participants’ responses. Private information such as participants’ last names, first names, and the name of the institution was not requested. An informational letter about the purpose and nature of the survey was given to participants in the introductory section of the survey. In our survey, participants were asked a total of 23 questions, 5 of which were related to demographic data. The first five questions were questions about age, gender, health facility, and title information to assess demographic data. Other questions were asked to assess participants’ attitudes and knowledge about regional anesthesia procedures used in ophthalmic surgery.
It was determined that the Web-based questionnaire (https://forms.gle/tNdqzXpwdsNiaqoV8) would close for responses after three weeks. The Regional Anesthesia Association assisted us in informing the specialists who were more interested in regional anesthesia in Turkey and sending the questionnaire to their e-mail addresses. The questionnaires were sent to approximately 526 physicians who were registered members of the Regional Anesthesia Association mail group at the time in question and had an e-mail address, regardless of title and institution.
Statistical analysis
The data obtained were analyzed in a computer environment using the SPSS 22.0 statistical package (SPSS Inc., Chicago IL, USA). Frequency distributions were calculated and shown as n (%).
Ethical Approval
Ethics Committe approval for the study was obtained.
Results
One hundred twenty-six physicians responded to the electronic questionnaire that we shared with the Regional Anesthesia Association postal group, and these responses formed the study population. Looking at the demographics of the study participants, those in the 30-40 age group accounted for 40.5% of all participants. Faculty members accounted for 60%, those with more than 20 years of experience accounted for 28.5%, and those working at the university hospital accounted for 59.5% (Table 1).
In the anesthesia training and experience questions, the time spent on ophthalmic surgery was found to be 54.8% in those with > 3 months. The rate of use of peribulbar, subtenonal, and retrobulbar blocks was quite low in the group of physicians who participated in the study, and the subconjunctival block was never used by participants. Physicians involved in regional anesthesia reported that they were observers in 68% of ocular block applications (Table 1).
In the questions asked about theoretical training and seminar topics in anesthesia specialization training, 76.2% answered “no” to the question of whether you attended lectures/seminars, etc., on regional block applications in ophthalmic surgery. At the national congresses, the attendance rate for the session on the regional block in ophthalmic surgery was 15%. 48% of participants answered the question that sessions on regional blocks in ophthalmic surgery should be included in national congresses (Table 2).
To the questions asked about clinical functioning and perioperative management: “Who applies regional anesthetic blocks in ophthalmic surgery at your institution?” 95.2% of respondents answered that ophthalmic surgeons perform the blocks. “Have you been asked by ophthalmic surgeons to perform a block?” All participants answered “no” to this question. When asked who should perform the eye blocks, 59.5% of participants responded that they should be performed by ophthalmic surgeons. Responses to the questions about monitorization and sedation of patients undergoing regional anesthetic block in ophthalmic surgery are shown in detail in Table 2.
The answers to the Likert-type questions regarding the level of knowledge about anatomy, physiology, pharmacology, appropriate indications, and complications of ophthalmic regional anesthesia are shown in Table 3.
Discussion
In our study, it was found that the majority of participants almost never performed ophthalmic blocks and they considered their own level of knowledge about anatomy, physiology, pharmacology, appropriate surgical indications, and complications related to these blocks to be inadequate. The rotation period was defined as anesthesia (2 months) in ophthalmic surgery, according to the Core Curriculum of the Residency Committee Curriculum and Standard System, Anesthesia and Resuscitation Training in Residency; the degree of competence in anesthesia for intraocular surgery was defined as 4 (expresses the degree of ability to perform the procedure in all types of cases, whether it is complex or not). However, this article does not report the degree of competence specifically for eye blocks. Looking at the results of our study, all participants completed the appropriate rotations. However, since the anesthesiologist is not responsible for the implementation and follow-up of these blocks in the hospitals, we can conclude that the participants feel inadequate in terms of clinical practice and knowledge level.
Anesthesiologists are theoretically best suited to perform nerve blocks, provide monitored patient care, and manage life-threatening complications. Anesthesiologists have demonstrated the ability to perform eye blocks like other regional anesthetic techniques when properly trained [5]. Furthermore, ‘’who should perform these blocks?’’ the answer to the question “This should be performed by ophthalmologists” was given. Although this situation places the responsibility for performing the block on the surgeon, it does not relieve the anesthesiologist of the responsibility to recognize and manage the complications associated with the technique used. Participants reported insufficient knowledge of anatomy, physiology, pharmacology, specific indications, and complication management associated with blocks in ophthalmic surgery. Therefore, anesthesiologists in the responses in the study did not tend to share responsibility for the use of ocular blockade to a high degree with the surgeon.
Ophthalmologic local anesthesia dates back to the time of Koller and Knapp. They described local anesthesia and early retrobulbar block surgery with 5% cocaine. Since then, local anesthesia for ophthalmic surgery has undergone several changes, including retrobulbar, peribulbar, sub-tenon, subconjunctival, deep fornix and topical anesthesia. [6]. Lack of training and education seem to be the main reasons why anesthesiologists do not want to use these techniques.
Both intraocular procedures and extraocular procedures can be performed under local anesthesia, but anesthetic techniques vary. For other ophthalmic surgical procedures that require complete anesthesia and immobility, an injection technique such as peribulbar or retrobulbar block or sub-Tenon block is required. Although the sub-tenon block is gaining popularity and is widely used in certain parts of the world, the retrobulbar block remains the most commonly practiced technique in many developed and developing countries [1].
In 1934, Atkinson [7] described the classic retrobulbar block, in which patients look upward and inward. It is administered by injecting 2 to 3 ml of local anesthetic very close to the optic nerve. Akinesia and analgesia are achieved quickly, but blockade of the facial nerve is required for blockade of the orbicularis oculi muscle. Both retrobulbar and facial nerve blocks are associated with significant complications, and the technique has recently been modified [8].
In modern retrobulbar block, topical anesthesia (oxybuprocaine or similar eye drops) is required for perconjunctival injection. Four-five ml of local anesthetic is injected with the needle pointing upward and inward, but tangential to the globe. Separate facial nerve block is not required [9]. Peribulbar block has been established as an alternative to retrobulbar block. Here, 5 to 6 ml of local anesthetic is injected outside the muscle cone. The technique is essentially very similar to the retrobulbar block, except that the needle is not directed upward and inward [10].
In the sub-Tenon’s block technique, the local anesthetic is injected between the Tenon’s capsule and the sclera with a blunt cannula. This block is also known as parabulbar block, pin-point anesthesia, and episcleral block. A lower Tenon needle is inserted carefully along the curve of the eyeball; never use excessive force. The injected local anesthetic (4 to 5 ml) is diffused into and around the intraconal space. Anesthesia and immobility are achieved with this application. Sub-tenon blockade has been reported to have complications similar to other blockades [11].
2% lidocaine provides rapid, intense sensory and motor blockade, and the duration of action is usually sufficient to perform cataract surgery. On the other hand, 0.5% bupivacaine can be used for longer procedures such as vitreo-retinal surgery because it has a longer duration of action. [12, 13]. Retrobulbar, peribulbar and sub-Tenon’s blockade with Hyaluronidase have been shown to shorten the insertion time and improve its quality [10].
If we look at systemic complications due to ophthalmic blocks, toxicity of local anesthetics and vasovagal reactions are the most common systemic complications associated with local anesthesia. Hyaluronidase, an adjuvant used to improve block formation and quality, can rarely cause allergic reactions [14]. Accidental intra-arterial injection of local anesthetic for brainstem anesthesia may result in retrograde flow of the anesthetic from the ophthalmic artery into the cerebral artery or internal carotid artery, leading to injection of the anesthetic into the central nervous system. Signs and symptoms include severe tremor, contralateral vision loss, unconsciousness, apnea, hemiplegia or quadriplegia [15].
Blockage of the eighth to twelfth cranial nerves results in deafness, tinnitus, vertigo, dysarthria, dysphagia, and aphasia. These symptoms are prominent manifestations of the spread of local anesthetic into the cerebrospinal fluid, but may occur in combinations with different clinical manifestations, and the anesthesiologist should be alert and prepared to perform cardiopulmonary resuscitation [16, 17]. Most of the participants reported that they had no role in complication management and that they experienced low rates of complications during the procedures for which they were present as observers.
Therefore, careful selection and monitoring of patients is important. Monitoring should begin before blockade is applied and continue until the surgical procedure is completed. Probably the most important monitoring is the communication with an anesthesiologist who is in constant contact with the patient. Patient’s hand can be held for communication and reassurance. Pulse oximetry, electrocardiogram, and noninvasive blood pressure monitoring are sufficient for most procedures [18, 19].
With careful patient selection, information, patient-doctor trust, and a compassionate approach, most patients accept ophthalmic surgery under local anesthesia. Although there are participants who are unaware of hospital practices for monitoring and follow-up of patients who have undergone regional anesthesia in ophthalmic surgery, monitoring is generally performed, but sedation has been observed to be performed to a lesser extent [20,21].
The limitations of our study: due to the current pandemic conditions, the sample size could be larger for face-to-face congresses and symposia with high attendance. In addition, we think it would be more appropriate to contact the Association of Ophthalmologists and conduct descriptive or comparative studies with a larger number of participants on both groups of physicians. In addition, we believe that the heavy workload that the pandemic brought to anesthesiologists may have imposed a limitation on their experience with these regional techniques through direct observation and the expansion of knowledge through their applied training.
Conclusions
Even among the group of anesthesiologists involved in regional anesthesia, the lack of theoretical knowledge and practical application in ophthalmic nerve blocks is striking. Awareness and knowledge of these blocks can be improved through in-clinic seminars, theoretical courses, practical block applications on cadavers, and congresses, or these applications should continue to be performed exclusively by ophthalmologists as a continuation of the current practice in our country. However, the main responsibility of the anesthesiologist cannot be ignored when it comes to the management of complications that may occur even if the surgeon performs the nerve block. Therefore, even if it is not self-applying, the goal should be to increase the basic level of knowledge regarding the block technique, the field of application, and possible complications and mechanisms.
Scientific Responsibility Statement
The authors declare that they are responsible for the article’s scientific content including study design, data collection, analysis and interpretation, writing, some of the main line, or all of the preparation and scientific review of the contents and approval of the final version of the article.
Animal and human rights statement
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. No animal or human studies were carried out by the authors for this article.
Funding: None
Conflict of interest
None of the authors received any type of financial support that could be considered potential conflict of interest regarding the manuscript or its submission.
References
1. Leaming DV. Practice styles and preferences of ASCRS members-2003 survey. J Cataract Refract Surg. 2004;30(4):892-900.
2. EKe T, Thompson JR. The national survey of local anaesthesia for ocular surgery. II. Safety profiles of local anaesthesia techniques. Eye. 1999;13(2):196-204.
3. Miller-Meeks MJ, Bergstrom T, Karp KO. Prevalent attitudes regarding residency training in ocular anesthesia. Ophthalmology. 1994;101(8):1353-6.
4. Grizzard WS, Kirk NM, Pavan PR, Antworth MV, Hammer ME, Roseman RL. Perforating ocular injuries caused by anesthesia personnel. Ophthalmology. 1991;98(7):1011-6.
5. Ripart J, Nouvellon E, Chaumeron A. Regional anesthesia for eye surgery. Reg Anesth Pain Med. 2005;30(1):72-82.
6. Nørregaard JC, Schein OD, Bellan L, Black C, Alonso J, Bernth-Petersen P, et al. International variation in anesthesia care during cataract surgery: results from the International Cataract Surgery Outcomes Study. Arch Ophthalmol. 1997;115(10):1304-8.
7. Atkinson WS. Local anesthesia in ophthalmology. Trans Am Ophthalmol Soc. 1934;32:399.
8. Kumar CM, Dowd TC. Complications of ophthalmic regional blocks: their treatment and prevention. Ophthalmologica. 2006;220(2):73-82.
9. Kumar CM, Dodds C. Ophthalmic regional block. Ann Acad Med Singap. 2006;35(3):158-67.
10. Palte HD. Ophthalmic regional blocks: management, challenges, and solutions. Local Reg Anesth. 2015;8:57-70.
11. Kumar C, Williamson S, Manickam B. A review of sub-Tenon’s block: current practice and recent development. Eur J Anaesthesiol.2005;22(8):567-77.
12. Aksu R, Bicer C, Ozkiris A, Akin A, Bayram A, Boyaci A. Comparison of 0.5% levobupivacaine, 0.5% bupivacaine, and 2% lidocaine for retrobulbar anesthesia in vitreoretinal surgery. Eur J Ophthalmol. 2009;19(2):280-4.
13. Borazan M, Karalezli A, Akova Y, Algan C, Oto S. Comparative clinical trial of topical anaesthetic agents for cataract surgery with phacoemulsification: lidocaine 2% drops, levobupivacaine 0.75% drops, and ropivacaine 1% drops. Eye. 2008;22(3):425-9.
14. Ahluwalia H, Lukaris A, Lane C. Delayed allergic reaction to hyaluronidase: a rare sequel to cataract surgery. Eye. 2003;17(2):263-6.
15. Hamilton RC. A discourse on the complications of retrobulbar and peribulbar blockade. Can J Ophthalmol. 2000;35(7):363-72.
16. Cyriac IC, Roberto Pineda I. Postoperative complications of periocular anesthesia. Int Ophthalmol Clin. 2000;40(1):85-91.
17. George RB, Hackett J. Bilateral hearing loss following a retrobulbar block. Can J Anaesth. 2005;52(10):1054-7.
18. Astbury N. A hand to hold: communication during cataract surgery. Eye. 2004;18(2):115-6.
19. Checketts M, Alladi R, Ferguson K, Gemmell L, Handy J, Klein A, et al. Recommendations for standards of monitoring during anaesthesia and recovery 2015: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia. 2016;71(1):85-93.
20. Katz J, Feldman MA, Bass EB, Lubomski LH, Tielsch JM, Petty BG, et al. Adverse intraoperative medical events and their association with anesthesia management strategies in cataract surgery. Ophthalmology. 2001;108(10):1721-6.
21. Greenhalgh D, Kumar C. Sedation during ophthalmic surgery. Eur J Anaesthesiol|. 2008;25(9):701-7.
Download attachments: 10.4328.ACAM.21647
Birzat Emre Gölboyu, Bahadir Ciftci. Evaluation of attitudes and knowledge of anesthesiologists about regional anesthesia methods in ophthalmic surgery: A national survey study. Ann Clin Anal Med 2023;14(9):777-781
Citations in Google Scholar: Google Scholar
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/
Relationship of chronotype and sleep quality with crime in schizophrenia patients in the high-security forensic psychiatry clinic
Burcu Sırlıer Emir 1, Aslı Kazgan Kılıçaslan 2, Sevler Yıldız 3, Osman Kurt 4
1 Department of Psychiatry, Elazığ Fethi Sekin City Hospital, Elazığ, 2 Department of Psychiatry, Bozok University, Yozgat, 3 Department of Psychiatry, Binali Yıldırım University, Erzincan, 4 Department of Public Health, Adıyaman Provincial Health Directorate, Adıyaman, Turkey
DOI: 10.4328/ACAM.21729 Received: 2023-04-15 Accepted: 2023-05-30 Published Online: 2023-06-09 Printed: 2023-09-01 Ann Clin Anal Med 2023;14(9):782-787
Corresponding Author: Burcu Sırlıer Emir, Department of Psychiatry, Elazığ Fethi Sekin City Hospital, 23100, Elazığ, Turkey. E-mail: bsirlier@hotmail.com P: +90 424 606 60 00 F: +90 424 238 76 58 Corresponding Author ORCID ID: https://orcid.org/0000-0002-3389-5790
This study was approved by the Clinical Research Ethics Committee of Firat University (Date: 2021-12-16, No: 2021/13-20)
Aim: It has been reported that schizophrenia (SZ) patients had poor sleep quality and displayed evening chronotype, and certain behavioral differences had been observed between chronotypes. In this study, we aimed to compare chronotype and sleep quality in criminal SZ patients and to examine the correlation of chronotype with crime types.
Material and Methods: Ninety-one criminal SZ patients and 91 healthy controls were included. Participants were administered the Positive and Negative Syndrome Scale (PANSS), Pittsburgh Sleep Quality Index (PSQI), and the Morningness – Eveningness Questionnaire (MEQ).
Results: While 28.6 % of the patient group were evening-, 36.3 % were intermediate- and 35.2% waere morning-type, it was seen that 8.8% of the control group were evening-, 31.9% were intermediate- and 59.3% were morning-type, and a significant difference was observed between them (p<0.001). The sleep quality in the patient group was significantly lower than in the control group (p<0.001). In the patient group, the crime rate between 24:00 and 06:00 was found to be significantly higher among evening types compared to other types (p<0.001).
Discussion: Criminal schizophrenia patients are of the evening type compared to the control group and have poor sleep quality. Corrective interventions for sleep and chronotype in SZ patients may change the rates and nature of crimes.
Keywords: Sleep, Schizophrenia, Chronotype, Circadian Rhythms, Crime
Introduction
The largest diagnostic group among medical conditions, accompanied by sleep-related complaints, consists of mental conditions. An average of 50-80 % of persons with a mental condition have sleep disorders and approximately 50 % of patients with sleep disorders are diagnosed with a mental condition. One of such conditions is schizophrenia (SZ). Depending on the severity of the condition, sleep disorder is seen in approximately 30-80 % of SZ patients [1,2].
Sleep-related complaints since the first drug-free episode in SZ patients, which is a patient group, open to polypharmacy, suggest that patients have sleep problems independently from pharmaceutical treatment [1,2]. Polysomnographic changes, such as poor sleep quality and delay in REM sleep, decrease in REM intensity, and delayed onset of sleep have been observed in SZ patients [1,3]. In SZ patients, it has been shown that bad sleep quality was associated with increased positive and negative symptoms, worsened cognitive performance, decreased quality of life and decreased treatment response [2,4]. One of the physiological concepts, affecting sleep, is the chronotype.
Chronotype is a reflection of the endogenous circadian rhythm of an individual, which defines the time of physiological functions, including sleep. It has been reported that 60 % of adults were of “intermediate type” and the remaining 40 % were of “morning-type” or “evening-type” [5]. Chronotype subgroups, determined to be associated with psychiatric disorders, as well as physical conditions, have been studied in persons, demonstrating substance abuse disorders, anxiety disorders, attention deficit hyperactivity disorder, mood disorders, and it has been found that predominant subtypes were related with diseases [6]. It has been shown that evening-type chronotype was associated with mental conditions, in particular mood disorders (depressive disorders, bipolar disorder), yet a recent meta-analysis, similar to mood disorders, has demonstrated that SZ patients predominantly were of evening type compared to controls, and this could be a risk factor for SZ [7]. In a genomic study with extensive sampling, based on the hypothesis that chronotype could have an effect on the pathophysiology of schizophrenia, it has been shown that possession of morning chronotype was associated with a decrease in the risk of schizophrenia [8].
There are studies, in which differences in terms of psychopathology have been observed between chronotypes. For example, it has been determined that the evening type was more inclined to impulsivity, carelessness, aggressive behavior, crime and social problems [9]. In detailed compilations by Casey et al., an association between the evening type and aggressiveness has been reported. The transformation of chronotype tendency to a strong shift towards evening with the onset of puberty, has been explained by limbic system dominance and the process of maturation of the prefrontal cortex [10]. As a consequence of low executive function, impulsive responses and weak judgment are characteristics that are also observed in SZ patients, and in this sense, they have a similar neurobiological infrastructure with adolescence [7]. What are the chronotype characteristics in SZ patients, who have committed “crimes,” which are indicators of aggressiveness?
Despite the presence of studies in the literature, which have examined chronotypes and sleep quality in schizophrenia patients and reported different results, to the best of our knowledge, there are no data in the literature concerning chronotypes for forensic psychiatric patients, who have committed a crime. As far as we know, there are no data concerning the time of the day at which the crimes had been committed by these patients. The objective of the study is to compare chronotype and sleep quality in schizophrenia patients, treated in an inpatient setting at High-Security Forensic Psychiatry (HSFP) Clinic with healthy controls and to examine the relationship with the nature and time of crime.
Material and Methods
The study was approved by the Firat University Clinical Research Ethics Committee (Date: 16 December 2021. Number: 2021/13-20). While calculating the sample of the study, the G*Power 3.1.9.2 program was used and the study “Quality of sleep in patients with schizophrenia is associated with quality of life and coping” was taken as a reference [11]. Accordingly, it was determined that at least 70 people, at least 35 with schizophrenia and 35 healthy groups should be reached with a 95% confidence interval and 95% power (Effect size=0.878).
Patients, who have been admitted to Elazığ Fethi Sekin City Hospital HSFP Clinic with schizophrenia diagnosis according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) and inpatients who satisfied the study criteria, were included. One hundred and thirty SZ patients were available for study; yet among these, eighteen were excluded due to a change of psychotropic treatment regime within the last 2 months, fifteen were excluded due to accompanying alcohol and substance use disorders, four were excluded due to non-completion of forms, and two due to discharge before completion of forms, and a total of 91 schizophrenia patients were included in the study. Ninety-one healthy controls with no psychiatric conditions according to DSM-5 have been included in the study. In the sleep routine of the clinic, all patients are taken to their rooms at 10:00 in the evening to sleep, and the staff wakes them up at 7 in the morning.
Our study is a descriptive study with case-control nature. The study was conducted in Elazığ Fethi Sekin Hospital HSFP Clinic following ethics committee approval. After a full description of the study, all participants gave written informed consent according to the Helsinki Declaration. Evaluations, structured according to DSM-5, were made by a psychiatry specialist. All participants were administered a socio-demographic data form, the Positive and Negative Syndrome Scale (PANSS), the Pittsburgh Sleep Quality Index (PSQI), the Morningness-Eveningness Questionnaire (MEQ). Questionnaire completion process has taken an average of 30-40 minutes.
The inclusion criteria for patients were age between 18 and 65, schizophrenia diagnosis according to DSM-5 diagnostic criteria, a conviction under the Turkish Criminal Code (TCC), no accompanying psychiatric conditions, continuing hospitalization in HSFP clinic, no cognitive dysfunction and medical obstacles, precluding the completion of form and affecting the distribution of existing psychiatric symptoms (such as dementia, epilepsy, cerebrovascular disease, history of head trauma), no alcohol and substance abuse disorder diagnosis within the last 6 months, the signed informed consent form, no mental retardation, no changes in psychotropic treatment regime within the last two months, no sleep disorder diagnosis according to DSM-5 (such as sleep terror, parasomnia, sleep paralysis, narcolepsy). Those who received hypnotic drugs in hospitalized patients were not included, but those who took sedative antipsychotic drugs were not excluded.
Data Collection Instruments
Socio-demographic Data Form: It was developed by the authors based on the aim of the study. The form aimed to collect demographic data such as age, marital status, education level, residency, employment, and economic status, and clinical evaluation data such as inpatient treatment anamnesis, smoking or alcohol use.
Morningness-Eveningness Questionnaire (MEQ): MEQ, created by Horne and Östberg [12] is a tool for determining chronotypes, designated as ‘morning-type,’ ‘intermediate’ and ‘evening-type.’ If the score, calculated in the scale is between 16 and 41, this shows ‘evening-type’ chronotype, if it is between 42-58, the ‘intermediate type chronotype’ and if it is between 59-86, the ‘morning-type chronotype.’
Pittsburgh Sleep Quality Index (PSQI): This is a 19-item self-report scale, developed by Buysse et al. [13] evaluating the sleep quality and disorders in the previous month. Any score above 5 shows poor sleep quality.
Positive and Negative Syndrome Scale (PANNS): This is a 30-item scale, developed by Kay et al. [14] with 7 items related to the positive symptom subscale, 7 items, related to the negative symptom subscale and the remainder 16 to general psychopathology subscale. It is expressed as a total score and varies between 30 and 210.
Data analysis
In the evaluation of findings, provided in the study, SPSS (Statistical Package for Social Sciences) for Windows 22.0 program was used for statistical analyses. In the study, descriptive data have been shown as n, % values in categorical data, and in continuous data, as mean±standard deviation (Mean±SD) values. In the comparison of categorical variables between groups, chi-square analysis (Pearson Chi-Square) was applied. The consistency of continuous variables with normal distribution was evaluated with the Kolmogorov-Smirnov test. When comparing two groups, Student’s t-test was used and when comparing more than two groups, the One-Way ANOVA test was used. In order to determine the source of significance, the Tukey test was used as a post-hoc analysis. Significance was considered at a level of p<0.05.
Ethical Approval
Ethics Committee approval for the study was obtained.
Results
A total of 182 participants, including 91 patients and 91 controls, were included in the study. There were no significant differences between the groups with respect to socio-demographic characteristics (other than prevalence of psychiatric conditions (68.1 %), history of suicide (6.6 %) and smoking (67 %)) (p>0.05) (Table 1).
Twenty-one patients (23.1%) had a diagnosis term of less than 5 years, 28 (30.8%) between 5-10 years and 42 (46.2 %) greater than 10 years; 29 patients (31.9 %) had been admitted to HSFP Clinic for observation and 62 (68.1 %) for protection. While 70 patients (76.9%) had been admitted to HSFP once, twelve (9.9 %) had been admitted twice and 9 (9.9%) had been admitted three or more times, 25 (27.5%) did not have non-HSFP psychiatric hospitalization, 29 (31.9 %) had 1-2 and 37 (40.7%) had 3 or more non-HSFP psychiatric hospitalizations.
Twenty-eight patients (30.8%) had committed bodily injury, 9 (9.9 %), sexual offenses, 8 (8.8%) murder, 3 (3.3%) insulting, 23 (25.3 %) other offenses (theft, property damage, intimidation, slander, plunder) and 20 (22%) have committed multiple crimes (Figure 1).
While 28.6 % of the patient group were evening-type, 36.3 % were intermediate and 35.2 % were morning-type, it was seen that 8.8 % of the control group were evening-type, 31.9 % were intermediate and 59.3 % were morning-type and a significant difference was observed between the groups (p<0.001). Accordingly, it can be said that the patient group was the evening-type and the control group was the morning-type. By taking cut-off value according to PSQI, as 5, the good sleep quality in the patient group (39.6 %) was significantly lower than good sleep quality in the control group (75.8%) (p<0.001). Accordingly, the sleep quality in the patient group was lower (Table 2).
It was determined that there was no significant difference among patients’ MEQ categories and sleep qualities in terms of PANSS scores (p>0.05). There was no significant difference in terms of PANNS-positive between the MEQ categories in the patient group (p=0.381) (dual p values: evening-mid=0.722; evening-morning=0.851; mid-morning=0.350). There was no significant difference in terms of PANNS-negative between the MEQ categories in the patient group (p=0.746) (dual p-values: evening-mid=0.728; evening-morning=0.872; mid-morning=0.960). There was no significant difference in terms of PANNS-total between the MEQ categories in the patient group (p=0.700) (dual p-values: evening-mid=0.954; evening-morning=0.690; mid-morning=0.839).
It was observed that 25 % of patients were convicted for bodily harm, 11.1 % for sex offenses and 62.5 % for murder and 47.8 % for other crimes, and 10 % of those were convicted for multiple crimes and were found as evening-type. There was a significant difference between crimes in terms of chronotype (p=0,038). There was no significant difference between the duration of schizophrenia diagnosis (p=0.132) and the number of admissions to HSFP (p=0.238) in terms of chronotype (Table 3).
In the patient group, the crime rate between 24:00 and 06:00 was found to be significantly higher among evening types (57.7%) compared to intermediate (9.1%) and morning types (6.3%) (p<0.001).
Discussion
In our study, it was seen that 36.3% of criminal SZ patients were of intermediate type, consistent with the general population, followed by morning types with 35.2 % and evening types with 28.6%. However, when we compared SZ patients with healthy controls, they had significant evening type. We may say that criminal SZ patients were of evening-type, compared to healthy persons. When evening-type is broadly considered in combination with neurophysiological and environmental factors, it has been generally shown as tendency to impulsivity, aggressive behavior and crime [9]. At the same time, it is reported that evening-type demonstrates intensive psychopathological bias with mediator factors, such as difficulties in mood regulation and disturbed reward pathway and impulsivity [5]. In addition to these, sleep qualities of patients in our study were significantly worse compared to healthy controls. Poor sleep qualities in SZ patients have been previously reported. Independently from relapse and remission phases in these patients, poor sleep quality has been shown both with scales and polysomnographic changes [1,3]. We provided similar findings among SZ patients in HSFP.
As another finding of our study, the presence of evening-type chronotype in 62.5 % of SZ patients who were treated at HSFP Clinic due to murder was striking. It is known that there are phase differences between chronotypes in the secretion of hormones, such as physiological adrenalin, melatonin and cortisol, which play a crucial role in response to stress [15]. Also, neurological, cognitive and behavioral performances vary in individuals depending on chronotypes. Both with this aspect and effects on sleep, chronotype may pave the way for loss of control in emotional reactions. In this respect, chronotype may have a direct effect on “committing a crime.” On the other hand, it is known that poor sleep deteriorated stabilization of affection and increased the emotional reaction rate [16]. It has been reported that poor sleep quality was related to hostile and aggressive behavior and aggressiveness and loss of sleep affected prefrontal cortical functionality and could cause mitigation of behavioral reaction inhibition [17]. When all these are considered together, high levels of emotional reactivity may be expected from SZ patients in the study, who have poor sleep quality, together with a neurophysiological deficiency. From this aspect, our study shows promise for future studies, concerning the effects of chronotypes on crimes.
Limitations and Strengths
The strong point of our study is that it is the first study, examining the relationship between chronotypes and crime in SZ patients and the findings can provide inspiration for future studies. Restrictions of our study are the selection of samples from a single center and the inclusion of patients also in the psychotic attack phase. Since sleep quality may also be affected in psychotic attacks, we have to state that this issue must be considered in the results of the study.
Conclusion
In conclusion, criminal schizophrenia patients are of evening type compared to the control group and have poor sleep quality. Evening-type patients predominantly commit crimes after midnight. A difference was seen between chronotypes in terms of the nature of the crime. Schizophrenia patients, who have committed murder, predominantly have evening chronotype. Chronotype itself may have an effect on crime. However, it must be considered that chronotype is a rhythm, which may be affected by factors, such as age, gender, heredity, and environment [5]. Future studies, involving biological, psychosocial and individual factors, are required. Chronotype-crime relationship in SZ patients, which is poorly known, may provide a new perspective to forensic psychiatry and corrective interventions in these patients, related to sleep and chronotype may allow mitigation of crime rates.
Scientific Responsibility Statement
The authors declare that they are responsible for the article’s scientific content including study design, data collection, analysis and interpretation, writing, some of the main line, or all of the preparation and scientific review of the contents and approval of the final version of the article.
Animal and human rights statement
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. No animal or human studies were carried out by the authors for this article.
Funding: None
Conflict of interest
None of the authors received any type of financial support that could be considered potential conflict of interest regarding the manuscript or its submission.
References
1. Chan MS, Chung KF, Yung KP, Yeung WF. Sleep in schizophrenia: a systematic review and meta-analysis of polysomnographic findings in case-control studies. Sleep Med Rev. 2017;32: 69–84.
2. Hofstetter JR, Lysaker PH, Mayeda AR. Quality of sleep in patients with schizophrenia is associated with quality of life and coping. BMC Psychiatry. 2005;5(1): 13.
3. Meyer N, Faulkner SM, McCutcheon RA, Pillinger T, Dijk DJ, MacCabe JH. Sleep and circadian rhythm disturbance in remitted schizophrenia and bipolar disorder: a systematic review and meta-analysis. Schizophr Bull. 2020;46(5): 1126–43.
4. Ritsner M, Kurs R, Ponizovsky A, Hadjez J. Perceived quality of life in schizophrenia: Relationships to sleep quality. Qual Life Res. 2004;13(4): 783–91.
5. Adan A, Archer SN, Hidalgo MP, Di Milia L, Natale V, Randler C. Circadian typology: A comprehensive review. Chronobiol Int. 2012;29(9): 1153–75.
6. Taylor BJ, Hasler BP. Chronotype and mental health: recent advances. Curr Psychiatry Rep. 2018;20(8): 1-10.
7. Linke M, Jankowski KS. Chronotype in individuals with schizophrenia: A meta-analysis. Schizophr Res. 2021;235: 74-9.
8. Jones SE, Lane JM, Wood AR, van Hees VT, Tyrrell J, Beaumont RN, et al. Genome-wide association analyses of chronotype in 697,828 individuals provides insights into circadian rhythms. Nat Commun 2019;10(1): 1–11.
9. Gau SS, Shang CY, Merikangas KR, Chiu YN, Soong WT, Cheng AT. Association between morningness-eveningness and behavioral/emotional problems among adolescents. J Biol Rhythms. 2007;22(3): 268-74.
10. Casey B, Jones RM, Hare TA. The adolescent brain. Ann NY Acad Sci. 2008;1124: 111-26.
11. Hofstetter JR, Lysaker PH, Mayeda AR. Quality of sleep in patients with schizophrenia is associated with quality of life and coping. BMC Psychiatry. 2005;5: 13.
12. Horne JA, Ostberg O. A self assessment questionnaire to determine Morningness Eveningness in human circadian rhythms. Int J Chronobiol. 1976;4(2): 97–110.
13. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989; 28(2): 193-213.
14. Kay SR, Opler LA, Lindenmayer JP. Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Res. 1988;23(1): 99–110.
15. Selvi Y, Beşiroğlu L, Aydın A. Chronobiology and mood disorders. Psychiatry Interpers Biol Process. 2011;3: 368-86.
16. Anderson C, Platten CR. Sleep deprivation lowers inhibition and enhances impulsivity to negative stimuli. Behav Brain Res. 2011;217(2): 463-6.
17. Yoo SS, Gujar N, Hu P, Jolesz FA, Walker MP. The human emotional brain without sleep—a prefrontal amygdala disconnect. Curr Biol. 2007;17(20): R877-8.
Download attachments: 10.4328.ACAM.21729
Burcu Sırlıer Emir, Aslı Kazgan Kılıçaslan, Sevler Yıldız, Osman Kurt. Relationship of chronotype and sleep quality with crime in schizophrenia patients in the high-security forensic psychiatry clinic. Ann Clin Anal Med 2023;14(9):782-787
Citations in Google Scholar: Google Scholar
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/
Electrophysiological severity of carpal tunnel syndrome and body composition measurement
Nuray Can Usta 1, Gökhan Peker 2
1 Department of Neurology, 2 Department of Orthopedia, University of Health Sciences, Trabzon Kanuni Training and Research Hospital, Trabzon, Turkey
DOI: 10.4328/ACAM.21748 Received: 2023-05-07 Accepted: 2023-06-12 Published Online: 2023-07-08 Printed: 2023-09-01 Ann Clin Anal Med 2023;14(9):788-792
Corresponding Author: Nuray Can Usta, Department of Neurology, University of Health Sciences, Trabzon Kanuni Training and Research Hospital, 61040, Trabzon, Turkey. E-mail: dr.nuraycan@hotmail.com P: +90 505 886 06 08 Corresponding Author ORCID ID: https://orcid.org/0000-0001-9238-1194
This study was approved by the Clinical Research Ethics Committee of Health Sciences University Kanuni Training and Research Hospital (Date: 2022-01-31, No: 2022/16)
Aim: In this study, it was aimed to determine the relationship between electrophysiological severity findings and body composition measurement (BCM) in patients with carpal tunnel syndrome (CTS).
Material and Methods: In this retrospective study, electromyography (EMG)-diagnosed CTS patients who had BCM were evaluated. In addition to general demographic data, total fat mass (TFM), total lean mass (TLM), total muscle mass (TMM), arm fat mass (AFM), arm lean mass (ALM) and arm muscle mass (AMM) data were recorded. According to their electrophysiological results, CTS patients were divided into three groups: mild, moderate, and severe.
Results: The study group consisted of 186 hands of 100 CTS patients. A significant association was detected between the increase in TFM (p<0.01), AFM (p<0.01), ALM (p=0.041), and AMM (p=0.029) among the BCM data and disease severity. There was a difference between CTS patient groups in terms of TFM, AFM, ALM and AMM values (p<0.001). A significant but weak negative correlation was found between TFM and AFM and the median nerve EMG study (p<0.05).
Discussion: Our results revealed that the relationship between CTS disease severity and BMI increased not only with total adiposity in the body, but also with lean and muscle mass in the arm, especially in the arm fat mass. An increase in AFM value may help as a follow-up or predictive metric for the CTS.
Keywords: Carpal Tunnel Syndrome, Body Composition Measurements, Electromyography, Obesity
Introduction
Carpal tunnel syndrome (CTS) is the most common form of peripheral nerve entrapment neuropathy [1]. This condition occurs due to the compression of the median nerve in the carpal tunnel [2]. The prevalence is approximately 1- 6% in the adult population [3]. Patients complain of wrist and arm pain due to paresthesia in the hand [4]. CTS is typically bilateral both clinically and electrically. Women are affected more often than men. Paresthesia complaints related to CTS occur during routine activities such as driving a car, holding a phone, book or newspaper or at night [5].
It is known that the risk of developing CTS increases in occupations or activities that require repeated hand use. Other risk factors for CTS include advanced age, pregnancy, systemic illnesses, including thyroid disease and diabetes, local causes such as rheumatic diseases, and occupational exposure [6,7]. Obesity is another etiological factor for CTS [8]. The most used method for obesity assessment is body mass index (BMI, kg/m2). BMI ≥ 30 is defined as obesity [9]. In different studies, it has been reported that waist circumference measurements, anthropometric measurements, may be effective as an alternative to BMI in predicting obesity risk [10,11]. Although waist circumference and BMI measurement provide information about the overall increase in adipose tissue, they cannot provide detailed data on local fat and muscle mass. Another method used to assess obesity in recent years is body composition measurement (BCM) [8]. BCM is used to assess the relationship between nutritional supplements and cardiovascular diseases, osteoporosis, and osteoarthritis, as well as a marker for athletic health and performance [9-12]. BCM is a non-invasive method that evaluates lean mass and muscular mass, which cannot be evaluated by measuring BMI and waist circumference assessment [13].
There are limited studies examining the relationship between electrophysiological severity of CTS and body composition measurements [14-16]. These studies have shown that there is a relationship between personal anthropometric measurements and the severity of CTS. It was concluded that the use of multiple obesity indices would be useful in reconstructing the relationship between CTS and body composition. BMI is mostly used in previous studies examining the relationship between obesity and CTS. In this study, we aimed to investigate the relationship between body fat mass, lean mass, and muscle mass, as well as their distribution in the arm, and the electrophysiological severity of CTS.
Material and Methods
Ethical approval was obtained from the institutional ethics committee on non-pharmacological clinical research (Number: 2022/16). This study was designed as a retrospective review of the medical records of patients who were referred to the obesity outpatient clinic between August 2021 and December 2021 and were diagnosed with CTS confirmed by electromyography (EMG) within the last month. All patients included in the study were invited for a control visit, neurological examinations were performed and missing data were completed. The study included patients who had received BCM and had CTS diagnosed by an EMG. The exclusion criteria were the presence of another entrapment neuropathy such as ulnar or radial neuropathy in the upper extremity, the presence of polyneuropathy, the presence of brachial plexopathy, a history of upper-extremity trauma or surgery, the presence of diabetes, the presence of other neurological diseases such as multiple sclerosis, amyotrophic lateral sclerosis, the presence of pregnancy, thyroid or rheumatic disease, the presence of malignancy in the last 5 years, incomplete medical records.
General demographic data of the patients, including age, sex, BMI, smoking status, occupation, presence of hypertension, and disease duration, were recorded.
Electromyography (EMG) recordings were performed using a Nihon Kohden Neuropack S1 MEB-9400K device. According to the recommendations of the American Association of Electrodiagnostic Medicine, CTS was identified [17]. The room temperature was 25° during the CTS examination, and the hand temperature ranged from 31° to 34°. Surface electrode recording and the antidromic supramaximal percutaneous stimulation method were used. Sensory nerve action potentials (SNAP) and motor action potentials (CMAP) of median and ulnar nerves were analyzed. Median CMAP was performed with wrist and antecubital fossa stimulation of abductor pollicis brevis muscle. Ulnar CMAP was recorded with wrist and grove stimulation of the abductor digiti minimi muscle. It was obtained by stimulating the ring electrodes placed on the median SNAP digit 2 at the wrist level. For ulnar SNAP, ring electrodes were placed on digit 5 and stimulation was done at the wrist level. In addition, digit 4 median-ulnar peak latencies were recorded. All patients were recorded bilaterally. The hand without CTS was excluded from the study.
We used a validated 5-stage scale to assess the electrophysiological severity of CTS. We classified the severity of CTS by reducing the 5-point scale for electrophysiological because of the limited sample in three groups as mild (stages 1-2), moderate (stage 3), and severe (stages 4-5). Mild CTS was defined as median SNAP latency greater than 2.5 ms or difference between median-ulnar SNAP peak latencies >0.5 ms. Moderate CTS: median CMAP latency was prolonger than 4.0 ms and median SNAP latency was prolonged than 2.5 ms. Severe CTS: no median SNAP and median CMAP amplitude <5 mV or latency >5.5 ms, or no median SNAP and CMAP.
BCM was performed using a TANITA MC 780 MA bioimpedance body composition analyzer, which works as a low amperage current from the tips of the toes and measure the voltage taken from the tips of the fingers. Different impedance measurements were obtained in the form of fat, lean, and muscle mass compartments of the whole body, right leg, left leg, right arm, and left arm, respectively [18]. The data obtained from the BCM included total fat mass (TFM), total lean mass (TLM), total muscle mass (TMM), arm fat mass (AFM), arm lean mass (ALM), and arm muscle mass (AMM) data.
Statistical Analysis
Statistical analyses were performed using SPSS (version 22.0) for Windows. Descriptive analyses were presented as mean ± standard deviation. The quantitative data distribution was tested using the Shapiro-Wilk test, and the data distribution was consistent with the non-parametric test. The Mann-Whitney U test was used for the quantitative comparison of two independent groups. The chi-square test was used to compare qualitative data. Fischer’s exact chi-square test was used when the number of observations was below 5 in the Chi-square test. Statistical significance was set at P < 0.05. The tests have been added and explained.
Results
The study group consisted of 186 hands of 100 patients, including 84 (84%) females and 16 (16%) males whose CTS was detected with EMG. The average age of the patients was 52.12±11.29 (25-82) years. The mean BMI was 32.12±5.61 kg/m2. The number of smokers was 24 (24%), and the majority of the patients were housewives (n=45, 45%). The duration of CTS disease was 2.57±1.51 (1-10) years. Patient demographic data are presented in Table 1.
CTS electrophysiological severity stage was mild in 62 hands (26.3%), moderate in 88 hands (37.3%), severe in 38 hands (15.4%). BMI values were 29.75±0.65 kg/m2, 31.84±0.51 kg/m2, and 37.00±0.91 kg/m2 (mild, moderate and severe CTS groups respectively) (p<0.001).
When CTS patients were compared as 3 groups in terms of BCM data, there was a difference between the groups in terms of TFM, AFM, ALM and AMM values (p<0.001). The comparison of the 3 groups is demonstrated in Table 2. In the pairwise comparison of BCM data in CTS patients; TFM, AFM, ALM and AMM values in comparison of mild and severe CTS patients; in the comparison of moderate and severe CTS patients, it was determined that TFM and FM values increased as the disease severity increased. Median nerve EMG data (SNAP and CMAP latency, amplitude, and velocity ratio) analyzed by TFM and AFM showed a substantial but weak negative correlation when the association between EMG data and BCM data was evaluated (p<0.05). Correlation relations are shown in Table 3.
Discussion
This study examined the association between CTS patient electrophysiological severity and BCM data. It was shown that TFM, AFM, AMM, and ALM values from BCM data increased as the disease severity of CTS patients categorized according to their electrophysiological findings increased. In the two-group comparison, patients with mild and severe CTS showed differences in TFM, AFM, ALM, and AMM values, whereas patients with moderate and severe CTS showed differences in TFM and AFM values.
When the data from the BCM results and the electrophysiological results of the median nerve were analyzed, a significant but weak correlation with the TFM value was observed for nearly all of the median sensory and motor nerves. Moreover, a significant correlation was found between AFM and all parameters of median SNAP and median CMAP amplitude, and between ALM and AMM, similar to median SNAP amplitude, conduction velocity and median CMAP conduction velocity. Among the electrophysiological findings, a significant difference was observed between the median SNAP amplitude and conduction velocity for the TFM, AFM, ALM, and AMM.
Although obesity is considered a predisposing factor for CTS, there are studies showing different results in the literature [7,19-22]. Some previous studies have shown that obesity is not a risk factor for CTS. Although Shiri et al. reported that CTS may be seen twice as often in obese people in their study, Blandn’s study suggested that this could only be true in people younger than 63 years of age [19,20]. The prevalence of obesity in patients with CTS is between 26.8% and 37% [7,21,22]. Adebayo et al. examined the prevalence of severe CTS among obese and overweight people, and stated that obesity is not a predictor for severe CTS, but adiposity may be investigated as an indicator [8]. Therefore, underlining that BMI may be more useful in the clinical evaluation of CTS reveals the importance of our study. Furthermore, differences in body weight and BMI may cause abnormalities in electrophysiological findings such as median nerve distal motor latency [18]. These different results suggest that new studies are required to explain the association between obesity and CTS.
Adebayo et al. examined the prevalence of severe CTS among obese and overweight people and stated that obesity is not a predictor for severe CTS, but adiposity formed by fat structures may be investigated as an indicator [8]. Therefore, underlining that fat mass may be more useful in the clinical evaluation of CTS reveals the importance of our study. Furthermore, differences in body weight and BMI may cause abnormalities in electrophysiological findings such as median nerve distal motor latency [18]. These different results suggest that new studies are required to explain the association between obesity and CTS.
Radecki suggested that an increase in BMI may cause an increase in pressure at the carpal tunnel level of the median nerve as a result of increased blood flow to the translocated upper body, including the thorax and arms [23]. However, no association was found between obesity and intra-carpal tunnel pressure and median nerve cross-sectional area in another study conducted by Werner et al. No association was found between BMI and the degree of fibrosis in the tenosynovium or the severity of edema in another previous study [24]. These studies were based on hypotheses attempting to explain the conditions associated with CTS severity due to local causes; however, sufficient evidence was not found. In our study, however, a significant correlation was found between the increase in arm fat mass and the EMG stage of CTS.
BMI may cause poor or sometimes false results as an indicator of adiposity [16]. This has led to total, visceral, and segmental body composition measurements, which are considered a more reliable method [16]. Habib et al. detected a significant association between CTS severity and BMI, BMI, body fat mass (BFM), TFM, and TF% in their study. These data are in line with those of our study, and an association was also revealed between AFM, ALM, AMM, and disease severity. It was noted that as the severity of the disease increased, BMI also increased. This suggests that AFM, which is a marker of the increase in local adipose tissue, is significantly associated with the severity of CTS disease and that AFM can be used as a predictive and follow-up tool for CTS severity.
Among all the data obtained with BCM, parameters that were significantly related to EMG findings were the M SNAP amplitude and conduction velocity. Habib et al. found visceral fat mass to be an independent marker of disease severity and prolongation of median nerve latency in their study. In contrast, a decrease in amplitude and slowdown in conduction velocity were found to be important markers for all parameters of M SNAP in this study. We believe that this result will be more clearly demonstrated by further studies that compare electrophysiological parameters and BMI in patients with CTS. A study examining EMG findings of obese CTS patients showed that parameters such as median nerve sensory latency, prolongation of distal motor latency, and slowing of conduction velocity were more abnormal than those in non-obese CTS patients [25]. In the aforementioned study, moderately severe CTS was detected mostly in obese patients; however, severe CTS was detected in non-obese patients, and it was concluded that obesity had no effect on CTS severity. The same study suggested that adiposity should be evaluated with markers other than obesity.
Conclusion
Our results revealed that the relationship between CTS disease severity and BMI increased not only with total adiposity in the body, but also with lean and muscle mass in the arm, especially in the arm fat mass. An increase in AFM value might help as a follow-up or predictive metric for the CTS. As a result, it was determined that more extensive studies are needed to investigate the local CTS etiologic causes.
Scientific Responsibility Statement
The authors declare that they are responsible for the article’s scientific content including study design, data collection, analysis and interpretation, writing, some of the main line, or all of the preparation and scientific review of the contents and approval of the final version of the article.
Animal and human rights statement
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. No animal or human studies were carried out by the authors for this article.
Funding: None
Conflict of interest
None of the authors received any type of financial support that could be considered potential conflict of interest regarding the manuscript or its submission.
References
1. Padua L, Coraci D, Erra C, Pazzaglia C, Paolasso I, Loreti C, et al. Carpal tunnel syndrome: clinical features, diagnosis, and management. Lancet Neurol. 2016;15(12):1273-84.
2. Wright AR, Atkinson RE. Carpal Tunnel Syndrome: An Update for the Primary Care Physician. Hawaii J Health Soc Welf. 2019;78(11 Suppl. 2):6-10.
3. Razavi AS, Karimi N, Bashiri F. The relationship of serum lipid profiles and obesity with the severity of carpal tunnel syndrome. Pan Afr Med J. 2021;39:90.
4. Genova A, Dix O, Saefan A, Thakur M, Hassan A. Carpal Tunnel Syndrome: A Review of Literature. Cureus. 2020;12(3):e7333.
5. Jablecki CK, Andary MT, Floeter MK, Miller RG, Quartly CA, Vennix MJ, et al. American Association of Electrodiagnostic Medicine; American Academy of Neurology; American Academy of Physical Medicine and Rehabilitation. Practice parameter: Electrodiagnostic studies in carpal tunnel syndrome. Report of the American Association of Electrodiagnostic Medicine, American Academy of Neurology, and the American Academy of Physical Medicine and Rehabilitation. Neurology. 2002;58(11):1589-92.
6. Mansoor S, Siddiqui M, Mateen F, Saadat S, Khan ZH, Zahid M, et al. Prevalence of Obesity in Carpal Tunnel Syndrome Patients: A Cross-Sectional Survey. Cureus. 2017;9(7):e1519.
7. Mondelli M, Curti S, Farioli A, Aretini A, Ginanneschi F, Greco G, et al. Anthropometric measurements as a screening test for carpal tunnel syndrome: receiver operating characteristic curves and accuracy. Arthritis Care Res (Hoboken). 2015;67(5):691-700.
8. Adebayo PB, Mwakabatika RE, Mazoko MC, Taiwo FT, Ali AJ, Zehri AA. Relationship Between Obesity and Severity of Carpal Tunnel Syndrome in Tanzania. Metab Syndr Relat Disord. 2020;18(10):485-92.
9. Borga M, West J, Bell JD, Harvey NC, Romu T, Heymsfield SB, et al. Advanced body composition assessment: from body mass index to body composition profiling. J Investig Med. 2018;66(5):1-9.
10. Plastino M, Fava A, Carmela C, De Bartolo M, Ermio C, Cristiano D, et al. Insulin resistance increases risk of carpal tunnel syndrome: a case-control study. J Peripher Nerv Syst. 2011;16(3):186-90.
11. Mondelli M, Aretini A, Ginanneschi F, Greco G, Mattioli S. Waist circumference and waist-to-hip ratio in carpal tunnel syndrome: a case-control study. J Neurol Sci. 2014;338(1-2):207-13.
12. Kuriyan R. Body composition techniques. Indian J Med Res. 2018;148(5):648-58.
13. Campa F, Toselli S, Mazzilli M, Gobbo LA, Coratella G. Assessment of Body Composition in Athletes: A Narrative Review of Available Methods with Special Reference to Quantitative and Qualitative Bioimpedance Analysis. Nutrients. 2021;13(5):1620.
14. Shiri R, Pourmemari MH, Falah-Hassani K, Viikari-Juntura E. The effect of excess body mass on the risk of carpal tunnel syndrome: a meta-analysis of 58 studies. Obes Rev. 2015;16(12):2002-8.
15. Mokhtarinia HR, Parsons D, Bain CR, Gabel CP. Independent risk factors of carpal tunnel syndrome: Assessment of body mass index, hand, wrist and finger anthropometric measurements. Work. 2022;73(1):157-64.
16. Habib SS, Alanazy MH. Predictive Value of Markers of Adiposity in Carpal Tunnel Syndrome: A Clinical and Electrophysiological Evaluation. J Coll Physicians Surg Pak. 2020;30(8):828-32.
17. Stevens JC. AAEM minimonograph #26: the electrodiagnosis of carpal tunnel syndrome. American Association of Electrodiagnostic Medicine. Muscle Nerve. 1997;20(12):1477-86.
18. Buschbacher RM. Mixed nerve conduction studies of the median and ulnar nerves. Am J Phys Med Rehabil. 1999;78(Suppl. 6):S69-74.
19. Bland JD. The relationship of obesity, age, and carpal tunnel syndrome: more complex than was thought? Muscle Nerve. 2005;32(4):527-32.
20. Shiri R, Pourmemari MH, Falah-Hassani K, Viikari-Juntura E. The effect of excess body mass on the risk of carpal tunnel syndrome: a meta-analysis of 58 studies. Obes Rev. 2015;16(12):1094-104.
21. Becker J, Nora DB, Gomes I, Stringari FF, Seitensus R, Panosso JS, et al. An evaluation of gender, obesity, age and diabetes mellitus as risk factors for carpal tunnel syndrome. Clin Neurophysiol. 2002;113(9):1429-34.
22. Karpitskaya Y, Novak CB, Mackinnon SE. Prevalence of smoking, obesity, diabetes mellitus, and thyroid disease in patients with carpal tunnel syndrome. Ann Plast Surg. 2002;48(3):269-73.
23. Radecki P. Personal factors and blood volume movement in causation of median neuropathy at the carpal tunnel. A commentary. Am J Phys Med Rehabil. 1996;75(3):235-8.
24. Werner RA, Jacobson JA, Jamadar DA. Influence of body mass index on median nerve function, carpal canal pressure, and cross-sectional area of the median nerve. Muscle Nerve. 2004;30(4):481-5.
25. Gazioglu S, Boz C, Cakmak VA. Electrodiagnosis of carpal tunnel syndrome in patients with diabetic polyneuropathy. Clin Neurophysiol. 2011;122(7):1463-9.
Download attachments: 10.4328.ACAM.21748
Nuray Can Usta, Gökhan Peker. Electrophysiological Severity of Carpal Tunnel Syndrome and Body Composition Measurement. Ann Clin Anal Med 2023;14(9):788-792
Citations in Google Scholar: Google Scholar
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/
Toilet mastectomy: 12 year-experience of a high-volume breast surgery center
Murat Kartal 1, Tolga Kalaycı 2, Vefa Atış 1, Fuat Şentürk 3, Erdem Karadeniz 1, Müfide Nuran Akçay 1
1 Department of General Surgery, Faculty of Medicine, Atatürk University, Erzurum, 2 Department of General Surgery, Faculty of Medicine, Ağrı İbrahim Çeçen University, Ağrı, 3 Department of Surgical Oncology, Faculty of Medicine, Atatürk University Erzurum, Turkey
DOI: 10.4328/ACAM.21777 Received: 2023-06-04 Accepted: 2023-07-10 Published Online: 2023-08-30 Printed: 2023-09-01 Ann Clin Anal Med 2023;14(9):793-796
Corresponding Author: Murat Kartal, Department of General Surgery, Faculty of Medicine, Atatürk University, Erzurum, Turkey. E-mail: m.kartal2587@gmail.com P: +90 507 191 96 09 Corresponding Author ORCID ID: https://orcid.org/0000-0003-1396-5365
This study was approved by the Clinical Research Ethics Committee of Atatürk University Faculty of Medicine (Date: 2023-05-02, No: B.30.2.ATA.0.01.00/356)
Aim: Breast cancer is a global public health problem, and the life-saving effect of early diagnosis and treatment is evident. This study aimed to present the clinicopathological features of patients who underwent toilet mastectomy for metastatic breast cancer.
Material and Methods: Files of patients who underwent toilet mastectomy for metastatic breast cancer in a high-volume breast surgery center between January 2011 and January 2023 were retrospectively reviewed. Clinicopathological data of the patients were gathered and presented.
Results: Of the 32 patients who met the study criteria, 31 (96.9%) were female, and the mean age was 60 (33-85) years. There was involvement in the left breast in 19 (59.3%) patients and in the right breast in 13 (40.7%). Indications for surgery were ulceration in 13 (40.6%) patients, infection in 11 (34.4%) patients, and bleeding in 8 (25%) patients. Twenty-four (75%) of the defects were closed primarily, 6 (18.8%) with a skin graft and 2 (6.2%) with an advancement flap. Morbidity and mortality rates of the study were 37.5% (n=12) and 3.2% (n=1), respectively, and the most common postoperative complication was bleeding at the surgical site (n=5; 15.6%).
Discussion: In the presence of an overgrowth of tumor tissue, chest wall invasion, ulceration of the breast skin, discharge or bleeding, toilet mastectomy performed without adhering to oncological principles is aimed at reducing the tumor burden and increasing the quality of breast cancer.
Keywords: Bleeding, Mastectomies, Morbidities
Introduction
Breast cancer is the second most common cancer in the world after lung cancer and the most common cancer in the female gender. On the other hand, it ranks second among cancer-related deaths worldwide [1]. Survival due to breast cancer varies according to the cancer stage. At the time of diagnosis, 65% of the cases have localized breast cancer, 26% have regional breast cancer, and 5% have metastatic breast cancer. While 5-year survival is approximately 99% in localized breast disease, this rate drops to 29% in the presence of distant metastases [2].
The determinant of breast cancer treatment is the cancer stage at the time of diagnosis. Although surgery has a place in breast cancer at every stage, it is the first choice in localized breast cancer. In regional diseases, surgery is applied after chemotherapy and radiotherapy. However, the place of surgical treatment in metastatic disease is quite limited. In metastatic disease, surgical treatment is mainly applied to tumor-related complications (bleeding, infection, and ulceration). This palliative surgery is called a toilet mastectomy. Toilet mastectomy is performed without adhering to oncological principles and aims to increase the patient’s quality of life by reducing the tumor burden [3].
This study aimed to present the clinicopathological features of patients who underwent toilet mastectomy for metastatic breast cancer.
Material and Methods
This retrospective study was conducted after ethical approval by the Clinical Research Ethics Committee of Atatürk University Faculty of Medicine (Decision number: B.30.2.ATA.0.01.00/356; Decision date: 02.05.2023). Files of patients who underwent toilet mastectomy for metastatic breast cancer in the Atatürk University Faculty of Medicine Department of General Surgery between January 2011 and January 2023 were retrospectively reviewed. The age and gender of the cases, comorbid disease status, the reason for performing toilet mastectomy (infection, bleeding, or ulceration), the location of the metastasis focus, the type of surgery, pathological data, and morbidity and mortality were evaluated. The presence of complications occurring in the first 30 days postoperatively was evaluated for morbidity, while the mortality that occurred in the first 30 days postoperatively was taken as the basis for mortality. In addition, postoperative survival status was determined using the E-Nabız system (the Ministry of Health of the Republic of Turkey application) and by phone calling the relatives of the cases.
Ethical Approval
Ethics Committee approval for the study was obtained.
Results
Of the 32 patients who met the study criteria, 31 (96.9%) were female, and the mean age was 60 (33-85) years. There was involvement in the left breast in 19 (59.3%) patients and in the right breast in 13 (40.7%). At least one comorbid disease was present in 23 (71.9%) patients, and the most common comorbid disease was hypertension (n=14, 43.8%). In preoperative imaging, 8 (25%) patients had vertebrae, 5 (15.6%) lung, 3 (9.3%) liver and 2 (6.2%) multiple metastases. Indications for surgery were ulceration in 13 (40.6%) patients, infection in 11 (34.4%) patients, and bleeding in 8 (25%) patients. Mastectomy and various levels of axillary dissection were performed in all patients. Twenty-four (75%) of the defects were closed primarily, 6 (18.8%) with a skin graft and 2 (6.2%) with an advancement flap. Morbidity and mortality rates of the study were 37.5% (n=12) and 3.2% (n=1), respectively, and the most common postoperative complication was bleeding at the surgical site (n=5; 15.6%).
The most common pathology diagnosis was invasive ductal carcinoma (n=27; 84.3%), and 6 (18.8%) patients had positive surgical margins. The clinicopathological features of the patients are shown in Table 1. In addition, the mean survival time was found to be 25 (0-62) months.
Discussion
The incidence of breast cancer is increasing in our country as well as all over the world. The stage of the disease at the time of diagnosis is the most important indicator that affects treatment planning and prognosis. Lack of education, awareness of breast cancer, socioeconomic reasons and false beliefs make it difficult to detect the disease early. While the incidence of locally advanced breast cancer is 20% in the western regions of our country, this rate rises to 50% in the eastern regions [4].
The mainstay of treatment in advanced breast cancer is systemic therapy. Although recent studies show that primary tumor resection reduces tumor burden and increases survival, surgical treatment in advanced diseases is still controversial. Surgical treatment is mainly applied in symptomatic diseases such as bleeding, ulceration, and infection to improve the patient’s quality of life, and this surgery is called a toilet mastectomy [5, 6].
In advanced breast cancer, the patient’s complaints may be symptoms specific to the metastatic organ and infection, ulceration, or bleeding in the breast skin. In a study by Constantin et al., the most common complaint at admission in patients who underwent toilet mastectomy was ulceration and infection [7]. Ulceration on the skin of the mammary gland facilitates super-infection, resulting in a foul-smelling and abscess-containing infection. The increased vascularity of the tumoral tissue prepares the ground for bleeding. Bleeding of tumoral tissue opened to the skin may cause continuous blood loss and anemia symptoms in patients. These bleedings can be controlled with local treatments or may require surgical intervention. Affecting the nerves innervating the breast can cause severe pain in the patient. Pain can be controlled with local or systemic analgesics, but surgery may be considered in appropriate patients, given the side effects associated with long-term use [8, 10]. In our study, the most common complaint of patients who underwent toilet mastectomy was ulceration, followed by infection and bleeding.
Chemotherapy is primarily applied in advanced breast cancer, and the place of surgery is limited. In patients with ulcers, infections and bleeding masses, toilet mastectomy is preferred mainly. The issue of adding axillary dissection to mastectomy in these patients is controversial. In patients with locally advanced breast cancer without distant metastases, adding axillary dissection may increase the survival time. Still, the application of complete axillary dissection in patients with distant metastases should be decided by evaluating the benefit and additional morbidity that it will bring to the patient [11]. In our study, 56.1% of the patients had distant metastases, and all patients underwent salvage mastectomy and varying degrees of axillary dissection.
Removal of large volumes of tumor and necrotic tissue from the breast usually results in a large defect in the chest wall. It is important to note that the chest wall requires adequate soft tissue reconstruction with function, stability, integrity, and an aesthetically acceptable outcome in these patients. Many authors have suggested closure of the thoracic defect using local flaps (e.g., bilateral advancement flap, thoracoabdominal or thoracoepigastric flap) or skin grafts. The choice should be made according to the size and location of the flap, considering the risk of postoperative tension and flap necrosis, which prolongs the duration of adjuvant chemotherapy [12, 13]. The defects of 24 patients in the present study were closed primarily, six with skin grafts and 2 with advancement flap.
Conclusion
Breast cancer is a global public health problem, and the life-saving effect of early diagnosis and treatment is evident. With the detection of the disease at an early stage, good oncological results such as longer disease-free and more prolonged survival can be obtained. However, in patients diagnosed at an advanced stage, both treatment options are limited, and oncological outcomes are poor. In the presence of an overgrowth of tumor tissue, chest wall invasion, ulceration of the breast skin, discharge or bleeding, toilet mastectomy performed without adhering to oncological principles is aimed at reducing the tumor burden and increasing the quality of breast cancer.
Scientific Responsibility Statement
The authors declare that they are responsible for the article’s scientific content including study design, data collection, analysis and interpretation, writing, some of the main line, or all of the preparation and scientific review of the contents and approval of the final version of the article.
Animal and human rights statement
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. No animal or human studies were carried out by the authors for this article.
Funding: None
Conflict of interest
The authors declare no conflict of interest.
References
1. Radziszewski M, Choromańska E, Nowak A, Kowalewski R, Radziszewski J. Toilet mastectomy as a possible and recommended solution to improve the quality of life of advanced breast cancer patients-case series. Palliative Med. 2021;13(2):97-100.
2. Giaquinto AN, Sung H, Miller KD, Kramer JL, Newman LA, Minihan A, et al. Breast cancer statistics 2022. CA Cancer J Clin. 2022;72(6):524-41.
3. Zihni İ, Erakın M, Bodur MS, Karaca İ, Acar S, Çelik G, et al. Metastatik Meme Kanseri Hastalarında Salvage Mastektomi (Salvage Mastectomy in Metastatic Breast Cancer Patients). Suleyman Demirel University J Health Sci. 2022; 13(1):140-5.
4. Ozmen V. Meme Hastalıkları Dernekleri Etkinlikleri (Breast Diseases Associations Activities). J Breast Health. 2010;6:43-44.
5. Singletary SE, Connolly JL. Breast cancer staging working with the sixth edition of the AJCC Cancer Staging Manual. CA Cancer J Clin. 2006;56(1):37-47.
6. Sakarya MH, Fakirullahoğlu M, Yeni M. Meme kanseri nedeniyle tuvalet mastektomi uygulanan hastaların klinik özelliklerinin incelenmesi: 10 yıllık deneyim (Investigation of clinical features of patients who underwent toilet mastectomy for breast cancer: 10 years of experience). Ağrı Med J. 2023;1(1):1-4.
7. Constantin A, Predescu D, Ciofu R, Achim F, Constantinoiu S. Palliative (Toilet) mammectomy, A decision-making dilemma-short review. Chirurgia (Bucur). 2021;116(2):150-61.
8. Piggin C, Jones V. Malignant fungating wounds: an analysis of the lived experience. Int J Palliat Nurs. 2007;13(8):384-91.
9. Nomoto S, Akai T, Nomiyama H, Kuwano H, Kuwabara Y, Yoshimitsu K. A retrospective study of the effectiveness of haemostatic radiotherapy with conventional fractionation in patients with advanced cancer. J Cancer Res Ther. 2015;3(11):124-8.
10. Satoh E, Osanai T, Tomi Y, Nakamura M, Yonekura K, Murakata A, et al. A case report of recurrent bleeding and massive malodorous effusion due to skin invasion of advanced breast cancer successfully treated with Mohs’ paste. Gan to Kagaku Ryoho. 2018;45(13):1997-9.
11. Polat AK, Soran A. Metastatik meme kanseri tanısı alanlarda primer tümör cerrahisinin yeri (Role of primary tumor surgery in patients diagnosed with metastatic breast cancer). Turkish J Surg. 2010;26(4):185-91.
12. Matros E, Disa JJ. Uncommon flaps for chest wall reconstruction. Semin Plast Surg. 2011;25(1):55-9.
13. Ahmad HH, Nicolas G, Saliba C, Ghandour MA, Zeaiter NM, Alzein H, et al. Chest wall reconstruction with a bilayered wound matrix mesh following toilet mastectomy. Am J Case Rep. 2019;20:1736-9.
Download attachments: 10.4328.ACAM.21777
Murat Kartal, Tolga Kalaycı, Vefa Atış, Fuat Şentürk, Erdem Karadeniz, Müfide Nuran Akçay. Toilet mastectomy: 12 years experience of a high-volume breast surgery center. Ann Clin Anal Med 2023;14(9):793-796
Citations in Google Scholar: Google Scholar
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/
Comparison of the effectiveness of transverse friction massage and thiele massage in female patients with chronic pelvic pain
Sena Öndeş, Aybüke Ersin
Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Istanbul Atlas University, Istanbul, Turkey
DOI: 10.4328/ACAM.21780 Received: 2023-06-06 Accepted: 2023-07-31 Published Online: 2023-08-10 Printed: 2023-09-01 Ann Clin Anal Med 2023;14(9):797-802
Corresponding Author: Sena Öndeş, Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Atlas University, 34408, Istanbul, Turkey. E-mail: sena.ondes@atlas.edu.tr P: +90 538 709 45 35 Corresponding Author ORCID ID: https://orcid.org/0000-0002-9715-3083
This study was approved by the Non-Interventional Scientific Research Ethics Committee of Istanbul Atlas University (Date: 2022-06-21, No: E-22686390-050.01.04-17613)
Aim: This study aimed to investigate and compare the effectiveness of transverse friction massage and Thiele massage applied to the pelvic floor muscles in female patients with chronic pelvic pain.
Material and Methods: Twenty patients were divided into two groups of 10 people each: the transverse friction group and the Thiele massage group. Patients received transverse friction massage or Thiele Massage 2 days a week for 4 weeks. Measured parameters were pain, quality of life, sexual functions, and lower urinary tract symptoms. Visual Analog Scale and Mcgill Melzack Pain Questionnaire, Nottingham Health Profile, Female Sexual Function Index, and Bristol Female Lower Urinary Tract Symptoms Questionnaire were used to evaluate parameters, respectively.
Results: Statistically significant improvements were observed in all parameters in the transverse friction massage group (p<0.05) and all parameters except sexual functions improved significantly in the Thiele group compared to pre-treatment (p<0.05). When the two groups were compared with each other, no statistically significant difference was found in any of the parameters between the groups (p>0.05).
Discussion: Transverse friction massage and Thiele massage applied to the pelvic floor muscles in patients with chronic pelvic pain are easily applicable noninvasive treatment methods that can reduce the symptoms of the disease and increase the quality of life.
Keywords: Chronic Pelvic Pain, Pelvic Floor Muscles, Transverse Friction Massage, Thiele Massage
Introduction
Chronic pelvic pain (CPP) is defined as pain in the pelvic region lasting more than six months that is not associated with pregnancy, menstrual cycle, local trauma, or pelvic surgery [1]. 60-90% of women have musculoskeletal system disorders with CPP. It has been proven that musculoskeletal dysfunctions such as spasms in the pelvic floor muscles (PFM) such as the levator ani and piriformis are frequently seen. Abnormal posture patterns, muscle shortness, and spasms create a vicious cycle and cause myofascial pelvic pain [1,2].
Myofascial pelvic pain refers to pain and tenderness in the PFM and fascia. This pain may occur without related medical pathology or may be a precursor or sequelae of urological, gynecological, and colorectal medical conditions or other musculoskeletal conditions. Increased tone, spasm, and trigger points in the PFM cause pain and tenderness in the pelvic region. It has been observed that 22% of women with CPP have tenderness in the levator ani muscle [2,3].
Patient education, which is the first step of physiotherapy, includes recommendations for pain control and relaxation techniques. It has been proven that electrotherapy applications have positive effects on pain and quality of life (QoL) in patients with CPP [4]. Manual therapy, massages, and other techniques are used in the continuation of the treatment. These are Thiele massage (TM), treatment of trigger points with ischemic compression, osteopathic manual therapy methods, transverse friction massage (TFM), classical massage, perineal massage, myofascial relaxation techniques, abdominal massage, biofeedback and exercise [5,21]. Physical exercise sessions are started with low-intensity exercises that increase the body awareness of individuals. Patients are encouraged to recognize postural adaptations that may affect pain and function, including sexual activity, and to gain awareness of changes in tone and tension, particularly in the PFM and other skeletal muscles. Breathing and relaxation exercises are also used [4,5].
Thiele massage is a transvaginal massage technique applied in cases of PFM sensitivity and spasms. It is done by stripping movements from the origin of the muscles to the insertion. In order not to traumatize the spasmatic muscles, the massage is started lightly, and the pressure is gradually increased as the sessions progress and the sensitivity decreases. Its mechanism is to provide elongation in the muscles with pressure. With this elongation, the tone of the hypertonic PFM decreases and the spasm relaxes [6,7].
Transverse friction massage is used to relieve pain and inflammation in musculoskeletal problems. The friction is applied transverse to the fiber direction of the relevant tissue. With this technique, stress is applied to the reshaped collagen of the tissue to soften the adhesion. This prevents or destroys abnormal fibrous adhesions. Also, TFM causes an increase in blood flow in the local application area through vasodilation in the tissue with a strong and deep movement. This blood support provides for the transport of endogenous opiates, resulting in pain relief [8].
When the literature was examined, there were not enough studies on TM and TFM applied to patients with CPP. Although our study is in line with the literature findings we discussed, and to the best of our knowledge, this is the first clinical study to compare the effectiveness of TFM and TM in CPP.
This study was conducted to determine and compare the effects of TFM and TM on pain, QoL, sexual functions and lower urinary system symptoms applied to CPP patients with PFM tenderness and spasm. We hypothesized that TM and TFM have an effect and superiority over each other on pain, QoL sexual dysfunctions, and lower urinary tract symptoms in CPP patients.
Material and Methods
Design and randomization
A blinded statistician generated a randomization list using a computer-based allocation program (www.randomizer.org). Twenty participants were randomized into two intervention groups after initial assessments. Group 1 was named the Thiele group (TG) and Group 2 was the transverse friction group (TFG). Individuals participating in the groups did not know which group they belonged to, and no information was given about the difference between the two interventions.
Ethical approval was obtained for this study from the Non-Interventional Scientific Research Ethics Committee dated 21.06.2022 with the decision number E-22686390-050.01.04-17613. The study was prospectively registered at www.ClinicalTrials.gov website (NCT05788653). All individuals participating in the study were informed about the study and signed informed consent was obtained from all individuals.
Participants
Twenty-six CPP patients with PFM tenderness and spasms were directed to a physiotherapist by a urologist. Inclusion criteria were age from 20 to 60 years, the presence of pelvic pain for 6 months or more. The exclusion criteria were the presence of neurological pathology, having urogynecological surgery in the last 6 months, having advanced pelvic prolapse, pelvic malignancy, and radiotherapy.
Outcome Measurements
The physiotherapist evaluated the tenderness and spasms in the levator ani, coccygeus, obturator internus, and piriformis muscles with digital palpation. During palpation, an imaginary clock is used for localizing the PFM, with the symphysis pubis at 12 and the anus at 6 o’clock. In the deep layer, the pubococcygeus at 1,5,7, and 11, the iliococcygeus at 4 and 8, and the coccygeus at the deeper level of 5 and 7 o’clock are palpable. In addition, the obturator internus and piriformis can also be palpated transvaginally [5].
The researcher recorded personal information, urological and gynecological clinical conditions, previous surgeries, and current medications with a socio-demographic information form specially prepared for the participants. All assessments were performed by the same physiotherapist twice, at the beginning and the end of the intervention.
Visual Analog Scale (VAS) developed by Hayes and Patterson in 1921, is used to determine the severity of pain. At the beginning of a 10 cm long line, the words “no pain” and “severe intolerable pain” are placed at the end. The patient is asked to put a mark on the scale according to the severity of the pain. Pain intensity is determined by measuring the distance from the expression “no pain” to the area where the patient puts a sign [9].
McGill Pain Questionnaire (MPQ) was developed by Melzack and Targerson in 1971. It consists of four parts. In the first part, the patient marks the painful place on the human body diagram and states that it is deep and/or superficial. In the second part, the characteristics of pain are questioned. The third part consists of questions evaluating the time-dependent change of pain. In the fourth part, the severity of pain is measured comparatively. The total score ranges from 0 to 112. A high score indicates a worsening of pain and related parameters [10].
Nottingham Health Profile is a valid and reliable scale that measures general health status in musculoskeletal disorders and chronic diseases. It was developed in 1981 by Hunt et al. Individuals’ physical, emotional, and social well-being is questioned. It consists of 38 questions and six sub-parameters: pain, emotional reactions, sleep, social isolation, physical abilities, and energy level. The score is calculated between 0-600 points, with a maximum of 100 points for each sub-parameter. A high score indicates low QoL [11].
The Female Sexual Functioning Index (FSFI), developed by Rosen et al. in 2000, is a 5-point Likert-type scale consisting of 19 questions and 6 sub-parameters that evaluate female sexual functions. It evaluates many parameters such as frequency and level of sexual desire, level of arousal, frequency, and difficulty of lubrication and orgasm, emotional intimacy during sexual intercourse, sexual life satisfaction, and pain during sexual intercourse. The first two questions are calculated between 1-5 points, while the other questions are calculated between 0-5 points. As the score increases, sexual functions improve [12].
Bristol Female Lower Urinary Tract Symptom Questionnaire (BFLUTS) was developed by Jackson et al. in 1996 to evaluate female lower urinary tract symptoms, their severity, and the effects of these symptoms on QoL and sexual functions. It consists of 34 Likert-type questions. The score ranges from 0 to 71. A high score indicates worsening of lower urinary tract symptoms [13].
Intervention
TM was applied to the TG in the lithotomy position for 30 minutes, 2 days a week for 4 weeks. For each muscle group, 15-20 repetitions were used.
TFM was applied to the TFG by the same physiotherapist with the same frequency in the lithotomy position. It was applied for 3-5 minutes on each tense muscle group and trigger points, crossing the direction of the muscle fibers. It was started uni-digitally and continued bi-digitally according to the patient’s tolerance.
Statıstical Analysis
The statistical analysis program of “Statistical Package for Social Sciences” (SPSS) Version 28.0 was used for statistical analysis. The statistical significance level was determined as p<0.05 for all data. The Shapiro-Wilk test was used to determine whether the data were normally distributed. Paired Sample T-test was used for intra-group comparison to normally distributed data, while Independent Samples T-test was used for inter-group comparison. The Wilcoxon test was used for inter-group comparisons, which did not show normal distribution and ordinal data, and the Mann-Whitney U test was used for comparisons between groups.
Ethical Approval
Ethics Committee approval for the study was obtained.
Results
At the end of the study, 20 of the 26 participants completed the study. The participation status of the individuals is given in Figure 1.
The socio-demographic and clinical characteristics of the patients in the two groups participating in the study are given in Table 1. No statistically significant difference was found between the groups (p>0.05).
The comparison of VAS, MPQ, NHP, FSFI, and BFLUTS total scores of the two groups before and after treatment is given in Table 2. A statistically significant difference was found in post-treatment VAS, MPQ, NHP, and BFLUTS scores compared to pre-treatment for both groups (p<0.05). In the TFG, there was a statistically significant difference in all FSFI scores (p<0.05). Yet, no statistically significant difference was found regarding FSFI sexual desire, arousal, pain sub-parameters, and the total score in the TG (p > 0.05). In addition, a statistically significant difference was found in all BFLUTS scores in TG except for urinary incontinence and sexual functions sub-parameters (p<0.05).
The intergroup comparison of VAS, MPQ, NHP, FSFI, and BFLUTS total scores after treatment are shown in Table 3. No significant difference was found in any of the parameters.
Discussion
We found that in the treatment of CPP, TFM and TM have a positive effect on pain, QoL, and lower urinary tract symptoms. In addition, TFM has been found to improve sexual functions. However, TFM and TM were not found to be superior to each other.
The majority of studies in the literature suggest that TM performed in female patients with CPP who have PFM spasms, trigger points, and tenderness reduces pelvic pain [7,14]. In addition, decreased muscle tone in PFM has been reported [15,16]. Similar to the studies in the literature, it was found in this study that TM provided improvements in both pain parameters evaluated.
El-Hefnawy et al. recently investigate the effects of self-administered TM in patients with PFM tenderness and spasms. The researchers found that the severity of pain worsened [17]. Considering other studies in which the treatment was applied by physiotherapists [14-16], it is thought that the results are worsened because the TM is not applied by experts.
It has been stated in many studies that myofascial physical therapy applied to muscles with trigger points and spasm reduces pain [18,19]. In a study conducted with CPP patients, myofascial physical therapy applied to the PFM and surrounding areas (abdominal wall, waist, legs, and gluteal region) statistically significantly reduced the pain parameter [18,20]. In this study, TFM massage was found to provide statistically significant improvements in pain parameters, such as myofascial release. The pain relief mechanism of TFM has similarities to the mechanism of myofascial release. These can be summarized as restoring the proper alignment of the connective tissue fibers by moving the muscle fibers, equalizing the length of the sarcomeres with the application of local pressure, providing pain control with activation of the spinal reflex mechanism and muscle relaxation, and relieving pain by providing the transport of endogenous opiates with vasodilation in the region [19].
Ersin et al. investigated the effects of TFM in patients with CPP. Statistically significant improvements were observed in the pain parameter compared to pre-treatment. Also, it has been reported that transvaginal TFM statistically significantly improved QoL scores [21].
Quality of life is one of the important parameters affecting patients with CPP. Studies in the literature indicate that psychological symptoms, especially anxious and depressive states are risk factors for pain, urinary symptoms, and QoL in CPP patients [22].
In a study conducted with patients with CPP, it was determined that myofascial treatment approaches applied to the PFM and surrounding areas increased the QoL [18]. Similarly, in this study, it was determined that TFM provided significant improvements in QoL after treatment compared to pretreatment.
The literature has reported that TM applied to patients with CPP who have tenderness and tension in the PFM reduces depression, increases psychological well-being, and positively affects the QoL [14,15]. In this study, significant changes in QoL in the TG and improvements in the emotional state sub-parameter of the QoL scale suggest that TM can be used to improve anxiety and depression and increase psychological well-being.
CPP can cause pelvic floor dysfunctions and deterioration in sexual functions in patients. Tone changes of PFM encountered in CPP are one of the important causes of dyspareunia in women. PFM has been reported to be active in female genital stimulation and orgasm, and tone changes in PFM may adversely affect these phases [23]. Studies have shown that TM applied to PFM reduced dyspareunia in CPP patients but had no effect on sexual functions [7,14]. In this study, after TM, there was a significant improvement in the FSFI pain subparameter, while no significant improvement was found in the FSFI total score and lubrication subparameter.
Studies in the literature have found that myofascial physical therapy applied to the PFM and surrounding areas significantly improved pain and sexual functions [18,24]. In this study, it was determined that TFM reduces pain during sexual intercourse. In addition, statistically significant improvements were seen in FSFI total score.
In this study, TFM and TM were found to be effective in dyspareunia, but TM was not found to be effective in sexual functions. Considering the effect of peripheral and central sensitization on dyspareunia [25], both massage techniques acted as desensitization, and in addition, provided improvements in dyspareunia by reducing muscle tone. However, it may be that the rubbing and stripping technique of the TG may cause decreases in lubrication, therefore there is no significant difference in sexual functions.
Lower urinary system dysfunctions such as urgent and frequent urination and nocturia are frequently seen in CPP [26]. Studies in the literature show that TM reduces symptoms such as urgency-frequent urination and bladder pain in women with CPP [18,20]. It has been observed that myofascial release and trigger point treatment applied to the pelvic floor and its surroundings in patients with CPP positively affect lower urinary systems symptoms such as voiding frequency and duration [18]. Similarly, in this study, statistically significant improvements in lower urinary tract symptoms were observed in both groups after the treatment, but no significant difference was found between the groups.
Limitations
Our present study has a limitation. Although we conducted our study with two experimental groups, our sample size was limited. Therefore, CPP rehabilitation is not common in our country. Our further studies will be planned to increase the sample size.
Conclusion
In conclusion, TFM and TM are inexpensive, easily applicable, and accessible methods that can be used to reduce pain and lower urinary tract symptoms, improve QoL and sexual dysfunctions in female patients with CPP.
Scientific Responsibility Statement
The authors declare that they are responsible for the article’s scientific content including study design, data collection, analysis and interpretation, writing, some of the main line, or all of the preparation and scientific review of the contents and approval of the final version of the article.
Animal and human rights statement
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. No animal or human studies were carried out by the authors for this article.
Funding: None
Conflict of interest
The authors declare no conflict of interest.
References
1. Wang M, Xia R, Shi J, Yang C, Zhang Y, Xu Z, et al. Effect of high-frequency repetitive transcranial magnetic stimulation under different intensities upon rehabilitation of chronic pelvic pain syndrome: protocol for a randomized controlled trial. Trials. 2023;24(1):40.
2. Tettambel MA. An Osteopathic Approach to Treating Women with Chronic Pelvic Pain. Journal of Osteopathic Medicine. 2005; 105(4): 20-2.
3. Vincent K. Chronic pelvic pain in women. Postgrad Med J. 2009;85(999):24-9.
4. Fuentes-Márquez P, Cabrera-Martos I, Valenza MC. Physiotherapy interventions for patients with chronic pelvic pain: a systematic review of the literature. Physiother Theory Pract. 2019;35(12):1131-8.
5. Sağır K, Mutlu EK. Kronik Pelvik Ağrı: Pelvik Tabana Özgü Değerlendirme ve Manuel Yaklaşımlar (Chronic Pelvic Pain: Pelvic Floor Specific Evaluation and Manual Approaches). Sağlık Profesyonelleri Araştırma Dergisi/ Health Professionals Research Journal. 2021;3(2):103-13.
6. Thiele GH. Coccygodynia: cause and treatment. Dis Colon Rectum. 1963;6(5):422-36.
7. De Souza Montenegro MLL, Mateus-Vasconcelos EC, Candido dos Reis FJ, Rosa e Silva JC, Nogueira AA, Poli Neto OB. Thiele massage is a therapeutic option for women with chronic pelvic pain caused by the tenderness of pelvic floor muscles. J Eval Clin Pract. 2010;16(5):981-2.
8. Loew LM, Brosseau L, Tugwell P, Wells GA, Welch V, Shea B, et al. Deep transverse friction massage for treating lateral elbow or lateral knee tendinitis. Cochrane Database Syst Rev. 2014;(11).
9. Hayes MHS, Patterson DG. Experimental development of the graphic rating method. Psychol Bull. 1921;18:98-9.
10. Melzack R, Torgerson WS. On the language of pain. Anesthesiology. 1971;34(1):50-9.
11. Hunt SM, McKenna SP, McEwen J, Williams J, Papp E. The Nottingham Health Profile: subjective health status and medical consultations. Soc Sci Med. 1981;15(3):221-9.
12. Rosen C, Brown J, Heiman S, Leiblum C, Meston R, Shabsigh D, Ferguson R, D’Agostino R. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191-208.
13. Jackson S, Donovan J, Brookes S, Eckford S, Swithinbank L, Abrams P. The Bristol female lower urinary tract symptoms questionnaire: development and psychometric testing. Br J Urol. 1996;77(6):805-12.
14. Da Silva APM, Montenegro ML, Gurian MBF, De Souza Mitidieri AM, Da Silva Lara LA, Poli-Neto OB, E Silva JCR. Perineal massage improves the dyspareunia caused by The tenderness of the pelvic floor muscles. Rev Bras Ginecol e Obstet. 2017;39(1):26-30.
15. Oyama IA, Rejba A, Lukban JC, Fletcher E, Kellogg-Spadt S, Holzberg AS, Whitmore KE. Modified Thiele massage as a therapeutic intervention for female patients with interstitial cystitis and high-tone pelvic floor dysfunction. Urology. 2004;64(5):862-5.
16. Holzberg A, Kellog-Spadt S, Lukban J, Whitmore K. Evaluation of transvaginal Thiele massage as a therapeutic intervention for women with interstitial cystitis. Urology. 2001;57(6):122-5.
17. El-Hefnawy AS, Soliman HMM, Abd-Elbary SOM, Shereif WI. Long-standing nonulcerative bladder pain syndrome: Impact of Thiele massage on the bladder and sexual domains. Low Uriny Tract Symptoms. 2020;12(2):123-7.
18. FitzGerald MP, Anderson RU, Potts J, Payne CK, Peters KM, Clemens JQ, et al.; Urological Pelvic Pain Collaborative Research Network. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol. 2009;182(2):570-80.
19. Doley M, Warikoo D, Arunmozhi R. Effect of positional release therapy and deep transverse friction massage on gluteus medius trigger point- a Comparative Study. J Exerc Sci Physiother. 2013;9(1):40-5.
20. Doggweiler-Wiygul R, Wiygul PJ. Interstitial cystitis, pelvic pain, and the relationship to myofascial pain and dysfunction: A report on four patients. World J Urol. 2002;20(5):310-14.
21. Ersin A, Tarhan F, Başol G, Şakul BU, Algun ZC. The effect of transverse friction massage on pain and quality of life in women with chronic pelvic pain: a quasi-experimental study. International Journal of Therapy And Rehabilitation. 2023;30(6):1-8.
22. Dybowski C, Loewe B, Bruenahl C. Predictors of pain, urinary symptoms and quality of life in patients with chronic pelvic pain syndrome (CPPS): A prospective 12-month follow-up study. J Psychosom Res. 2018;112:99-106.
23. Bortolami A, Vanti C, Banchelli F, Guccione AA, Pillastrini P. Relationship between female pelvic floor dysfunction and sexual dysfunction: An observational study. J Sex Med. 2015;12(5):1233-41.
24. Schvartzman R, Schvartzman L, Francisco Ferreira C, Vettorazzi J, Bertotto A, Celeste Osório Wender M. Physical therapy intervention for women with dyspareunia: A randomized clinical trial. J Sex Marital Ther. 2019;1-31.
25. Shigeta M, Sekiguchi Y, Nakamura R. 037 Effects of Physical Therapy on Female Dyspareunia in Japan. J Sex Med. 2016;13(6):S255.
26. Marszalek M, Wehrberger C, Temml C, Ponholzer A, Berger I, Madersbacher S. Chronic pelvic pain and lower urinary tract symptoms in both sexes: Analysis of 2749 participants of an urban health screening project. Eur Urol. 2009;55(2):499-508.
Download attachments: 10.4328.ACAM.21780
Sena Öndeş, Aybüke Ersin. Comparison of the effectiveness of transverse friction massage and thiele massage in female patients with chronic pelvic pain. Ann Clin Anal Med 2023;14(9):797-802
Citations in Google Scholar: Google Scholar
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/
Do preoperative hemoglobin and hematocrit levels predict postoperative nausea and vomiting in orthognathic surgery patients? A retrospective case-control study
Seher Orbay Yasli, Dilek Gunay Canpolat, Fatma Dogruel, Canay Yılmaz Asan, Emrah Soylu, Ahmet Emin Demirbas
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Erciyes University, Kayseri, Turkey
DOI: 10.4328/ACAM.21786 Received: 2023-06-09 Accepted: 2023-07-10 Published Online: 2023-07-22 Printed: 2023-09-01 Ann Clin Anal Med 2023;14(9):803-807
Corresponding Author: Seher Orbay Yaşli, Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Erciyes University, Melikgazi, Kayseri, Turkey. E-mail: sehersin81@hotmail.com P: +90 352 207 66 66 F: +90 352 438 06 57 Corresponding Author ORCID ID: https://orcid.org/0000-0001-5163-3893
This study was approved by the Ethics Committee of Erciyes University Faculty of Medicine (Date: 2023-05-31, No: 2023/366)
Aim: Postoperative nausea and vomiting (PONV) is a common and distressing complication following orthognathic surgery. This retrospective study aimed to investigate the relationship between hemoglobin (Hgb) and hematocrit (HCT) levels and PONV occurrence in orthognathic surgery patients.
Material and Methods: A total of 52 patients who underwent orthognathic surgery were included in this retrospective analysis. Patients were divided into two groups: 26 patients who experienced PONV and 26 patients who did not. Demographic and clinical characteristics, including age, sex, American Society of Anesthesiologists (ASA) class, body mass index (BMI), operation time, and visual analog scale (VAS) scores for pain were compared between the groups. Hemoglobin and hematocrit levels were also compared, and receiver operating characteristic (ROC) analysis was performed to identify the optimal cut-off values for PONV prediction.
Results: No significant differences in age, sex, ASA class, or operation time were observed between the two groups. However, patients in the PONV group had significantly lower Hgb (12.9 ± 1.0 g/dL) and HCT (39.1 ± 3.0%) levels compared to those in the non-PONV group (14.2 ± 1.5 g/dL and 43.05 ± 3.5%, respectively; p < 0.001). The ROC analysis revealed that the optimal cut-off values for PONV prediction were Hgb ≤ 13.3 g/dL (AUC = 0.778, sensitivity = 73.08%, specificity = 69.23%, p < 0.001) and HCT ≤ 39.3% (AUC = 0.808, sensitivity = 65.38%, specificity = 88.46%, p < 0.001).
Discussion: Lower preoperative Hgb and HCT levels were significantly associated with the occurrence of PONV in orthognathic surgery patients. These findings suggest that Hgb and HCT levels may be useful predictive factors for PONV and can potentially assist in developing targeted preventive strategies to improve patient outcomes.
Keywords: Hematocrit, Hemoglobin, Orthognathic Surgery, Postoperative Nausea And Vomiting
Introduction
Postoperative nausea and vomiting (PONV) are common and distressing complications that occur following orthognathic surgery, with reported incidence rates ranging from 30% to 80% [1,2]. PONV can negatively affect patient comfort, prolong hospital stays, and increase healthcare costs [3]. Identifying patients at risk for PONV can facilitate the implementation of appropriate prophylactic measures and improve patient outcomes.
Several risk factors for PONV have been identified, including patient-related factors (e.g., female gender, history of motion sickness), anesthetic factors (e.g., volatile anesthetics, nitrous oxide), and surgical factors (e.g., duration of surgery, type of surgery) [4]. However, there is limited research on the relationship between preoperative hematological parameters and the incidence of PONV, particularly in patients undergoing orthognathic surgery.
Although PONV is a well-studied postoperative complication, its relationship with preoperative hematological parameters, specifically hemoglobin (Hgb) and hematocrit (HCT) levels, needs to be better established. Anemia, generally associated with low levels of Hgb and HCT, has been linked with an increased risk of postoperative complications [5,6]. However, data specifically associating these parameters with PONV are sparse. Hemoglobin and hematocrit levels primarily determine the oxygen-carrying capacity in the body, and their decreased levels are often associated with hypoxia, which could potentially influence the risk of PONV [7,8]. However, the exact mechanisms of how this influence occurs have yet to be entirely understood and warrant further investigation.
While several studies have indicated an association between anemia and general postoperative complications, more attention needs to be paid to PONV[9-10]. Given the scarcity of research specifically examining the relationship between Hgb, HCT, and PONV, especially in the context of orthognathic surgery, this study aimed to address this gap in the literature and provide new insights into potential predictors of PONV.
Also, Hgb and HCT levels have been shown to influence blood viscosity, which may affect cerebral blood flow and perfusion in the area postrema, the brain’s vomiting center [11]. As Hgb and HCT levels influence blood viscosity and potentially affect cerebral blood flow and perfusion in the area postrema, understanding their association with PONV is crucial.
Our study was guided by the following hypothesis – patients undergoing orthognathic surgery with lower preoperative hemoglobin and hematocrit levels may be more likely to experience postoperative nausea and vomiting than those with higher levels. This relationship could serve as a predictive tool for identifying patients at an increased risk of postoperative nausea and vomiting, thus guiding the implementation of preventive strategies.
Thus, this retrospective study investigated the association between preoperative Hgb and HCT levels and the occurrence of PONV in patients undergoing orthognathic surgery.
Material and Methods
In this retrospective study, we examined the medical records of a total of 52 patients who underwent surgery at our institution between January 2020 and December 2021. The study was conducted following approval from the Ethics Committee of the University’s Faculty of Medicine, with ethical approval number 2023/366. The study was conducted in accordance with the principles of the Declaration of Helsinki.
The inclusion criteria were adult patients (≥18 years) who had undergone elective surgery under general anesthesia. Exclusion criteria were patients with missing data, those with a history of motion sickness or PONV, and patients with chronic medical conditions that could affect the study results.
Intravenous 5-hydroxytryptamine (HT)-3 antagonist ondansetron was routinely administered to all orthognathic surgery patients, including those in this study, for PONV prophylaxis. The patients included 26 individuals who experienced PONV and another 26 individuals who did not experience PONV.
The study’s main objective was to investigate the relationship between PONV and various demographic and clinical factors, including hemoglobin Hgb and HCT levels. Nurses identified and recorded instances of PONV, defined as active vomiting, retching, or nausea followed by vomiting, in the patient’s medical records within the first 24 hours postoperatively.
Demographic and clinical data, including age, sex, American Society of Anesthesiologists (ASA) class, body mass index (BMI), operation time, and Hgb and HCT levels, were collected from the medical records.
Statistical Analysis
We used descriptive statistics to present the data in this investigation. Continuous variables exhibiting normal distribution were expressed as the mean ± standard deviation. We reported the median and minimum-maximum values for those not following a normal distribution. Categorical variables were presented as numbers and percentages. The normal distribution of numerical variables was assessed through the Shapiro-Wilk, Kolmogorov-Smirnov, and Anderson-Darling tests.
To analyze differences between categorical variables in 2×2 tables, we used the Pearson Chi-Square and Fisher’s Exact tests. For RxC tables, we utilized the Fisher-Freeman Halton test.
When comparing two independent groups for numerical variables exhibiting a normal distribution, we applied the Independent Samples t-test. For variables not following a normal distribution, we employed the Mann-Whitney U test for comparisons between independent groups.
To evaluate the predictive power of Hgb and HCT levels in relation to PONV, we conducted a Receiver Operating Characteristic (ROC) analysis. We computed the area under the curve (AUC), sensitivity, specificity, and cut-off values for both Hgb and HCT levels.
Statistical analysis was carried out using Jamovi (Version 2.3.24.0) and JASP (Version 0.17.1). A significance level (p-value) of 0.05 was set for all statistical tests. Power analysis was performed considering the effect sizes suggested by Cohen and using parameters consistent with similar studies in the literature [12]. For our specific study parameters, particularly the differences in preoperative hemoglobin (Hgb) levels between the two groups, the effect size was computed using Cohen’s d formula, yielding a value of 0.95 [(14.2 – 12.9) / sqrt((1.5^2 + 1.0^2) / 2)]. Following a post hoc power analysis, and setting an alpha level (Type I error rate) at 5%, it was determined that a sample size of 25 in each group (total of 50 individuals) was required to achieve a statistical power of approximately 95%. Therefore, based on our power analysis, the sample size in our study was considered adequate to detect the estimated effect size with a 5% Type I error rate.
Ethical Approval
Ethics Committee approval for the study was obtained.
Results
In the study, the demographic and clinical characteristics of all patients were assessed. The average age of the patients was found to be 21.2 years, with a majority of 67.3% being female and 32.6% being male. Most patients (92.3%) belonged to ASA class 1, while only 7.7% belonged to ASA class 2. The average operation time was determined as 264.3 minutes and the average BMI value was 22.4 kg/m2. The average Hgb value of all patients was 13.5 g/dL, and the average HCT value was 41.2% (Table 1).
In the comparison of patients with and without PONV, there were no significant differences in age (p=0.804), sex (p=0.768), ASA class (p=0.676), and operation time (p=0.652) (Table 2). However, the BMI was significantly higher in the PONV group (23.3 ± 2.5) compared to the non-PONV group (21.5 ± 2.8) (p=0.021). Both Hgb and HCT levels were significantly lower in the PONV group (12.9 ±1.0 g/dL and 39.1 ± 3.0%, respectively) compared to the non-PONV group (14.2 ±1.5 g/dL and 43.05 ± 3.5%, respectively) (p<0.001 for both) (Table 2).
To predict PONV, ROC analysis was performed to determine the cut-off values for Hgb and HCT (Table 3). The cut-off value for Hgb was determined to be ≤ 13.30 g/dL, with an AUC of 0.778, sensitivity of 73.08%, and specificity of 69.23% (95% CI: 0.600-0.852, p<0.001). The cut-off value for HCT was found to be ≤ 39.30%, with an AUC of 0.808, sensitivity of 65.38%, and specificity of 88.46% (95% CI: 0.685-0.904, p<0.001).
Discussion
This study examined the associations between PONV and demographic as well as clinical data that included age, sex, ASA class, BMI, operation time, and Hgb and HCT levels. These data were meticulously collected from the patients’ medical records. Our investigation revealed that a higher BMI and lower Hgb and HCT levels significantly contributed to the occurrence of PONV in patients.
Previous studies have reported associations between PONV and demographic and clinical factors. For instance, Apfel et al. conducted a large-scale study involving over 2500 patients. They identified female gender, a history of PONV or motion sickness, non-smoking status, and the use of postoperative opioids as significant risk factors for PONV [13]. Our study found a significant association between higher BMI and an increased risk of PONV. This finding aligns with numerous other studies in the literature. Qiu et al. conducted a retrospective study on same-day surgery patients and identified BMI as a predictor of PONV [14]. Similarly, Stephenson et al. observed a reduction in PONV after implementing preoperative risk stratification and adherence to a standardized antiemetic prophylaxis protocol, further supporting the association between higher BMI and PONV [15].
In contrast to our study, several other investigations have identified a significant relationship between lower BMI and the occurrence of PONV. For instance, Apipan et al. reported an association between PONV and lower BMI in patients undergoing oral and maxillofacial surgery [16]. Similarly, Silva et al. found a link between lower BMI and PONV in a retrospective study of patients who had orthognathic surgery [17]. Nitahara et al. observed an association between lower BMI and the risk of nausea and vomiting in adult patients following vitrectomy [18]. Furthermore, Kranke et al. demonstrated in a systematic review that an increased BMI does not pose a risk factor for PONV [19], while Kim et al. conducted a propensity analysis revealing the impact of BMI on postoperative nausea and vomiting [20].
While there are studies in the literature investigating the relationship between platelet count, mean platelet volume, neutrophil-to-lymphocyte ratio (NLR), and PONV, no studies specifically exploring the association between Hgb, HCT, and PONV were found. Our study contributes to this knowledge gap by examining the potential relationship between these hematological parameters and PONV. We found that lower Hgb and HCT levels were significantly associated with PONV. One possible explanation for this association could be the impact of Hgb and HCT on blood viscosity and oxygen-carrying capacity [21]. Lower Hgb and HCT levels may lead to reduced oxygen-carrying capacity and decreased tissue oxygenation. Similarly, lower HCT levels could result in decreased blood viscosity, which may contribute to PONV by reducing blood flow and oxygen delivery to the brain [22]. This situation could potentially trigger PONV. It is important to note that our patient population did not include any anemic patients. In elective orthognathic surgeries, preoperative examinations include an assessment for anemia. If anemia is detected, appropriate consultations are made, and treatment is initiated. Surgery is then scheduled at a suitable time following the completion of the necessary treatment for anemia.
Despite the absence of anemic patients in our study, evaluating the relationship between Hgb and HCT parameters and PONV and determining cut-off values could provide valuable guidance in effective PONV prevention. By considering these cut-off values, healthcare professionals may be better equipped to identify patients at risk for PONV and take appropriate measures to prevent its occurrence.
Limitations
Our study has some limitations that should be acknowledged. Firstly, the limited sample size may restrict the broad applicability of the conclusions drawn. Secondly, the study’s retrospective nature may introduce selection bias and limit the ability to establish a causal relationship between the variables. Lastly, as this research was conducted at a single institution, the generalizability of its findings to other contexts or demographic groups might be constrained.
Conclusion
The present study demonstrated that lower preoperative Hgb and HCT levels, as well as higher BMI, were significantly associated with PONV in patients undergoing orthognathic surgery. We also determined cut-off values for Hgb (≤ 13.30 g/dL) and HCT (≤ 39.30%), which may aid healthcare professionals in identifying patients at a higher risk of PONV. By considering these cut-off values, appropriate prophylactic measures can be implemented to improve patient outcomes. Further investigations involving multicenter studies and larger sample sizes are necessary to validate and strengthen the conclusions derived from our research, and to explore the potential underlying mechanisms linking Hgb, HCT, and PONV. Additionally, future research should investigate the role of other preoperative hematological parameters and their association with PONV.
Scientific Responsibility Statement
The authors declare that they are responsible for the article’s scientific content including study design, data collection, analysis and interpretation, writing, some of the main line, or all of the preparation and scientific review of the contents and approval of the final version of the article.
Animal and human rights statement
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. No animal or human studies were carried out by the authors for this article.
Funding: None
Conflict of interest
The authors declare no conflict of interest.
References
1. Apfel CC, Korttila K, Abdalla M, Kerger H, Turan A, Vedder I, et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med. 2004;350(24):2441-51.
2. Apfel CC, Heidrich FM, Jukar-Rao S, Jalota L, Hornuss C, Whelan RP, et al. Evidence-based analysis of risk factors for postoperative nausea and vomiting. Br J Anaesth. 2012;109(5):742-53.
3. Gan TJ, Diemunsch P, Habib AS, Kovac A, Kranke P, Meyer TA, et al. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2014;118(1):85-113.
4. Kovac AL. Update on the management of postoperative nausea and vomiting. Drugs. 2013;73(14):1525-47.
5. Musallam KM, Tamim HM, Richards T, Spahn DR, Rosendaal FR, Habbal A, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet. 2011;378(9800):1396-407.
6. Beattie WS, Karkouti K, Wijeysundera DN, Tait G. Risk associated with preoperative anemia in noncardiac surgery: a single-center cohort study. Anesthesiology. 2009;110(3):574-81.
7. Weiskopf RB, Viele MK, Feiner J, Kelley S, Lieberman J, Noorani M, et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA. 1998;279(3):217-21.
8. Hsia CCW. Respiratory function of hemoglobin. N Engl J Med. 1998;338(4):239-47.
9. Gupta PK, Sundaram A, Mactaggart JN, Johanning JM, Gupta H, Fang X, et al. Preoperative anemia is an independent predictor of postoperative mortality and adverse cardiac events in elderly patients undergoing elective vascular operations. Ann Surg. 2013;258(6):1096-102.
10. Leichtle SW, Mouawad NJ, Lampman R, Singal B, Cleary RK. Does preoperative anemia adversely affect colon and rectal surgery outcomes? J Am Coll Surg. 2011;212(2):187-94.
11. Dagal A, Lam AM. Cerebral autoregulation and anesthesia. Curr Opin Anaesthesiol. 2009;22(5):547-52.
12. Cohen J. A power primer. Psychol Bull. 1992; 112(1): 155-9.
13. Apfel CC, Laara E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology. 1999;91(3):693-700.
14. Qiu L, Cai J, Mei A, Wang X, Zhou Z, Sun J, et al. Predictors of Postoperative Nausea and Vomiting After Same-day Surgery: A Retrospective Study. Clin Ther. 2023;45(3):210-17.
15. Stephenson SJ, Jiwanmall M, Cherian NE, Kamakshi S, Williams A. Reduction in post-operative nausea and vomiting (PONV) by preoperative risk stratification and adherence to a standardized antiemetic prophylaxis protocol in the day-care surgical population. J Fam Med Primary Care. 2021;10(2):865-70.
16. Apipan B, Rummasak D, Wongsirichat N. Postoperative nausea and vomiting after general anesthesia for oral and maxillofacial surgery. J Dent Anesth Pain Med. 2016;16(4):273-81.
17. Silva AC, O’Ryan F, Poor DB. Postoperative nausea and vomiting (PONV) after orthognathic surgery: A retrospective study and literature review. J Oral Maxillofac Surg. 2006;64(9):1385-97.
18. Nitahara K, Sugi Y, Shono S, Hamada T, Higa K. Risk factors for nausea and vomiting following vitrectomy in adults. Eur J Anaesthesiol. 2007;24(2):166-70.
19. Kranke P, Apfel C, Papenfuss T, Rauch S, Löbmann U, Rübsam B, et al. An increased body mass index is no risk factor for postoperative nausea and vomiting: A systematic review and results of original data. Acta Anaesthesiol Scand. 2001;45(2):160-6.
20. Kim JH, Hong M, Kim YJ, Lee HS, Kwon YS, Lee JJ. Effect of Body Mass Index on Postoperative Nausea and Vomiting: Propensity Analysis. J Clin Med. 2020;9(6):1612.
21. Lenz C, Rebel A, Waschke KF, Koehler RC, Frietsch T. Blood viscosity modulates tissue perfusion: sometimes and somewhere. Transfus Altern Transfus Med. 2008;9(4):265-72.
22. Madjdpour C, Spahn DR, Weiskopf RB. Anemia and perioperative red blood cell transfusion: a matter of tolerance. Crit Care Med. 2006;34(Suppl.5):S102-8.
Download attachments: 10.4328.ACAM.21786
Seher Orbay Yasli, Dilek Gunay Canpolat, Fatma Dogruel, Canay Yılmaz Asan, Emrah Soylu, Ahmet Emin Demirbas. Do Preoperative Hemoglobin and Hematocrit Levels Predict Postoperative Nausea and Vomiting in Orthognathic Surgery Patients? A Retrospective Case-Control Study. Ann Clin Anal Med 2023;14(9):803-807
Citations in Google Scholar: Google Scholar
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/
Etiologic and demographic characteristics of patients with anisocoria
Gamze Yıldırım Biçer 1, Dilek İşcan 2
1 Department of Ophthalmology, 2 Department of Neurology, Faculty of Medicine, Niğde Ömer Halisdemir University, Nigde, Turkey
DOI: 10.4328/ACAM.21792 Received: 2023-06-13 Accepted: 2023-07-17 Published Online: 2023-08-08 Printed: 2023-09-01 Ann Clin Anal Med 2023;14(9):808-811
Corresponding Author: Gamze Yıldırım Biçer, Department of Ophthalmology, Faculty of Medicine, Niğde Ömer Halisdemir University, Bor Yolu, Nigde, Turkey. E-mail: gmz_y_06@hotmail.com P: +90 505 353 28 32 F: +90 388 212 14 11 Corresponding Author ORCID ID: https://orcid.org/0000-0003-3058-6308
This study was approved by the Non-Invasive Clinical Research Ethics Committee of Niğde Ömer Halisdemir University Faculty of Medicine (Date: 2023-01-26, No: 7/2023)
Aim: In this study, we aimed to present the etiological causes and clinical features of the patients followed for anisocoria and to determine the most common causes according to age groups.
Material and Methods: The medical records of the patients aged 18 years and over who were followed up for anisocoria between June 2017 and December 2022 were retrospectively reviewed. Two groups were formed including patients aged 18-45 as Group 1 and patients over 45 years old as Group 2. The etiological causes were divided into 4 groups as physiological anisocoria, pharmacological anisocoria, ocular pathologies and nervous system pathologies. It was examined whether there was a difference between the two groups in terms of four main etiological reasons.
Results: A total of 99 patients followed for anisocoria between January 2017 and December 2022 were included in the study analysis. The most common cause of anisocoria was found to be due to ocular pathologies (64 eyes, 64.6%). The second most common etiologic cause was found to be physiological anisocoria (20 eyes, 20.2%). Anisocoria was observed in 12 (12.1%) patients due to neurogenic dysfunction and in 3 (3%) patients due to pharmacological effects. There was no statistically significant difference between groups 1 and 2 according to etiological causes (p=0.089).
Discussion: The ocular pathologies were found to be the most common cause of anisocoria. The most common ocular causes detected also varied in parallel to demographic changes. There is a need for descriptive studies of the etiology of anisocoria with a higher number of participants.
Keywords: Anisocoria, Parasympathetic System, Pupil Diameter, Sympathetic System, 3rd Cranial Nerve
Introduction
Anisocoria is defined as a difference between two pupil diameters greater than 0.1 mm [1]. Benign causes such as physiological anisocoria can take place in the etiology of anisocoria, as well as life-threatening causes such as intracranial mass can be seen [2]. As in many diseases, first of all, a detailed anamnesis should be collected from the patient. The probability of a long-standing anisocoria is much less likely to represent a dangerous medical condition than a sudden onset of anisocoria. Therefore, it is necessary to question how long anisocoria has been present. Medical conditions such as medications used by the patient, history of eye and cranial trauma, and history of eye surgery should be questioned. After collecting a comprehensive anamnesis, an abnormal pupil needs to be identified. Changes in anisocoria to light provide valuable information about the underlying pathology. Since the pupil is dilated in the dark, anisocoria, which becomes more prominent in the dark, indicates that the smaller pupil is abnormal and points out that there is a problem in the sympathetic pathways. Since the pupil is required to shrink in the light, the larger pupil in the anisocoria that becomes evident in the light is abnormal and makes us think of a problem in the parasympathetic pathways [3].
Systemic and topical drug use, headaches, trauma, ophthalmologic diseases, autonomic ganglion pathology, and intracranial diseases are among the potential etiologies of anisocoria [4,5 ]. Since anisocoria can be an important clinical finding of nervous system dysfunction due to causes such as intracranial hemorrhage, cerebral neoplasm, aneurysm, and meningeal infiltration, it should be evaluated urgently and the underlying pathology should be revealed [4 ]. Literature studies of anisocoria are generally presented in the form of case reports. In our study, the etiological causes and clinical features of the patients followed for anisocoria were presented and the most common causes according to age groups were tried to be determined.
Material and Methods
This descriptive study was conducted retrospectively. The study was approved by the local ethics committee (Date: 26.01.2023, no: 7/2023) and was conducted in accordance with the Declaration of Helsinki. The medical records of patients aged 18 years and over who were followed up for anisocoria between June 2017 and December 2022 were retrospectively reviewed. The demographic characteristics of the patients such as age, gender, comorbidities and underlying etiological causes were analyzed. Two groups were formed: patients aged 18-45 years were included in Group 1 and patients over 45 years old were included in Group 2. The etiological causes were divided into 4 groups: physiological anisocoria, pharmacological anisocoria, ocular pathologies and nervous system pathologies.
Physiological anisocoria is a clinical condition in which the pupillary difference is usually 0.4-1.0 mm and this difference remains constant in dark and light, and there are no ophthalmological and neurological pathologies [6,7]. Pharmacological agents can cause both mydriasis and miosis. Ocular traumas and previous ocular surgeries, congenital anomalies, pseudoexfoliation syndrome (PES), iris disorders are the most common causes of ocular anisocoria. Aneurysms, intracranial hemorrhages and space-occupying lesions that cause 3rd cranial nerve (3rd CN) dysfunction can lead to parasympathetic nervous system dysfunction [1]. Hypothalamus lesions, spinal cord lesions, and carotid dissection, lung and thyroid diseases that can affect the cervical ganglia impaire the sympathetic discharge and thus a dysfunction in mydriasis can occur [1]. After our study patients were grouped into 4 main groups etiologically, the causes constituting each group were examined in detail. Ocular pathologies were grouped as congenital anomalies, iridocyclitis, traumatic iris defects, surgical iris defects, acute glaucoma crisis, benign episodic mydriasis, Adie’s tonic pupil, and PES. Causes causing neurogenic dysfunction were grouped as intracranial hemorrhages, intracranial masses, congenital 3rd CN pathologies, traumatic 3rd CN paralysis, non-traumatic 3rd CN paralysis (infection, inflammation, vascular, etc.), posterior communicating artery aneurysm and cervical ganglion and/or sympathetic nerve pathway pathologies.
It was examined whether there was a difference between the two groups in terms of 4 main etiological reasons. In addition, differences of the causes causing ocular pathologies between the two groups were statistically analyzed. A comparison between the 2 groups could not be made due to the very low number of patients having anisocoria depending on the neurogenic causes.
Statistical analysis
Data analysis was analyzed using SPSS version 25. Descriptive data were presented using mean, median, and percentage as appropriate. Differences in etiological factors between the two groups over 45 years old and under 45 years old were examined using the Pearson chi-square test. We considered p < 0.05 to be statistically significant.
Ethical Approval
Ethics Committee approval for the study was obtained.
Results
A total of 99 patients followed for anisocoria between January 2017 and December 2022 were included in the study analysis. Of 99 patients, 45 were female and 54 were male. The mean age of the patients was 49.97±21.57 years (range 18-88 years). The most common cause of anisocoria was found to be due to ocular pathologies (64 eyes, 64.6%). The second most common etiologic cause was found to be physiological anisocoria (20 eyes, 20.2%). Anisocoria was observed in 12 (12.1%) patients due to neurogenic dysfunction and in 3 (3%) patients due to pharmacological effects (Table 1).
There were 43 patients in Group 1, aged between 18-45 years, including 15 female patients and 28 male patients. Anisocoria was detected due to ocular causes in 22 patients, neurogenic dysfunction in 8 patients, and pharmacological effects in 2 patients. Physiological anisocoria was found in 11 patients. There were 30 female and 26 male patients in Group 2 (over 45 years old). The mean age was 66.84±10.48 (47-88) years. Similar to Group 1, ocular causes were seen in 42 (42.4%) patients and were found to be the most common cause. Physiological anisocoria was observed in 9 (9.1%) patients, and neurogenic dysfunction was observed in 4 (4%) patients. Pharmacological effects were observed in 1 (1%) patient in this group (Table 1). The most common and rarest etiological factors were found to be similar in both groups, and there was no statistically significant difference between the groups (p=0.089).
When the ocular pathologies causing anisocoria in Group 1 were examined among themselves, it was seen that the most common cause was trauma-related iris and sphincter defects (n=7, 7%). Congenital anomalies of the iris were found to be the second most common cause (n=6, 6%). Iridocyclitis was detected in 5 patients, surgical iris defects in 2 patients, and glaucoma crisis in 2 patients. PES, benign episodic mydriasis and Adie’s tonic pupil were not observed in Group 1.
The most common cause of anisocoria in Group 2 was iris defects secondary to ocular surgeries (n=16, 16.1%). There were glaucoma crises in 10 patients, PES in 7 patients, iris and sphincter defects due to trauma in 7 patients, and uveitis in 2 patients. Congenital anomalies of the iris, benign episodic mydriasis and Adie’s tonic pupil were not observed in Group 2. When the distributions of ocular pathologies were compared between the two groups, it was found that the two groups were statistically different from each other (p=0.000) (Table 2).
When the distribution of neurogenic pathologies causing anisocoria was examined in Group 1, the most common cause of the 3rd CN paralysis due to trauma was found. (n=4, 4%). Posterior communicating artery aneurysm was seen in 2 patients and intracranial hemorrhage was seen in 2 patients. In Group 2, 2 patients had intracranial hemorrhage, 1 patient had an intracranial mass, and 1 patient had nontraumatic 3rd CN palsy.
Discussion
Anisocoria is a clinical finding characterized by unequal pupil size. Anisocoria has a complex etiology ranging from benign causes to life-threatening causes. In our study, the potential etiologies of anisocoria were examined in 4 groups including physiological anisocoria, pharmacological anisocoria, ocular pathologies and pathologies that cause nervous system dysfunction. An attempt was made to determine the most common causes causing anisocoria in individuals aged 18-45 and over the age of 45. In both groups, anisocoria was most frequently caused by ocular pathologies and least by pharmacological agents.
Previous eye surgeries, traumas, iridocyclitis, PES, acute glaucoma crisis, congenital anomalies, benign episodic mydriasis and Adie’s tonic pupil are the main ocular causing anisocoria [1]. In our study, while ocular pathologies were the most common cause of anisocoria in both groups, they showed difference in terms of the variety of pathologies. It was found that the iris defects caused by trauma, most frequently in the 18-45 group, caused anisocoria. On the other hand, it was seen that the iris defects occurring secondary to the surgery most frequently caused anisocoria in the group over 45 years of age. While PES was not observed in the 18-45 age group, it is among the most common causes of anisocoria in individuals over the age of 45. Acute glaucoma crisis was seen 5 times more common in individuals over the age of 45 than in the age group of 18-45. Together with aging in the world, limitations and decreases occur in the activities of daily living of individuals and together with advancing age, an increase occurs in the incidence of ophthalmological diseases such as glaucoma, cataract, PES increases [8,9]. Having school and work life in individuals aged 18-45 can lead to a more active life and increase the likelihood of trauma exposure. These reasons explain the differences between the study groups.
Iris dysgenesis such as in coloboma, Axenfeld-Rieger syndrome, and congenital anomalies such as iris cysts can cause anisocoria by creating pupillary irregularity [10,11]. In our study, while anisocoria was detected due to the congenital anomalies in 6 patients aged 18-45 years, anisocoria depending on the congenital anomalies was not observed in any patient over 45 years of age. In acute iridocyclitis, miosis occurs in the pupillary due to iris edema and spasm of the sphincter muscle [12]. In our study, there was anisocoria depending on the iridocyclitis in 5 patients aged 18-45 years and in 2 patients over 45 years of age.
The parasympathetic nervous system causes miosis by activating the iris sphincter via the 3rd CN. These pathways arise in the brainstem and provide pupillary light reflex and accommodation. Pathologies that can occur on this pathway (such as intracranial hemorrhages and herniation, emboli, posterior communicating artery aneurysm) disrupt miosis and can cause anisocoria. In our study, 3rd CN paralysis was observed in 4 patients in the 18-45 age group depending on the trauma, intracranial hemorrhage was observed in 2 patients, and posterior communicating artery aneurysm was observed in 2 patients. In the patient group over 45 years of age, intracranial hemorrhage was observed in 2 patients, intracranial mass was observed in 1 patient, and non-traumatic 3rd CN paralysis was observed in 1 patient.
The sympathetic nervous system is responsible for mydriasis. Sympathetic fibers start from the hypothalamus, makes a synapse at C8-T2 spinal cord level, and extend along the sympathetic chain to synapse with a third neuron in the superior cervical ganglion. The third neurons proceed along the cavernous sinus and innervate the dilator pupillary muscle by entering into orbit [1,13,14 ]. Any pathology that will be able to affect this pathway (such as internal carotid artery dissection, Horner’s syndrome, lung apex tumors, thyroid diseases, cavernous sinus pathologies) can cause deterioration in mydriasis [1]. In our study, no anisocoria due to sympathetic dysfunction was found in either group.
In the literature, the prevalence of physiological anisocoria was reported to be around 10 % to 20% in general, and this rate varies from society to society [15]. The specific gender and age range for the physiological anisocoria has not been reported [16 ]. Physiological anisocoria was detected in 20 (20.2%) of 99 patients in our study. Eight of them were female and 12 were male.
Pharmacological agents affecting the sympathetic and parasympathetic nervous systems can alter pupil size. In general, drugs taken systemically do not cause anisocoria as both pupils will constitute shrinking or expanding, but these agents can cause anisocoria if administered to only one eye [17]. Nebulized bronchodilators such as ipratropium bromide can cause anisocoria by direct contact [18]. In our study, pharmacological anisocoria was detected in 3 patients treated with ipratropium bromide due to respiratory tract diseases.
Adie’s tonic pupil is a well-known cause of anisocoria and is more common in younger women. The diagnosis is made clinically. It is generally rare and its incidence was reported as 0.005% [19]. Benign episodic unilateral mydriasis is another cause of anisocoria. This phenomenon is thought to be related to the imbalance between the sympathetic and parasympathetic nervous systems [20]. In a neuroophthalmological study conducted, the incidence was found to be 0.08% [21]. These two diseases detected rarely were not detected in both patient groups in our study.
Limitations
As far as we know, the studies regarding anisocoria in the literature are found mainly in case reports. The fact that our study is one of the rare studies on the etiology of anisocoria makes our study strong. On the other hand, anisocoria formed in life-threatening situations may have been overlooked and not evaluated due to the need for urgent intervention. We can say that this situation is the most important limitation of our study. On the other hand, we think that we provide valuable information about the ocular causes of anisocoria.
Conclusion
In conclusion, ocular pathologies were found to be the most common cause of anisocoria. The most common ocular causes detected also varied in parallel to demographic changes. While trauma-induced anisocoria was seen in the age group of 18-45, anisocoria depending on the previous surgeries over the age of 45 was seen in the majority. There is a need for descriptive studies of the etiology of anisocoria with higher number of participants.
Scientific Responsibility Statement
The authors declare that they are responsible for the article’s scientific content including study design, data collection, analysis and interpretation, writing, some of the main line, or all of the preparation and scientific review of the contents and approval of the final version of the article.
Animal and human rights statement
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. No animal or human studies were carried out by the authors for this article.
Funding: None
Conflict of interest
The authors declare no conflict of interest.
References
1. Bakbak B, Gedik Ş. Anisocoria.Turk J Ophthalmol. 2012; 42(Suppl.):S68-72.
2. Witten NAK, Di Rocco PJ. The “Blown Pupil”: Imminent Death or Harmless Contamination? Hawaii J Health Soc Welf. 2019; 78(10): 308-10.
3. Biçer G Y, Zor KR, Küçük E. Do static and dynamic pupillary parameters differ according to childhood, adulthood, and old age? A quantitative study in healthy volunteers. Indian J Ophthalmol. 2022; 70(10): 3575-8.
4. Senthilkumaran S, Balamurugan N, Suresh P, Thirumalaikolundusubramanian P. Transient anisocoria: A pesky palpitation. J Neurosci Rural Pract. 2011; 2(2): 210-11.
5. Fierz FC, Gerth-Kahlert C. Long-Term Follow-Up in Children with Anisocoria: Cocaine Test Results and Patient Outcome. J Ophthalmol. 2017; 2017: 7575040.
6. Bosten JM, Lawrance-Owen AJ, Bargary G, Goodbourn PT, Mollon JD. 13q32.1 as a candidate region for physiological anisocoria. Br J Ophthalmol. 2022; DOI: 10.1136/bjophthalmol-2021-319936.
7. Prescott BR, Saglam H, Duskin JA, Miller MI, Thakur AS, Gholap EA, et al. Anisocoria and Poor Pupil Reactivity by Quantitative Pupillometry in Patients With Intracranial Pathology. Crit Care Med. 2022; 50(2): e143-e53.
8. Ay İ, Til A. Ocular Characteristics of Home Care Patients Over the Age of 65 Who Are on the Verge of Developing Ocular Diseases. Osmangazi J. Med. 2023; 45(1):110-17.
9. Schweitzer C. Pseudoexfoliation syndrome and pseudoexfoliation glaucoma. J Fr Ophtalmol. 2018; 41(1): 78-90.
10. Parakh S, Das S, Maheshwari S, Luthra G, Luthra S. Atypical superior iris and chorioretinal coloboma. Indian J Ophthalmol. 2022; 70(7): 2665-6.
11. Bengarai W, Chokrani H, Berraho A. Axenfeld-Rieger syndrome. J Fr Ophtalmol. 2018; 41(5): 470-1.
12. van der Woerdt A. Management of intraocular inflammatory disease. Clin Tech Small Anim Pract. 2001; 16(1): 58-61.
13. McDougal DH, Gamlin PD. Autonomic control of the eye. Compr Physiol. 2015;5(1):439-73.
14. Prasad S. A Window to the Brain: Neuro-Ophthalmology for the Primary Care Practitioner. Am J Med. 2018; 131(2): 120-8.
15. Antonio-Santos AA, Santo RN, Eggenberger ER. Pharmacological testing of anisocoria. Expert Opin Pharmacother. 2005; 6(12): 2007-13.
16. George AS, Abraham AP, Nair S, Joseph M. The Prevalence of Physiological Anisocoria and its Clinical Significance – A Neurosurgical Perspective. Neurol India. 2019; 67(6): 1500-3.
17. Caglayan HZ, Colpak IA, Kansu T. A diagnostic challenge: dilated pupil. Curr Opin Ophthalmol. 2013; 24(6): 550-7.
18. Derinoz-Guleryuz O, Fidanci İ, Men-Atmaca Y. Nebulized Ipratropium Bromide-induced Anisocoria: Why Is Anisocoria Observed? Iran J Allergy Asthma Immunol. 2021; 20(1): 125-8.
19. Chan RY, Hernandez MP. Incidence and Clinical Presentation of Adie’s Tonic Pupil Syndrome: Half-decade Experience. Invest Ophthalmol Vis Sci. 2002; 43(13):2647.
20. Schiemer A. Benign Episodic Unilateral Mydriasis in a Flight Nurse. Aerosp Med Hum Perform. 2017; 88(5): 500-2.
21. Martín-Santana I, González-Hernández A, Tandón-Cárdenes L, López-Méndez P. Benign episodic mydriasis. Experience in a specialist neuro-ophthalmology clinic of a tertiary hospital. Neurologia. 2015; 30(5): 290-4.
Download attachments: 10.4328.ACAM.21792
Gamze Yıldırım Biçer, Dilek İşcan. Etiologic and demographic characteristics of patients with anisocoria. Ann Clin Anal Med 2023;14(9):808-811
Citations in Google Scholar: Google Scholar
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/
COVID-19 patients with chronic disease symptoms at a Tertiary Care Hospital in Turkey
Semih Eriten
Department Of Emergency, Sultanbeyli State Hospital, Istanbul, Turkey
DOI: 10.4328/ACAM.21795 Received: 2023-06-17 Accepted: 2023-07-31 Published Online: 2023-08-10 Printed: 2023-09-01 Ann Clin Anal Med 2023;14(9):812-815
Corresponding Author: Semih Eriten, Department Of Emergency, Sultanbeyli State Hospital, 34935, Istanbul, Turkey. E-mail: semiheriten@hotmail.com P: +90 533 614 32 00 Corresponding Author ORCID ID: https://orcid.org/0000-0001-8516-372X
This study was approved by the Ethics Committee of Malatya Training and Research Hospital (Date: 2020-08-06, No: 23536505-000-13874)
Aim: The aim of this study is to evaluate the treatment of chronic diseases, which have a significant place in the course and mortality from COVID-19, taking into account the experience of a tertiary hospital.
Material and Methods: The study included a group of 407 patients with chronic disease symptoms who were followed up at the COVID-19 Polyclinic of Malatya Training and Research Hospital between August 1, 2020 and December 31, 2020. The research data were examined by the researcher using archive materials of COVID-19 Polyclinic according to the parameters determined by the researcher. The researcher gathered information about these study sample parameters from patient files and saved it in a Microsoft Office Excel file.
Results: In our study, patients with positive PCR test results had 30.9% asthma, 23.6% arrhythmia, 16.4% HT, 10.9% heart failure and 9.1% DM. Among patients with negative PCR results, 20.5% had HT, 17.6% had DM, 16.2% had asthma, 16.2% had arrhythmia and 11% had COPD.
Discussion: Based on the results of the study, it can be concluded that there is a significant association between chronic diseases and PCR test results. This suggests that individuals with pre-existing chronic conditions may be more prone to contracting the virus and testing positive for COVID-19.
Keywords: Chronic Diseases, Course Of COVID-19, COVID-19, Viral Infection, Patient Management
Introduction
In December 2019, a novel coronavirus virus was identified during the investigation of reported cases of viral pneumonia in Wuhan, China. In the early stages of discovery, the virus was called 2019-nCoV, due to its resemblance to the “Severe Acute Respiratory Syndrome (SARS)” virus. Then the name “SARS-CoV-2” was given. Due to the spread of the illness, the WHO declared it a global pandemic in March 2020. As of May 12, 2020, 4.2 million individuals were infected with a new coronavirus strain called Coronavirus Disease 2019 (COV1D-19), resulting in 291,200 deaths [1]. The disease has spread across the globe, infecting over 100 nations. As of July 30, 2021, it was estimated that at least 186 million individuals have been infected, 4,189,148 of them have already died.
Information on the clinical characteristics of the illness was enhanced as a result of the COVID-19 data. At-risk individuals who had COVID-19 infection were unable to receive immediate medical attention, which led to a high case fatality rate [2].
Chronic diseases, in fact, have formed a silent worldwide epidemic, which, when combined with the COVID-19 epidemic, has prepared the ground for the epidemic’s effects to be increased. The early data revealed that the disease is more common and has a more severe course in people who have chronic diseases. In a research published in Wuhan in January 2020, 51% of 99 patients had at least one chronic disease, with the majority of these diseases being cardiovascular diseases (CVD), cerebrovascular diseases (CVD), and DM [3].
The purpose of this study is to evaluate the management of chronic diseases, which have a significant place in the course and mortality of COVID-19, taking into account the experience of a tertiary hospital.
Material and Methods
This research was designed as a single-center retrospective study evaluating the management of patients with a history of chronic disease who presented with the complaint of COVID-19 infection to COVID-19 Polyclinic of Malatya Training and Research Hospital between August 1, 2020 and December 31, 2020. The study was approved by the ethics committee of Malatya Training and Research Hospital (approval number: 23536505-000-13874).
Patients who presented with COVID-19 infection to the COVID-19 Polyclinic of Malatya Training and Research Hospital between August 1, 2020 and December 31, 2020 and met the inclusion criteria for the research sample were included in the study.
The epidemiological characteristics (age, gender) and chronic diseases types of the patients constituting the sample of the study were determined. Information about these parameters of the sample of the study was obtained from the patient files and saved in the Microsoft Office Excel file by the researcher.
Clinical evaluation. Severe COVID infection was defined as dyspnea <50% increase in lung infiltration on CT within 24-48 hours, oxygen saturation <93%, PaO2/FiO2 <300, and septic shock [4]. In the center where the study was conducted, CP was applied to these cases.
Statistical Analysis
Within the scope of the study, Table 1 and Table 2 were created to examine the distribution of PCR test results and symptoms in patients. SPSS (Statistical Package for the Social Sciences) statistical analysis software was used to obtain descriptive statistics and evaluate relationships.
Ethical Approval
Ethics Committee approval for the study was obtained.
Results
The distribution of signs/symptoms and PCR test results seen in the patients included in the study is presented in Table 1.
The distribution of PCR test results of patients with a history of chronic disease is given in Table 2.
Discussion
Chronic diseases are those that progress slowly, last three months or longer, are caused by risk factors, have a complicated course, and negatively impact a person’s quality of life. These diseases are the primary cause of mortality in developed and developing countries all over the world, and are risk factors that increase case fatality rates in the COVID-19 epidemic [5]. COVID-19 patients had fever, shortness of breath, and radiological findings consistent with bilateral lung pneumonic infiltration. Individuals with advanced age or concomitant systemic disease (hypertension, diabetes, cardiovascular disease, cancer, and other immunosuppressive conditions, particularly chronic lung diseases) are more likely to die [6].
Type 2 DM is one of the chronic diseases that usually accompany COVID-19 disease and impacts the disease’s course and mortality. The Centers for Disease Control and Prevention (CDC) evaluated 20,982 patients in China, where the prevalence of diabetes is 10.9%, and found DM in 5% of the patients [7]. In a study from Italy on 1591 patients with severe COVID 19, 180 (17%) of the patients had DM [8].
In many epidemiological studies published on COVID-19, hypertension (HT) is the most common comorbidity. Many observational studies from China have shown that when COVID-19 patients suffer HT, their mortality and morbidity increase [9]. In an observational cohort study of 1004 suspected COVID-19 patients from 25 Chinese hospitals, 12% of 188 patients diagnosed with COVID-19 were found to have HT, compared to 7% in 816 undiagnosed patients [10].
Although comorbidities are less prominent in COVID-19 patients than in DM and HT, studies have indicated that CVDs are important in the progression of infection and mortality. In a retrospective investigation of 1590 cases from 575 hospitals in China, CVD was found in 3.7% of the patients [11]. In a study of 5700 COVID-19 patients hospitalized in New York, where more than 30% of cases are seen, CAD was found in 595 (11.1%) patients and congestive heart failure in 371 (6.9%) [12].
The median age of the 1099 patients in a multicenter epidemiological study in China was 47, the disease was more common in men (52.1%), and 23.7% of the patients had at least one concomitant chronic disease (such as hypertension (HT), diabetes (DM), and chronic obstructive pulmonary disease (COPD). According to the same study, 2.3% required invasive mechanical ventilation, 5.1% required intensive care, and 1.4% died [13]. According to the results of a systematic review by Zhu et al., males were more likely to be infected (56.9%). The main clinical features were fever (80.4%), fatigue (46%), cough (63.1%) and expectoration (41.8%). In the same study, respiratory failure or acute respiratory distress syndrome was observed in 19.5% of cases and mortality rate was 5.5% [14]. When the distribution between PCR test result and chronic diseases was analyzed in our study, it was found that 30.9% had asthma, 23.6% had arrhythmia, 16.4% had HT, 10.9% had heart failure and 9.1% had DM. Among patients with negative PCR results, 20.5% had HT, 17.6% had DM, 16.2% had asthma, 16.2% had arrhythmia, and 11% had COPD. The distribution between the signs/symptoms observed in the patients and PCR test results and PCR test results of patients with a history of chronic diseases are similar to those found in the literature.
The presence of chronic diseases increases the risk of contracting COVID-19, as well as significantly affects the course of the disease in infected patients, causing an increase in mortality and the need for intensive care. Close monitoring and control of chronic diseases will not only positively change the course of the COVID-19 disease, but will also enable the correct use of limited resources in the health sector. With the emergence of the COVID-19 virus, many uncertainties remain regarding some epidemiological, seroepidemiological (related to the identification of antibodies in the population), clinical and virological features of the virus, and related disease. Researche to evaluate these features in different environments is crucial.
Scientific Responsibility Statement
The authors declare that they are responsible for the article’s scientific content including study design, data collection, analysis and interpretation, writing, some of the main line, or all of the preparation and scientific review of the contents and approval of the final version of the article.
Animal and human rights statement
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. No animal or human studies were carried out by the authors for this article.
Funding: None
Conflict of interest
The authors declare no conflict of interest.
References
1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-33.
2. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) – China, 2020. China CDC Wkly. 2020; 2(8):113-22.
3. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-62.
4. Çelik I, Öztürk R. From asymptomatic to critical illness: decoding various clinical stages of COVID-19. Turk J Med Sci. 2021; (SI-1):3284-300.
5. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223):507-13.
6. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223): 497-506.
7. Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr. 2020; 14(4):303-10.
8. Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical Characteristics of Covid-19 in New York City. N Engl J Med. 2020; 382(24):2372-74.
9. Patel AB, Verma A. COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence? JAMA. 2020; 323(18):1769-70.
10. Mao B, Liu Y, Chai YH, Jin XY, Lu HW, Yang JW, al. Assessing risk factors for SARS-CoV-2 infection in patients presenting with symptoms in Shanghai, China: a multicentre, observational cohort study. The Lancet Digital Health. 2020; 2(6):e323-30.
11. Liang WH, Guan WJ, Li CC, Li YM, Liang HR, Zhao Y, et al. Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicenter) and outside Hubei (non-epicenter): A Nationwide Analysis of China. Eur Respir J. 2020; 55(6): 2000562.
12. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA. 2020; 323(20):2052-9
13. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382(18):1708-20.
14. Zhu J, Ji P, Pang J, Zhong Z, Li H, He C, et al. Clinical characteristics of 3,062 COVID-19 patients: a meta-analysis. J Med Virol. 2020; 92(10): 1902-14.
Download attachments: 10.4328.ACAM.21795
Semih Eriten. COVID-19 patients with chronic disease symptoms at a Tertiary Care Hospital in Turkey. Ann Clin Anal Med 2023;14(9):812-815
Citations in Google Scholar: Google Scholar
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/
Evaluation of the use of three ports in total laparoscopic hysterectomies
Aylin Önder Dirican
Department of Gynecology and Obstetrics, Konya Başkent Universty, Konya, Turkey
DOI: 10.4328/ACAM.21796 Received: 2023-06-20 Accepted: 2023-08-30 Published Online: 2023-08-30 Printed: 2023-09-01 Ann Clin Anal Med 2023;14(9):816-820
Corresponding Author: Aylin Önder Dirican, Department of Gynecology and Obstetrics, Başkent Universty, Ankara, Turkey. E-mail: dr.aylinonder@gmail.com P: +90 505 937 31 08 Corresponding Author ORCID ID: https://orcid.org/0000-0002-5121-6317
This study was approved by the Clinical Research Ethics Committee of Karatay University Faculty of Medicine (Date: 2023-05-25, No: 2023/029)
Aim: The aim of this study is to evaluate the patient profile in which fewer ports can be used in laparoscopic hysterectomy.
Material and Methods: The study is based on cases performed by a team experienced in laparoscopic hysterectomy in a tertiary education and research hospital. Variables of patients were collected retrospectively from hospital electronic medical databases and analyzed. The use of 4 ports and 3 ports in laparoscopic hysterectomy was compared in terms of uterine weights, blood parameters and complications.
Results: Of a total of 201 patients, 28% (56) were operated using 4 ports (port-4 group), 72% (145) using 3 ports (port-3 group). The mean age of the patients was 49.03 (±4.53) years. Mean gravida, parity, and history of abdominal surgery were similar in both groups. Preoperative and postoperative hematocrit and hemoglobin values were similar in both groups. Although the need for blood transfusion was higher in the port-4 group (13%) than in the port-3 group (6.9%), no significant difference (p=0.26) was observed. Mean uterine weight (gr) was found to be significantly (p<0.001) lower in the port-3 group (193.03±45.60) than in the port-4 group (237.25±57.16). Total operation time (min) was significantly shorter (p<0.001) in the port-3 group (68.52±14.94) compared to the port-4 group (91.91±23.96). Postoperative complication rates were similar in both groups.
Discussion: Laparoscopic hysterectomies may be associated with a reduced number of ports, shorter operation time and less need for blood transfusion in patients with a smaller uterus.
Keywords: Laparoscopy, Hysterectomy, 3-Port
Introduction
Today, minimally invasive surgery is preferred in most of the gynecological surgeries [1]. Many studies have shown many advantages of laparoscopic surgery over abdominal surgery, such as shorter hospital stay, shorter return to normal life, less infection rate, less pain, and better cosmetic results [2,3]. Hysterectomy is the most common surgical procedure in women. The most common indications for hysterectomy are unresponsive to medical therapy menorrhagia, leiomyoma, adenomyosis, prolapse of the pelvic organs, and chronic pelvic pain [4]. Although the type of hysterectomy operation depends on many factors such as the surgeon’s experience, uterus size, previous surgeries, and technical equipment, it is the most preferred minimally invasive surgery today [5]. Laparoscopic hysterectomy rates, which accounted for only 1% of all hysterectomies in the 1990s, have reached 30% in many countries today [6].
With the development of knowledge and technology over the years, the importance of minimally invasive surgery, especially in terms of complications, has been understood in conditions such as adhesions due to previous surgeries, a large uterus with multiple fibroids and obesity [7]. In laparoscopic hysterectomy, usually 4 or more ports can be used depending on the size of the uterus or the condition of intra-abdominal adhesions [8]. Since the benefits of minimally invasive surgery in terms of patient health and comfort are seen, it seems inevitable that the current procedure will evolve for the better. In this direction, applications such as reducing the abdominal entrance incisions or reducing the diameter of the ports are on the agenda. Evidence suggests that reducing port entries demonstrated comparable complication rates and reduced postoperative immediate pain [9]. In particular, to reduce the number of ports, alternatives include 2-port, multi-channel and single-port hysterectomy procedures [10,11]. Problems such as loss of triangulation and hand collision have emerged in single-port hysterectomy surgeries [12]. In addition, a large meta-analysis showed that although multiport laparoscopy from a single site found better cosmetic results, the operative time was increased [13]. While 2-port multi-channel techniques provided better triangulation, it was found to be associated with more postoperative pain due to the larger fascial defect [14, 15].
The aim of this study is to evaluate the results of total laparoscopic hysterectomy using three single-channel ports, including the camera port, in patients with increased uterine weight due to uterine myomatosis and/or adenomyosis, by comparing them with those using classical four ports.
Material and Methods
Study design
This study is a retrospective analysis of laparoscopic hysterectomy performed for benign reasons. The data of 243 patients who underwent total laparoscopic hysterectomy between January 2017 and December 2020 in Konya Training and Research Hospital, a tertiary hospital, were retrospectively analyzed from the hospital database. This study was planned after the approval of Karatay University Faculty of Medicine Clinical Research Ethics Committee (2023/029).
Data collection
Demographic and clinical characteristics of the patients included in the study, such as age, pregnancy history, menopausal status, previous abdominal surgeries, surgery indications, uterine specimen weights, intraoperative and postoperative complications, blood parameters and blood transfusion need, were recorded from the database. Patients who had undergone surgery for uterine myoma and adenomyosis and whose records were complete were included in the study. Possible malignancies were excluded by performing fluid-based cytology and endometrial sampling before surgery in all patients. A total of 201 patients were included in the study, excluding patients who had undergone supracervical hysterectomy, patients with pelvic organ prolapse requiring additional surgical repair, and patients requiring surgery for endometriosis or adnexal tumors. The patients were divided into 2 groups according to the single-channel three or four-port ports used during the operation, and all variables were compared between the two groups.
Definitions
Definitions The operations were performed by the same surgical team experienced in laparoscopic surgery, accredited by the Turkish Society of Minimally Invasive Gynecology, and certified in advanced endoscopic surgery [available at: http://minimalinvazivjinekolojikcerrahi.org].
In all operations, after endotracheal intubation under general anesthesia, the patients were placed in the lithotomy position and the arms were folded. After urinary catheterization and patient preparation, a 10 mm trocar was placed 3-5 cm above the umbilicus according to the size of the uterus, pneumoperitoneum was created, and then a 30° laparoscope was inserted through this port. In the Port-4 group, 2 ipsilateral 5mm trocars were placed on the left abdominal side walls and the last 5mm trocar was placed on the right abdominal wall [16]. In the Port-3 group, only 2 ipsilateral 5 mm trocars were placed on the left abdominal lateral wall. Abdominal lateral wall trocars were placed lateral to the inferior epigastric vessels [16]. In all cases, the same uterine manipulator, the rod of which was made of non-conductive material, was used and set to zero, completely covering the cervix and vagina. After the uterine manipulator and trocars were placed, classical hysterectomy steps were performed in both groups. With or without oophorectomy, bilateral salpingectomy was performed in both groups, and the first step was separation and closure of the ligamentum rotundum, followed by bladder dissection and vesicouterine space opening. By taking the uterus into lateral traction, the anterior leaf of the Broad ligament is opened parallel to the infundibulopelvic ligament with the help of bipolar forceps. A window is created in the posterior leaf of the broad ligament, medial to the ureter, under direct view of the ureters. If the ovaries are to be removed, the peritoneum is released from the lateral side of the gonadal vessels on both sides so that the ureter is fully visible. The gonadal vessels are then dried and cut with bipolar current. If the ovaries are to be left intact, the utero-ovarian ligament is sealed and cut on both sides. After the bladder flap is sharply created, the uterine arteries are sealed and cut with bipolar current. After adequate bladder dissection, the vaginal cuff is exposed and cut with a monopolar hook. After the uterus is released, it is removed vaginally and the vaginal cuff is sutured vaginally with No. 1 vicryl. In the first observation, in patients with intra-abdominal adhesions, adhesiolysis was performed using cold scissors or bipolar forceps. The total time to surgery was defined as the time from incision to closure.
Both groups were compared in terms of demographic characteristics, operation time, uterine weight, pre-/post-operative blood parameters, need for blood transfusion, and intra- and postoperative complications.
Statistical analysis
Mean and standard deviation for numerical variables, Frequency and percentage were used for categorical variables. T-test, Chi-square and Fisher tests were used for the analysis of numerical variables. Exact test was used in the analysis of categorical variables.
Analyzes were made with the R 4.2.2 program and p<0.05 was considered significant.
Ethical Approval
Ethics Committee approval for the study was obtained.
Results
A total of 201 patients who underwent laparoscopic hysterectomy and met the inclusion criteria were analyzed for the study. Clinical and demographic characteristics are given in Table 1. The mean age of the patients was 49.03±4.53, mean gravida 3.32±1.25 and parity 2.81±1.07. Of the patients, 28% (56) were operated using four ports and 72% (145) using three ports. The most common indication for laparoscopic hysterectomy was uterine myomatosis (134, 67%). Other pathologies were adenomyosis (17%; 35) and coexistence of uterine myomatosis and adenomyosis (16%; 32). The mean uterine specimen weight of all patients was 205.35±52.83. Blood transfusion was performed in 8.5% of the patients. Intraoperative complication was detected in one patient, and postoperative complications in two patients (Table 1). None of the patients underwent laparotomy, and the intraoperative bladder defect in one patient in the port-4 group was repaired laparoscopically. Minor cuff hematoma that developed in 2 patients within the first 10 days after surgery was followed up on an outpatient basis until it resolved spontaneously without the need for additional intervention.
Table 2 shows the comparison of the characters according to the port numbers. The mean age was 47.93±3.76 years in the port-4 group and was significantly (p=0.018) lower than in the port-3 group. Gravida, parity, menopausal status, and history of laparotomic abdominal surgery were similar in both groups (p= 0.22, p= 0.077, p=0.18, p=0.62, respectively). Preoperative and postoperative hematocrit and hemoglobin values were similar in both groups. Although the need for blood transfusion was higher in the port-4 group (13%) than in the port3 group (6.9%), no significant difference (p=0.26) was observed. Cases undergoing oophorectomy and adhesiolysis during TLH were similar in both groups (p=0.13, p=0.28, respectively). While intraoperative complication was not observed in the port-3 group, it was observed in one case (1.8%) in the port-4 group and was not significant between the groups (p=0.077). Postoperative complications were seen in one case in each group (Port-3 0.7%, Port-4 1.8%) and there was no significant difference between the groups (p=0.48). Mean uterine weight (gr) was found to be significantly (p<0.001) lower in the port-3 group (193.03±45.60) than in the port-4 group (237.25±57.16). Total operation time (min) was significantly shorter (p<0.001) in the port-3 group (68.52±14.94) compared to the port-4 group (91.91±23.96). Patients with only adenomyosis and only uterine myomatosis had higher rates in the port-3 group (19%, 70%, respectively) than in the port-4 group (14%, 59%, respectively). On the other hand, patients with uterine myomatosis and adenomyosis were observed higher in the port-4 group (27%) than in the port-3 group (12%). These differences in the indications of the operations were statistically significant (p=0.032) (Table 2).
Discussion
Today, even in minimally invasive surgery, new surgical techniques and equipment continue to be developed for less pain, less complications, same day discharge, less cost and much better cosmetic results. Attempts to reduce the number of ports in laparoscopic surgery are associated with less pain and intraoperative complications, as well as better cosmetic outcomes and patient satisfaction [17]. In this study, the possible effects of reducing the number of ports in TLH operations performed in patients with similar indications and in which patients they can be preferred were tried to be evaluated.
In our study, we compared the use of four ports and three ports in TLH operations. In all cases, the camera port (10mm) was placed 0-3cm above the umbilicus according to the size of the uterus. Proper trocar position provides adequate operative field vision and adequate mobility for instruments. Especially in cases with a large uterus, the supraumbilical camera port entry is important for a wide field of view [18]. Considering that the normal uterus weight is approximately 70 grams in an adult woman, the average uterus weight (205 grams) found in this study was found above normal. On the other hand, when the weight of the uterus exceeds approximately 280 grams, it is generally considered large and it is generally recommended to use 4 or more ports in laparoscopic hysterectomies above this weight [19]. In our study, the mean uterine weight (193 grams) of the patients we used 3 ports was significantly lower than the uterine weight (243 grams) of the patients who we used 4 ports, in line with the literature.
In our study, history of previous laparotomic abdominal surgery was similar for both groups. In addition, the rates of additional adhesiolysis were similar in both groups. This means that even if a previous abdominal surgery causes intra-abdominal adhesions, it will not be a limiting factor for reducing the number of ports. It is known that complication rates increase in subsequent abdominal surgeries, especially in women who have had a previous cesarean section [20]. However, it is difficult to predict the possible effects of previous abdominal surgeries for the hysterectomy type [21]. Previous abdominal surgeries are no longer considered risk factors for complications of laparoscopic surgery [7].
In this study, although the blood parameters were higher and the need for blood transfusion was lower in the port-3 group, it could not reach statistical significance. Since larger uteruses have more vascular structure, the need for blood transfusion is higher in patients both because of preoperative abnormal uterine bleeding and because of intraoperative bleeding [19]. A large uterus can lead to limited vision and instrument movement, and an increase in complications such as bleeding, urinary and bowel injury [22]. In this study, there was no significant difference between the two groups in terms of intraoperative and postoperative complications. There were no intraoperative complications in the Port-3 group, and there were no major complications such as urinary system and bowel injuries in both groups. In addition, total operation times were significantly shorter in the port-3 group (an average of 69 minutes) in our study. Zeng et al. described a three-port technique for laparoscopic hysterectomy in patients with a large uterus (over 800 g) in a case series of 18 patients with a mean duration of 107 minutes [19]. Tyan et al., in their study comparing the use of 2 and 4 ports in TLH, found shorter operative time and less blood loss in the 2-port group with a smaller weight (mean 143.1gr) uterus, similar to our results. In the same study, intraoperative and postoperative complication rates were similar between the groups [23].
In terms of operation indications, the cases in which uterine myomatosis and adenomyosis were seen together were significantly higher in the port-4 group. It is natural that more ports are needed for more uterine manipulation in laparoscopic surgeries performed in large uteruses.
Screening for surgical indications that only increase uterine weight and evaluating factors that may change the management of surgery, such as previous surgeries and uterine weight, are the strengths of the study. This study has some limitations. First, it is a retrospective study with a small sample size. Second, the fact that all surgeries are performed by the same surgical team may reduce the generalization probability of laparoscopic surgery, which requires personal experience and skill.
In this study, classical laparoscopic hysterectomy steps were evaluated in benign gynecological pathologies that only increase the size of the uterus by reducing the number of ports, rather than a new technique. In conclusion, reducing the number of ports up to a certain uterine weight in total laparoscopic hysterectomies, including women with a history of abdominal surgery, may be beneficial for shorter operation time, fewer intraoperative complications, and better cosmetic results.
Scientific Responsibility Statement
The authors declare that they are responsible for the article’s scientific content including study design, data collection, analysis and interpretation, writing, some of the main line, or all of the preparation and scientific review of the contents and approval of the final version of the article.
Animal and human rights statement
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Funding: None
Conflict of interest
The authors declare no conflict of interest.
References
1. Warren L, Ladapo JA, Borah BJ, Gunnarsson CL. Open abdominal versus laparoscopic and vaginal hysterectomy: analysis of a large United States payer measuring quality and cost of care. J Minim Invasive Gynecol. 2009; 16(5): 581-8.
2. Wright KN, Jonsdottir GM, Jorgensen S, Shah N, Einarsson JI. Costs and outcomes of abdominal, vaginal, laparoscopic and robotic hysterectomies. JSLS. 2012; 16(4): 519-24.
3. Aarts JW, Nieboer TE, Johnson N, Tavender E, Garry R, Mol BWJ. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev. 2015; (8): CD003677.
4. Committee on Gynecologic Practice. Committee Opinion No 701: choosing the route of hysterectomy for benign disease. Obstet Gynecol. 2017;129(6): e155-9.
5. Desai VB, Guo XM, Fan L, Wright JD, Xu X. Inpatient laparoscopic hysterectomy in the United States: trends and factors associated with approach selection. J Minim Invasive Gynecol. 2017;24(1): 151-8.
6. Walsh CA, Walsh SR, Tang TY, Slack M. Total abdominal hysterectomy versus total laparoscopic hysterectomy for benign disease: a meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2009; 144(1): 3-7.
7. Orhan A, Ozerkan K, Kasapoglu I, Ocakoglu G, Demir BC, Gunaydın T. Laparoscopic hysterectomy trends in challenging cases (1995–2018). Journal of Gynecology Obstetrics and Human Reproduction. 2019;48(10): 791-8.
8. Yi SW, Park HM, Lee SS, Park SM, Lee HM, Sohn WS. Two-port total laparoscopic hysterectomy with a multichannel port. J Laparoendosc Adv Surg Tech A. 2009; 19(2): 223-8.
9. Sandberg EM, la Chapelle CF, van den Tweel MM, Schoones JW, Jansen FW. Laparoendoscopic single-site surgery versus conventional laparoscopy for hysterectomy: a systematic review and meta-analysis. Arch Gynecol Obstet. 2017; 295(5): 1089-103.
10. Yim GW, Jung YW, Paek J, Lee SH, Kwon HY, Nam EJ, et al. Transumbilical single-port access versus conventional total laparoscopic hysterectomy: surgical outcomes. Am J Obstet Gynecol. 2010; 203(1): 26. e1-6.
11. Paek J, Nam EJ, Jung YW, Lee SH, Kim JH Kim YT, et al. Two-port access staging laparoscopy for gynecologic cancers: a pilot study. J Laparoendosc Adv Surg Tech A. 2010; 20(4):347-53.
12. Kim TJ, Shin SJ, Kim TH, Cho CH, Kwon SH, Seong SJ, et al. Multi-institution, prospective, randomized trial to compare the success rates of single-port versus multiport laparoscopic hysterectomy for the treatment of uterine myoma or adenomyosis. J Minim Invasive Gynecol. 2015; 22(5):785-91.
13. Pontis A, Sedda F, Mereu L, Podda M, Melis GB, Pisanu A, et al. Review and meta-analysis of prospective randomized controlled trials (RCTs) comparing laparo-endoscopic single site and multiport laparoscopy in gynecologic operative procedures. Arch Gynecol Obstet. 2016; 294(3):567-77.
14. American College of Obstetricians and Gynecologists Women’s Health Care Physicians. Technology Assessment No. 10: single-incision laparoscopy. Obstet Gynecol. 2013;122(2 pt 1): 429-31.
15. Donmez T, Sunamak O, Ferahman S, Uludag SS, Yildirim D, Hut A. Two-port laparoscopic appendectomy with the help of a needle grasper: better cosmetic results and fewer trocars than conventional laparoscopic appendectomy. Wideochir Inne Tech Maloinwazyjne. 2016; 11(2): 105-10.
16. Mencaglia L, Mereu L, Carri G, Arena I, Khalifa H, Tateo S, et al. Single port entry- are there any advantages? Best Pract Res Clin Obstet Gynaecol. 2013;27(3):441-55.
17. Lee D, Kim SK, Kim K, Lee JR, Suh CS, Kim SH. Advantages of single-port laparoscopic myomectomy compared with conventional laparoscopic myomectomy: a randomized controlled study. J Minim Invasive Gynecol. 2018; 25(1):124-32.
18. Wu KY, Lertvikool S, Huang KG, Su H, Yen CF, Lee CL. Laparoscopic hysterectomies for large uteri. Taiwan J Obstet Gynecol. 2011; 50(4):411-14.
19. Cassling C, Shay R, Strassle PD, Voltzke K, Schiff L, Louie M, et al. Use of Historical Surgical Times to Predict Duration of Hysterectomy: Stratifying by Uterine Weight. J Minim Invasive Gynecol. 2019; 26(7): 1327-33.
20. Zeng W, Chen L, Du W, Hu J, Fang X, Zhao X. Laparoscopic hysterectomy of large uteri using three-trocar technique. Int J Clin Exp Med. 2015; 8(4): 6319-26.
21. Lindquist SAI, Shah N, Overgaard C, Torp-Pedersen C, Glavind K, Larsen T, et al. Association of previous cesarean delivery with surgical complications after a hysterectomy later in life. JAMA Surg. 2017;152(12):1148-55.
22. Köhler C, Hasenbein K, Klemm P, Tozzi R, Schneider A. Laparoscopic-assisted vaginal hysterectomy with lateral transsection of the uterine vessels. Surg Endosc. 2003; 17(3): 485-90.
23. Tyan P, Robinson J, Dandapani M, Li J, Gu A, Moawad GN. Novel Approach for 2-Port Laparoscopic Hysterectomy. Surg Innov. 2019; 26(4): 442-8.
Download attachments: 10.4328.ACAM.21796
Aylin Önder Dirican. Evaluation of the use of three ports in total laparoscopic hysterectomies. Ann Clin Anal Med 2023;14(9):816-820
Citations in Google Scholar: Google Scholar
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/
Comparison of vacuum assisted closure (VAC) application with conventional treatment after surgical intervention in patients with Fournier’s gangrene
Doğan Öztürk, Bülent Öztürk, Sibel Özkara
Department of General Surgery, Atatürk Sanatoryum Training and Research Hospital, Ankara, Turkey
DOI: 10.4328/ACAM.21797 Received: 2023-06-17 Accepted: 2023-07-31 Published Online: 2023-08-03 Printed: 2023-09-01 Ann Clin Anal Med 2023;14(9):821-824
Corresponding Author: Doğan Öztürk, Department of General Surgery, Atatürk Sanatoryum Training and Research Hospital, Ankara, Turkey. E-mail: drdoganozturk@hotmail.com P: +90 537 295 03 22 Corresponding Author ORCID ID: https://orcid.org/0000-0003-1754-9246
This study was approved by the Ethics Committee of Atatürk Sanatoryum Training and Research Hospital (Date: 2023-06-21, No: 2012-KAEK-15/2734)
Aim: This study aims to evaluate the etiology and predisposing factors of patients with Fournier’s gangrene and to compare the results and effectiveness of vacuum-assisted wound closure (VAC) and traditional dressing and debridement methods on wound healing after surgical intervention.
Material and Methods: This retrospective study was conducted by collecting the data of 65 patients with Fournier’s gangrene who applied to our hospital between March 1, 2016 and March 1, 2023. In this study, we divided our patients into two groups: those who were treated with VAC and those who were treated with conventional treatment. We evaluated these two groups according to certain parameters, for example, DM and obesity. The study was approved by the Ethics Committee on 21 June, 2023.
Results: A total of 65 patients were included in the study. Of these, 50 (87%) were male and 15 (13%) were female. The mean age of the patients was 52.6 ±10.45 years. Thirty-one patients were followed up with VAC, while conventional treatment was used in 34. However, in the comparison made without considering the predisposing factors, no significant difference was found between the two groups in terms of length of hospital stay. In addition, it has been statistically proven that VAC treatment is ahead of the traditional treatment method in terms of hospital stay in cases with obesity and DM. Considering their comorbid diseases, it was seen that they were effective on the length of hospital stay.
Discussion: Many methods have been tried in the care and follow-up of the wound in Fournier’s gangrene. Although they do not have clear advantages over each other, an appropriate patient-based method is used. The importance of other factors such as having similar effects, cost analysis, and length of hospital stay come to the fore.
Keywords: Fournier Gangrene, Vacuum-Assisted Wound Closure (Vac), Hospitalization, Wound Care
Introduction
Fournier’s gangrene is an urgent microbial pathology characterized by necrotizing fasciitis involving the perianal and genital regions, which develops acutely, progresses rapidly and insidiously, and results in high mortality and morbidity when diagnosis and treatment are delayed [1]. Despite aggressive treatment, Fournier’s gangrene has high morbidity and mortality rates (3-67%), delay in diagnosis and treatment may cause a significant increase in mortality rate [3] (20-40%). This is followed by various skin pathologies [4]. In addition, some accompanying pathologies often accompany Fournier’s gangrene, regardless of the primary etiology. Diabetes mellitus leads to these pathologies with a rate of 20-70%, followed by chronic alcoholism with a rate of 20-50% [4,5]. Treatment of Fournier’s gangrene includes resuscitation for sepsis and surgical debridement with extensive antibiotics [6]. Despite all aggressive treatments, mortality can be as high as 63% [2]. The standard treatment in Fournier’s gangrene consists of debridement of necrotic tissues, broad-spectrum antibiotic therapy, frequently changing dressings, and intensive care resuscitation when necessary [1]. Long hospital stays and repetitive dressings increase the cost and cause a loss of workforce. In order to reduce this, many methods such as sterile saline, antiseptic sitz baths, Dakin’s solution (sodium hypochlorite), hydrogen peroxide, unprocessed honey, lyophilized collagenase, hyperbaric oxygen therapy, vacuum-assisted wound closure (VAC) have been tried [4]. VAC is a relatively new technology developed for the treatment of many acute and chronic wounds that are difficult to manage [8]. The VAC system creates negative pressure in the wound with the help of vacuum, thus removing the infected or exudative fluids that will occur in the wound from the environment, reducing the edema in the region with the help of micropressure, stimulating angiogenesis and thus accelerating wound healing [9]. Many studies have emphasized that VAC application is effective but its effect is not better than standard treatment methods. However, it has been determined that the use of VAC reduces the cost with fewer dressing changes and less need for analgesics [7]. In addition, the area of use has expanded upon successful results in the use of vac. In our study, we investigated the effects of vacuum-assisted wound closure (VAC) and traditional dressing and debridement methods on wound healing after surgical intervention.
Material and Methods
Following institutional review board approval from the Ethics Committee of Atatürk Sanatoryum Training and Research Hospital (Ethics No: 2012-KAEK-15/2734), we performed a single-center retrospective analysis of patients with Fournier’s gangrene and who underwent extensive surgical debridement and antibiotherapy in our hospital between March 1, 2016 and March 1, 2022. We included patients aged between 18-75 years, who were compliant with treatment, and who had no oncological comorbidities. We divided these patients into two groups: VAC treatment and conventional treatment.
Demographic data of the patients, length of hospital stay, time from the first debridement to wound healing, wound healing times were recorded. Most of the patients in our study group had obesity.
Wound healing was calculated as the time from initial debridement to discharge. The patients were divided into 2 groups. Vacuum-assisted wound closure (VAC), and traditional dressing and debridement methods were applied. Vacuum-assisted wound closure was performed after the first debridement. In patients who underwent VAC, VAC was changed every 72 hours. Nitrofurazone-containing dressing was applied after wound irrigation with saline every 24 hours in patients who had traditional dressings. Both groups were reevaluated between dressings. Debridement was performed again when necessary. In cases with clean wounds, the primary repair was completed.
Statistical analysis
Categorical variables were expressed as number of patients (frequency) and percentage (%). Descriptive statistics were presented as mean ± standard deviation for continuous numerical variables. Associations between variables were evaluated using the Student’s T-test (for continuous variables) and the Chi-Square test (for categorical variables), where appropriate. All analyzes were performed with SPSS v22 package program. A p-value <0.05 was considered significant.
Ethical Approval
Ethics Committee approval for the study was obtained.
Results
Table 1 Shows the number and percentage of patients who were applied VAC vs convational application according to sex, diabetes and obesity.
A total of 65 patients were included in the study. Of these, 50 (87%) were male and 15 (13%) were female. The mean age of the patients was 52.6 ±10.45 years. While 31 (47%) patients were followed with VAC dressing, 34 (53%) were followed up with traditional methods (with nitrofurazone-containing dressing). Among those who underwent VAC, there were 10 patients with concomitant DM and 21 patients with obesity. There were 8 patients who were associated with DM and 18 obese patients among the patients who underwent traditional dressing and debridement. Table 2 shows the number of Group A and Group B patients by their predisposing factors.
In the comparison made without considering the predisposing factors, there was no statistically significant difference in terms of recovery time between Group-A VAC patients and Group-B conventional dressing patients (p=0,087). The mean hospital stay of the patients was 23.78. While the length of stay was 22.3 ± 4.6 in those who underwent VAC, the length of stay in the hospital was 25.1 ± 4.7 in the patients who underwent conventional dressing. It was statistically significant that the wound healing time was shorter in patients who underwent VAC compared to patients who underwent dressings (p=0,003). Table 3 shows the numerical and statistical results of the effects of predisposing factors and treatment methods on the length of hospital stay.
The number of patients with diabetes was 10 in those treated with VAC and 8 in those treated with conventional therapy. Diabetes-related recovery time between both groups was shorter in those who underwent VAC and was statistically significant (p=0,002).
Discussion
Standard treatment in Fournier’s gangrene consists of debridement of necrotic tissues, broad- spectrum antibiotics, frequently changing dressings, and intensive care resuscitation when necessary. Many methods have been tried in the care and follow-up of the wound in Fournier’s gangrene. Although they do not have clear advantages over each other, the appropriate patient-based method is used [5]. The importance of other factors such as having similar effects, cost analysis and length of hospital stay come to the fore. In studies conducted so far, DM accelerates the progression of infection and delays wound healing. However, in our study, DM alone did not make a significant difference in the length of hospital stay in the evaluation made without considering the treatment methods. The positive effects of VAC therapy on wound healing and its safe use are now known [4]. In other studies, it has been shown that hospitalization time is shorter in patients who are treated with VAC compared to those who do not receive VAC treatment [8]. In our study, we found that VAC therapy provided a significant shortening of wound healing and hospital stay. Although diabetes is the most important predisposing factor, it did not adversely affect the prognosis and clinical outcomes in our study [10]. However, we think that diabetes affects the disease negatively and induces the development of Fournier disease in patients with diabetic Fournier’s gangrene, and there are studies supporting this theory. Diabetes can accelerate the progression of the infection and delay wound healing. In addition, in our study, we encountered results regarding the superiority of VAC therapy in the comparison of treatment methods in patients with DM. As a result, we observed a significant decrease in hospitalization times in patients with diabetes who underwent VAC compared to the traditional treatment method. Advanced age, diabetes mellitus, chronic liver disease, chronic kidney failure, alcoholism, smoking and immunosuppressive conditions are known risk factors for Fournier’s gangrene [2,6]. However, we did not include them in our study because the number of these additional diseases was too low to be statistically significant in our patients. As a result, early diagnosis and determination of the severity of the disease, decreases the time of treatment and increase the success of treatment. We think that aggressive surgical debridement and appropriate antibiotic therapy may have a positive effect on the prognosis of the disease. Fournier’s gangrene is a disease with high mortality rates, although the possibilities for diagnosis, follow-up and treatment have increased recently. Early diagnosis is the most important factor in obtaining satisfactory results. Multi-step and aggressive treatment methods including protective colostomy, hyperbaric oxygen and VAC applications and reconstructive surgery are effective and beneficial in the treatment of Fournier’s gangrene. Morbidity and mortality can be reduced in patients with Fournier’s gangrene with a multidisciplinary treatment approach. In particular, the application of VAC had a positive impact on both the length of hospital stay and the recovery process. Therefore, we think that using VAC should have wider usage areas compared to cost ratios.
Acknowledgment
Many thanks to Dr. Mücahit Aydoğdu for his support in reviewing and translating the manuscript into English. We are deeply grateful to him for his kind concerns.
Scientific Responsibility Statement
The authors declare that they are responsible for the article’s scientific content including study design, data collection, analysis and interpretation, writing, some of the main line, or all of the preparation and scientific review of the contents and approval of the final version of the article.
Animal and human rights statement
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. No animal or human studies were carried out by the authors for this article.
Funding: None
Conflict of interest
The authors declare no conflict of interest.
References
1. Erickson BA, Flynn KJ. Management of necrotizing soft tissue infections (Fournier’s Gangrene) and surgical reconstruction of debridement wound defects. Urologic Clinics. 2022; 49(3): 467-78.
2. Yanaral F, Balci C, Ozgor F, Simsek A, Onuk O, Aydin M, et al. Comparison of conventional dressings and vacuum-assisted closure in the wound therapy of Fournier’s gangrene. Arch Ital Urol Androl. 2017; 89(3): 208-11.
3. Zagli G, Cianchi G, Degl’Innocenti S, Parodo J, Bonetti L, Prosperi P, et al. Treatment of Fournier’s gangrene with combination of vacuum-assisted closure therapy, hyperbaric oxygen therapy, and protective colostomy. Case Rep Anesthesiol. 2011; DOI: 10.1155/2011/430983
4. Shyam DC, Rapsang AG. Fournier’s gangrene. Surgeon. 2013;11(4):222-32.
5. Katušić J, Štimac G, Benko G, Grubišić I, Šoipi Š, Dimanovski J, et al. Management of fournier’s gangrene: case report and literature review. Acta Clin Croat. 2010;49(4):453-7.
6. Pernetti R, Palmieri F, Sagrini E, Negri M, Morisi C, Carbone A, et al. Fournier’s gangrene: Clinical case and review of the literature. Arch Ital Urol Androl. 2016; 88(3): 237-8.
7. Furr J, Watts T, Street R, Cross B, Slobodov G, Patel S, et al. Contemporary trends in the inpatient management of fournier’s gangrene: predictors of length of stay and mortality based on population-based sample. Urology. 2017;102:79-84.
8. Sugihara T, Yasunaga H, Horiguchi H, Fujimura T, Ohe K, Matsuda S, et al. Impact of surgical intervention timing on the case fatality rate for Fournier’s gangrene: an analysis of 379 cases. BJU Int. 2012; 110(11 Pt C): E1096-100.
9. Iacovelli V, Cipriani C, Sandri M, Filippone R, Ferracci A, Micali S, et al. The role of vacuum-assisted closure (VAC) therapy in the management of FOURNIER’S gangrene: a retrospective multi-institutional cohort study. World J Urol. 2020; 39(1):121-8.
10. Insua-Pereira I, Ferreira P C, Teixeira S, Barreiro D, Silva Á. Fournier’s gangrene: a review of reconstructive options. Cent European J Urol. 2020;73(1):74-9.
Download attachments: 10.4328.ACAM.21797
Doğan Öztürk, Bülent Öztürk, Sibel Özkara. Comparison of vacuum assisted closure (VAC) application with conventional treatment after surgical intervention in patients with Fournier’s gangrene. Ann Clin Anal Med 2023;14(9):821-824
Citations in Google Scholar: Google Scholar
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/
Comparison of opioid and opioid-free anesthesia in bariatric surgery
Şükrü Ümit Yaşar 1, Aslı Mete Yıldız 2
1 Department of Anesthesiology and Reanimation, Special Odak Hospital, 2 Department of Anesthesiology and Reanimation, Pamukkale University, Denizli, Turkey
DOI: 10.4328/ACAM.21801 Received: 2023-06-22 Accepted: 2023-08-23 Published Online: 2023-08-25 Printed: 2023-09-01 Ann Clin Anal Med 2023;14(9):825-829
Corresponding Author: Aslı Mete Yıldız, Department of Anesthesiology and Reanimation, Faculty of Medicine, Denizli, Turkey. E-mail: aslimete22@hotmail.com P: +90 530 932 23 34 Corresponding Author ORCID ID: https://orcid.org/0000-0002-5621-7407
This study was approved by the Non-Interventional Clinical Research Ethics Committee of Pamukkale University (Date: 2019-12-11, No: 60116787-020/88341)
Aim: Opioids are widely used in anesthesia. Postoperative nausea and vomiting (PONV) is known to have side effects such as tremors and urinary retention and so on. Several studies have been conducted in recent years indicating that multimodal analgesia reduces opioid consumption. There are very few studies comparing opioid-free anesthesia with Laparoscopic Sleeve Gastrectomy (LSG). The aim of this study is to evaluate the effects of opioid-free anesthesia on pain scores and healing process in patients with LSG surgery.
Material and Method: This study was conducted on 64 cases between the ages of 18-65 prospectively in the general surgical operating room of Pamukkale University Hospital. Patients were randomly selected and grouped according to anesthesia method at the beginning of the surgery. Remifentanil as an opioid was administered for analgesia in Group I. Iv paracetamol, ibuprofen, ketamine and magnesium sulfate were administered in Group II. NRS was used as a pain score. Patients included in the study were followed from the beginning of the operation to the end of the postoperative 24 hours. The obtained data were analyzed using the SPSS 25 software.
Results: The body mass index (BMI) of the patients included in the study was 40 and above. In the study, women in both groups were in the majority (≥75%). In both groups, cesarean section was in the majority of patients in the history of a previous surgery. Patients in Group I were significantly higher when hypotension was examined. There was no significant difference in SpO2<94%, obstructive respiration, nausea, vomiting, chills, tramadol use, antiemetic need and mean TOF values in postoperative recovery unit. There was no significant difference in NRS score between groups at postoperative 1, 6, 12 and 24 hours. There were partially more complications in postoperative Group I.
Discussion: There was no significant difference between non-opioid anesthesia and opioid anesthesia, but the non-opioid anesthesia protocol can be safely used in LSG.
Keywords: Opioid-Free Anesthesia, Bariatric Surgery, NRS Score, Laparoscopic Sleeve Gastrectomy
Introduction
Bariatric surgical procedures have made great progress over time. While open surgery was initially used in bariatric surgery, advances in surgical methods and the more comfortable strategy of laparoscopic treatments for patients reduced recovery time and postoperative discomfort [1]. However, wound site discomfort persists after laparoscopic operations. The amount of opioid use and opioid-related side effects influence the duration of hospital stay. Obstructive sleep apnea (OSAS), which is frequently associated with weight, complicates the safe administration of analgesic [2,3]. A combination of analgesic agents that can target various areas of the pain region is optimal for postoperative pain control [4]. Multimodal analgesia is the combination of two or more analgesic drugs that work through distinct processes in different areas of the central nervous system, resulting in synergistic analgesia when compared to central opioids alone [5]. Multimodal analgesia lowers individual analgesic doses and adverse effects, encouraging better pain control. It also enhances analgesia efficacy and allows for a better functional state to be achieved. Multimodal analgesia is well accepted and reduces opioid consumption in orthopedic, abdominal, cardiac, and otolaryngological surgical studies [6]. However, few studies compare the effects of non-opioid use with Laparoscopic Sleeve gastrectomy (LSG). The aim of this study is to evaluate the effect of opioid-free anesthesia on pain scores and the recovery process in patients undergoing LSG surgery.
Material and Methods
The research was carried out on 64 patients between the ages of 18-65, in the ASA I-III group, who applied to Pamukkale University Medical Faculty Hospital General Surgery Department for bariatric surgery. The research was carried out between 01-12-2019 and 01-05-2020 in Pamukkale University Hospital operating room. This study was a prospective, randomized (double-blind) study. Cases for the research were randomly selected (envelope technique) from patients undergoing laparoscopic sleeve gastrectomy (LSG) and divided into two groups. The patients were evaluated preoperatively and verbal and written consent was obtained by providing information about the anesthesia and analgesia method. Inclusion criteria were as follows: ASA I-II-III group patients aged between 18-65 who will undergo bariatric surgery in general surgery operating rooms, patients with a body mass index (BMI) ≥ 35 kg / m2, and patients whose surgery performed under general anesthesia (from incision to closure) is not expected to exceed 2 hours. Numeric Ratio Scale (NRS) was explained to the patients participating in the study the night before the operation. The pain levels of the cases in both groups were determined by the service nurse at 0 and 30 minutes and 1, 6, 12 and 24 hours after the operation. Balanced electrolyte solution solution 1000 ml was given to the patients. Local or systemic allergic complaints and hemodynamic changes were monitored periodically for 24 hours perioperatively and postoperatively. An ampule of 8 mg of dexamethasone was administered as iv push 30 minutes before admission to the operating room for postoperative nausea and vomiting prophylaxis. In the operating room, the patients were monitored and 0.05 mg/kg of midazolam iv was administered according to ideal body weight (IBW). For induction, propofol was administered according to IBW (1.5-2 mg/kg). Lidocaine was administered as 1mg/kg IV push according to adjusted body weight (ABW). As a muscle relaxant, rocuronium iv push was administered according to IBW (0.6 mg/kg). Sevoflurane was titrated to a MAC value of 1 and a BIS monitoring value of 40-60. Rocuronium was administered in boluses with a TOF value of 0.5 and below. During the operation, iv balanced electrolyte solution was administered at a rate of 15 ml/kg/h according to IBW and this rate was reduced to 8 ml/kg/h until the end of the surgery. When MAP decreased more than 25% of normal, 250 ml bolus IV balanced electrolyte solution was administered. If the decline continued, intravenous administration of 5 mg of ephedrine was planned. The patients were divided into two groups. In Group I (Opioid (+) Anesthesia), an initial dose of 1mcg/kg was administered for 30 to 60 seconds according to IBW 0.5-1 mcg/kg/min by continuous IV infusion in induction of remifentanil as an opioid for analgesia. A continuous IV infusion of remifentanil 0.25 mcg/kg/min (range 0.05 -2 mcg/kg/min) was administered for maintenance. Group II (Opioid (-) Anesthesia) patients received an IV infusion of 1 g of paracetamol and an infusion of 400 mg of ibuprofen IV for analgesia 30 minutes before the incision. Before the incision in the perioperative period, 0.2 mg/kg IV bolus ketamine was administered as an IV bolus of 0.5 mg/kg according to IBW (ideal body weight) between 30-45 minutes of surgery. A 30 mg/kg bolus of magnesium sulfate was administered followed by a 10 mg/kg/h perioperative infusion. At the end of the operation, intravenous sugammadex at a dose of 2-4 mg/kg was used to antagonize the muscle relaxant effect. Pain scores, consciousness levels, and opioid-related side effects (nausea, vomiting, constipation, inability to urinate, difficulty concentrating, lethargy, confusion, fatigue, itching, dry mouth, headache) of patients were followed up and recorded at postoperative 1st and 30th minutes and 1st, 6th, 12th and 24th hours. Postoperative analgesia was applied depending on the NRS score. Analgesia was not administered to patients with an NRS score of less than 5. Paracetamol 1000 mg IV infusion was administered to patients with NRS scores between 5 and 8. Tramadol iv 100 mg infusion (2 hours) was administered to patients with NRS >8. In the postoperative LSG protocol, the patient was mobilized, if no dizziness or nausea was observed, between postoperative 6-8 hours.
Statistical analysis
Sample size calculation was performed to determine the number of patients to be included in the pre-study groups. As a result of the power analysis, the study was performed on 64 patients. The data were analyzed with the SPSS package program. Continuous variables were presented as mean ± standard deviation and categorical variables were presented as numbers and percentages. Since the parametric test assumptions were met, one-way analysis of variance (Independent Samples T-test) was used to compare differences between independent groups. Differences between categorical variables were analyzed by Chi-square analysis.
Ethical Approval
Ethical approval for the study was obtained from Pamukkale University Non-Interventional Clinical Research Ethics Committee (11.12.2019/ 60116787-020/88341).
Results
When the distribution of the clinical data of the patients between the groups was examined, age, height, weight, body mass index (BMI), anesthesia and surgery durations in the groups were found to be within the same range (p>0.05). There was no statistically significant difference between the gender distribution and the ASA class values of groups (p>0.05). When the SpO2 values of the patients were examined, no significant difference was present between the groups. When the BIS score was examined, no statistically significant difference was found between the beginning of the perioperative period, 5th min, 10th min, 45th min, 60th min, 75th min, 90th min, 105th min and 120th min (p>0,05). There was no significant difference between the groups in terms of operation time. (Group 1: 99.97min /Group2: 97.19min p: 0.203). A statistically significant difference was found in terms of BIS scores between the groups (Group I>Group II) at the 15th and 30th minutes. When TOF values were examined, no statistically significant difference was found between the beginning of the perioperative period, 5th min, 10th min, 45th min, 60th min, 75th min, 90th min, 105th min and 120th min (p>0,05). A statistically significant difference was found in terms of TOF score between the groups (Group I>Group II) at the 5th and 10th minutes (Table 1). When the perioperative monitoring value of the patients was examined, there was no statistically significant difference between the groups in terms of bradycardia, tachycardia and hypertension. Hypotension was observed in 13 patients in Group I and in more patients than in Group II, and a statistically significant difference was found between Group I and II (Table 2). When the postoperative anesthesia care unit data of the patients were examined, there was no statistically significant difference between SpO2<94% (with 6 lt/min O2 mask), obstructive respiration, chills, tramadol use, need of an antiemetic, DBP, highest HR and lowest HR values. Nausea-vomiting was observed in 14 patients in Group I and in 6 patients in Group II, and a statistically significant difference was found. Systolic blood pressure values were higher in Group I, and a statistically significant difference was found between the groups. When the postoperative complications of the patients were examined, there was no statistically significant difference between the groups in complaints of vomiting, constipation, inability to urinate, difficulty concentrating, drowsiness, confusion, fatigue, itching, dry mouth and headache (p>0,05). When the presence of postoperative nausea was examined, nausea-vomiting was observed in 14 patients in Group I and 6 patients in Group II, and a statistically significant difference was found (p=0,029). When the NRS score changes of the patients were examined, the NRS scores between the groups were in similar ranges and there was no statistically significant difference (p>0,05). (Table 3).
Discussion
Obesity surgery is one of the most sustainable methods of achieving weight loss. It is considered the most effective treatment for obesity because it is effective in reducing obesity-related comorbidities and deaths and improves quality of life. Although bariatric surgery, which has been going on and spreading rapidly for ten years, is believed to reduce operative trauma compared to traditional open surgery due to minimally invasive laparoscopic surgery, the surgical stress response is still evident [7]. Opioids are powerful analgesics used to treat extreme pain; They are frequently used for perioperative or postoperative pain control. However, it has been associated with the onset of chronic illness. The widespread use of opioids in anesthesia is limited by side effects such as POBK, tremor, and urinary retention [8]. In this study, we examined the effects of perioperative and postoperative opioid use and opioid-free anesthesia on pain scores and the effect on perioperative vital functions in patients undergoing bariatric surgery. In a prospective observational cohort study conducted between October 2020 and July 2021, in a meta-analysis comparing opioid-free patients and patients taking opioids, less pain in the first 24 hours and less additional opioid use in the opioid-free patient group were found [9]. In a study conducted in patients who were given remifentanil in the opioid group and ibuprofen and tramadol in the opioid-free group, it was reported that pain scores decreased gradually in the measurements made at the 1st, 3rd, 6th, 12th, 24th and 48th hours after surgery. It has been reported that the NRS score at the 24th hour was 6 in patients given remifentanil, and in patients given ibuprofen and opioid-free analgesia the pain score was 5 [10]. In our study, while NRS scores were around 7 in both groups at the 1st hour, they gradually decreased until the 24th hour. No statistically significant difference was found between the two groups in the NRS scan performed at the 1st, 6th, 12th and 24th hours. When the results of a prospective study including 344 bariatric patients for three years were examined, 209 (60.8%) of the patients were opioid-free and 135 (39.2%) received standard anesthesia. There was no difference between the groups in terms of demographic data, BMI, related medical problems and type of surgery. Postoperatively, no significant difference in opioid requirement was observed between the two groups. However, it was determined that the opioid free group received a significantly lower dose of antiemetic on the 1st and 2nd postoperative days. It was stated that the duration of hospitalization was found to be significantly shorter in the opioid-free group [11]. Although the findings of this study and our study were similar, the limitations and heterogeneity of the study group may have caused the differences. The fact that nausea and vomiting were seen in fewer patients in the opioid-free groups in both studies makes this type of anesthesia more usable. A study of 257 patients who underwent laparoscopic bariatric surgery examined the use of morphine in the first 24 hours postoperatively between opioid-using and non-opioid-using groups. In summary, the main result of this study was that the proportion of patients who did not require morphine in the first 24 hours postoperatively was 87% in the opioid-free group, which was significantly higher than in the opioid-using group[ 12]. In our study, the need for additional analgesia as a need for rescue medication was more frequent in the group taking opioids. Tramadol 100 mg IV infusion was administered when NRS score was >8, paracetamol 1000 mg IV infusion was administered when NRS score was >5. Similar results are encountered in many studies and actually explain the low postoperative pain scores in opioid-free patients. In summary, there are many publications in the literature comparing opioid and non-opioid anesthesia in bariatric surgeries. The aim of this study was to describe our experience and positive effects of opioid-free anesthesia on pain scores and the recovery process in patients undergoing bariatric surgery.
In conclusion, this study examined whether opioid-free anesthesia applications, which has recently been introduced and frequently applied in bariatric surgery, make a difference and in the end, it was determined that the greatest benefit was in relation to postoperative nausea and vomiting. In addition, it was emphasized that opioid-free anesthesia would not increase the need for additional drugs in the postoperative period.
The limitations of this study may be the small sample size, the prospective randomized controlled trial, and the study involving only two surgeons.
Scientific Responsibility Statement
The authors declare that they are responsible for the article’s scientific content including study design, data collection, analysis and interpretation, writing, some of the main line, or all of the preparation and scientific review of the contents and approval of the final version of the article.
Animal and human rights statement
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Funding: None
Conflict of interest
The authors declare no conflict of interest.
References
1. Eipe N, Budiansky AS. Perioperative Pain Management in Bariatric Anesthesia. Saudi J Anesth. 2022;16(3):339-46.
2. Nasser K, Verhoeff K, Mocanu V, Kung JY, Purich K, Switzer NJ, et al. New persistent opioid use after bariatric surgery: a systematic review and pooled proportion meta‑analysis. Surg Endosc.2023; 37(1)703–14.
3. Raaff CA, Vries N, Wagensveld BA. Obstructive sleep apnea and bariatric surgical guidelines: summary and update. Curr Opin Anaesthesiol. 2018;31(1):104-9.
4. Carron M, Cassai A, Linassi F, Navelessi P. Multimodal analgesia in bariatric surgery: not just an intravenous approach. Surg Obes Relat Dis. 2020;16(12): 21323-5.
5. Chaouch MA, Daghmouri MA, Boutron MC, Ferraz JM, Usai S, Soubrane O, et al. Ketamine as a component of multimodal analgesia for pain management in bariatric surgery: A systematic review and meta-analysis of randomized controlled trials. Ann Med Surg (Lond). 2022;14:78,85.
6. O’Neill A, Lirk P. Multimodal Analgesia. Anesthesiol Clin. 2022;40(3): 455-68.
7. Hung KC, Chi Chiu C, Hsu CV, Lin CM, Liao SW, Teng IC, et al. Impact of Opioid‑Free Anesthesia on Analgesia and Recovery Following Bariatric Surgery: a Meta‑Analysis of Randomized Controlled Studies. Obes Surg. 2022; 32(9):3113-24.
8. Rivat C, Ballantyne J. The dark side of opioids in pain management: basic science explains clinical observation. Pain Rep. 2016;1(2):e570.
9. Ulbing S, Infanger L, Fleischmann E, Prager G, Hamp T. The Performance of Opioid‑Free Anesthesia for Bariatric Surgery in Clinical Practice. Obes Surg. 2023;33(6):1687-93.
10. Koo C-H, Cho YJ, Hong DM, Jeon Y, Kim TK. Influence of high-dose intraoperative remifentanil with intravenous ibuprofen on postoperative morphine consumption in patients undergoing pancreaticoduodenectomy: a randomized trial. J Clin Anesth. 2016; 35:47-53.
11. Torre A, Marengo M, Ledingham NS, Ajani C, Volontè F, Garofalo F, et al. Opioid‑Free Anesthesia in Bariatric Surgery: a Propensity Score–Matched Analysis. Obes Surg.2022; 32(5):1673-80.
12. Berlier J, Carabalona JF, Tete H, Bouffard Y, Le Goff MC, Cerro V, et al. Effects of opioid-free anesthesia on postoperative morphine consumption after bariatric surgery. J. Clin Anesth. 2022;8: DOI: 10.1016/j.jclinane.2022.110906.
Download attachments: 10.4328.ACAM.21801
Şükrü Ümit Yaşar, Aslı Mete Yıldız. Title Comparison of opioid and opioid-free anesthesia in bariatric surgery. Ann Clin Anal Med 2023;14(9):825-829
Citations in Google Scholar: Google Scholar
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/
Targeting one-carbon metabolism by methyl donors for prevention of
non-alcoholic fatty liver in rats
Huda Abdulaziz Al Doghaither
Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia
DOI: 10.4328/ACAM.21802 Received: 2023-06-22 Accepted: 2023-07-31 Published Online: 2023-08-10 Printed: 2023-09-01 Ann Clin Anal Med 2023;14(9):830-834
Corresponding Author: Huda Abdulaziz Al Doghaither, Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia. E-mail: haldoghaither@kau.edu.sa P: +966 50562 56 33 Corresponding Author ORCID ID: https://orcid.org/0000-0002-6192-8326
This study was approved by the Ethics Committee of King Fahd Medical Research Center (KFMRC), King Abdulaziz University (Date: 2022-04-01, No: 315-22)
Aim: The purpose of the current work was to demonstrate and compare the impacts of folate, methionine, and choline as methyl donors in the prevention of NAFLD induced by a high-fructose diet (HFrD).
Material and Methods: Sixty adult male albino rats were divided into five groups: G1 had a control-fed basal diet; in G2, the rats were fed an HFrD containing 45% fructose (HFrD); in G3, G4, and G5, the rats were fed an HFrD supplemented with folic acid, L-methionine, and choline chloride, respectively. The present study’s findings showed a close connection between methyl donors and lipid metabolism.
Results: The findings indicated that the folic acid supplemented diet (HFrD+ folate) exhibited the most substantial improvement in hepatic total lipids (TP), triacylglycerol (TG), phospholipid (PL), serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-c), free fatty acid (FFA), albumin (ALB), total bile acid (TBA), fasting blood glucose (FBG), proinflammatory cytokines levels, and enzyme activities of alanine transaminase (ALT), aspartate transaminase (AST), fatty acid synthase (FAS), and acetyl coenzyme A carboxylase (ACC). In the same context, L-methionine had the most significant improvement in oxidative stress biomarker (glutathione [GSH], superoxide dismutase [SOD], 4-hydroxynonenal [4-HNE]) levels, followed by folic acid and choline.
Discussion: Methyl donors such as folic acid, methionine, and choline are essential for maintaining OCM and can prevent animals with NAFLD from developing liver lipid accumulation.
Keywords: One-Carbon Metabolism, L-Methionine, Choline, Folic Acid, Methyl Donors
Introduction
Nonalcoholic fatty liver disease (NAFLD) is a combination of conditions that are caused by an excessive buildup of fat in the liver. However, no medications have been approved for the treatment of NASH [1]. Therefore, since NAFLD is now considered a significant global health burden, discovering new drug targets for the treatment of NASH is vitally important.
A metabolic mechanism called one-carbon metabolism (OCM) recycles one carbon atom through the methionine and folate cycles. This metabolism is vital for the management of amino acids, glucose, and vitamins in addition to the biosynthesis of macromolecules for the conservation of oxidation-reduction equilibrium and for the stabilization of the reaction of the methyl group, which makes methyl-group metabolism the link between epigenetic control and intermediate metabolism [2]. Various biochemical molecules such as vitamins and amino acids fuel the OCM cycle. As well as, the by-products of OCM are vital for a number of cellular functions.
Folic acid acts as a carbon donor in the production of purines/pyrimidine bases and serine from glycine. In order to re-methylate homocysteine into methionine, it also serves as a methyl donor to produce methylcobalamin. It has been demonstrated that dietary folic acid prevents the accumulation of hepatic lipids [3]. Folic acid and other methyl donors have been shown in numerous studies to have beneficial effects on chronic liver diseases [4].
Methionine is an essential amino acid for protein synthesis and growth, and free methionine is absorbed and converted to S-adenosylmethionine (SAM) [5]. SAM acts as a main sulfate and methyl-group donor in various biochemical reactions and is recommended for the treatment of particular diseases. Methionine metabolism, one of the key one-carbon metabolic pathways, connects the transsulfuration pathway to the folate cycle. It also acts as a precursor for the production of glutathione (GSH) in addition to being the main methyl donor for the methylation of proteins, histone, phospholipids, nucleic acids, and biogenic amines [6].
Choline, a main methyl donor, is a crucial nutrient and a fundamental component of various essential neurochemical and physiological reactions. Choline deprivation boosts the reduction of free radicals from mitochondria due to changed mitochondrial membrane structure and accelerated fatty acid oxidation. An absence of choline also changes DNA methylation and decreases folate metabolism and thymidylate production [7]. The aim of the study is to assess the impacts of folate, methionine, and choline as methyl donors in the prevention of NAFLD induced by a high-fructose diet (HFrD).
Material and Methods
Chemicals
Folic acid, L-methionine, and choline chloride were purchased from Now Foods company for natural food supplements, Bloomingdale, IL, USA.
Animals and Experimental Design
Adult male albino rats (8–10 weeks old) weighing between 128–137 g were used in the current study. The study was conducted from December 2022 to March 2023 and was approved by the Animal Care and Use Ethics committee at King Fahd Medical Research Center (KFMRC), King Abdulaziz University, Jeddah, Saudi Arabia. The rats were kept in air-conditioned animal housing at a temperature of 24°C in stainless steel cages, fed basal diet, and permitted water ad libitum throughout the experimental period (10 weeks). Sixty rats were classified into five groups (12 rats/group) as follows:
[1] Group 1 (Control): Healthy rats fed a basal diet. The control rats received an isocaloric diet (protein 18.3%, starch 66.5%, and fat 5.2%).
[2] Group 2 (HFrD): Rats fed an HFrD (45 g fructose/100 g diet) to induce NAFL. The rats received a diet containing 18.3% protein, 66.5% carbohydrate (consisting of 45% fructose and 21.5% starch) and 5.2% fat.
[3] Group 3 (HFrD + folic acid): Rats fed a diet of HFrD supplemented with 20 mg of folic acid/100 g.
[4] Group 4 (HFrD + met): Rats fed HFrD supplemented with 0.9 g L-methionine/100 g.
[5]: Group 5 (HFrD + chol): Rats fed HFrD supplemented with 0.6 g choline chloride/100 g.
Sample Collection and Biochemical Assessment
After 10 weeks, blood was drawn from the hepatic portal vein of ether-anesthetized rats that had fasted overnight. Serum samples were kept frozen at –20ºC for later biochemical testing. The livers were removed, washed out with saline solution (NaCl 0.9%), then blotted on filter paper, weighted, and frozen immediately at –20ºC for subsequent analysis. Liver lipids were extracted using the chloroform-methanol extraction technique.
Kits of total lipids (TL), total cholesterol (TC), triacylglycerols (TG), total phospholipids (PL), high-density lipoprotein cholesterol (HDL), alanine transaminase (ALT), aspartate transaminase (AST), albumin (ALB), and total bile acids (TBA) were purchased from Siemens Healthcare Diagnostics, U.S.A. Kits for assessing fatty acid synthase (FAS), acetyl coenzyme A carboxylase (ACC), and free fatty acids (FFA) were purchased from Bioassay Technology Laboratory (BT LAB), UK. Reduced GSH, 4-hydroxynonenal (4-HNE), and superoxide dismutase (SOD) kits were purchased from Bio Vision Inc. Co., USA. Kits for the assessment of tumor necrosis factor (TNF-α), interleukine-6 (IL-6), and interleukine-1 β (IL-1β) were purchased from Kamiya Biomedical Co. CA. USA.
Statistical Analysis
Data were statistically analyzed using SPSS software program (version 22.0) The results were presented as mean ± standard error (n = 12). The one-way analysis of variance (ANOVA) test was used to find the differences between mean values. Statistics were considered significant for P values under 0.01.
Ethical Approval
Ethics Committee approval for the study was obtained.
Results
HFrD rats showed a significant increase (P ≤ 0.01) in absolute and relative liver weight compared with the control group. However, those that consumed folate and choline supplemented diets showed a significant reduction (P ≤ 0.01) in both relative and absolute liver weights (Table 1).
Rats in the HFrD group showed significant dyslipidemia. Hepatic TG and TL and serum TC and LDL values were significantly elevated compared with the control rats, with decreased serum levels of HDL-c and hepatic total PL. Whereas, rats fed on folate-, choline-, and methionine-supplemented diets showed a considerable reduction (P ≤ 0.01) in TL, TG, TC, and LDL-c levels. Results demonstrated that the folate-supplemented group (HFrD+ folate) exhibited the greatest advancement in lipids biomarker values, followed by the choline and methionine-added groups, respectively, when compared to the HFrD group. HFrD-induced liver function disturbance was denoted as a significant reduction (P ≤ 0.01) in the serum values of ALB, significant increases in serum TBA levels, and activities of ALT and AST enzymes compared with the control group. There was an improvement observed in serum ALT and AST activities and ALB and TBA levels in rats that had been fed on diets supplemented with folate (HFrD+ folate) and choline (HFrD+ choline) compared with the control group. Serum levels of FFA, FAS, and ACC activities were increased in the HFrD rats compared with the control rats. An improvement was observed in the folate-treated rats (HFrD + folate) compared to the HFrD rats. No significant differences in serum FAS and ACC activities were found between rats supplemented with methionine or choline. (Table 2).
The results in Table 3 showed that HFrD-prompted oxidative stress and was represented as a substantial (P ≤ 0.01) decrease in SOD and GSH levels and an elevation in 4-HNE level when compared with the control rats. Alternatively, feeding the rat with folate (G3), methionine (G4), or choline (G5), improved the levels of oxidative stress biomarkers. The L-methionine-supplemented group, followed by the folate- and choline- supplemented groups, experienced the greatest improvements in oxidative stress biomarker values. Moreover, the results illustrated that the values of TNF-α, IL-6, and IL-1β in rats fed diets supplemented with folate, methionine, and choline were substantially upregulated when compared with the control rats.
Discussion
NAFLD pathogenesis has been linked to altered OCM. The current study results verified that feeding rats high-fructose diets resulted in considerable changes in the hepatic OCM pathway, which significantly increased serum TC, FFA, FBG, hepatic TL, hepatic TG, and LDL. The findings of the current work have shown a strong correlation between methyl-donor and lipid metabolism. The results displayed that the folate-supplemented rats (HFrD+ folate) exhibited the greatest improvement in hepatic TL, hepatic TG, hepatic PL, serum TC, LDL-c, FFA, and FBG levels and enzyme activities of FAS and ACC, followed by choline- and methionine-supplemented diets. Previous studies have demonstrated that folic acid supplementation had a positive influence on hepatic TG levels and attenuated the inflammatory response in mice fed a high-fat diet [8]. Additionally, studies have revealed that folic acid, through the hepatic activated protein kinase pathway, may lessen abnormal lipid metabolism and cholesterol deposition in the liver [9]. Significantly reduced FBG values in the folate group suggested that folic acid might be implicated in the management of glucose metabolism in disorders like NAFLD. OCM and NAFLD may be linked by a number of processes, but it appears that the production of very low-density lipoprotein (VLDL) and liver lipid export are the most significant.
Choline is used in transporting TG in VLDL, and abnormally high levels of one-carbon metabolites may decrease the secretion of VLDL, which then causes fat to build up in the liver. Since phosphatidylcholine is necessary for the formation of the VLDL envelope, its absence prevents the liver from exporting triglycerides, which causes them to build up in the cytosol. Phosphatidylcholine is formed in the liver by methylation of phosphatidyl-ethanolamine or from integration of preformed choline from food [10]. It has been suggested that choline supplementation had no protective impact on fatty liver in male mice fed a choline supplemented high-fat diet at a dose of 1.3 g/kg. However, they maintain mice blood cholesterol values within the normal range, thus improving their ability to function and preventing harmful liver changes [11]. Studies have also demonstrated that choline’s three labile methyl groups can be released and used to treat steatosis in mice [12] and via direct combination with phospholipid through the cytidine 5’-diphospho–choline pathway [13].
Methionine and folate pathways are connected in OCM. Methionine content is influenced by dietary intake, protein breakdown, and the remethylation of homocysteine (Hcy). Several processes, such as remethylation by methionine synthase, can convert Hcy back into methionine, which is constrained by 5-methyltetrahydrofolate’s (methyl-THF) availability or betaine synthesized from choline. S-adenosylmethionine (SAM) can then be produced from methionine, which is used in the majority of methyltransferase reactions as a universal methyl donor, such as the synthesis of phospholipids and methylation of proteins and nucleic acids [14]. Then, SAM is changed into S-adenosyl-L-homocysteine (SAH), and finally into Hcy. This Hcy remethylation process connects the methionine cycle to the folate cycle. Methyl-THF is produced from folate that is absorbed from dietary food, the predominant form of folate found in plasma. Then, folic acid supplement enters the cycle by dihydrofolate (DHF). In these pathways, the main function of folate is supplying or receiving one-carbon units. However, THF is the main acceptor molecule that is transformed into 5,10-methylene tetrahydro-folate (methylene-THF) and then by the methylene-THF reductase enzyme, resulting in the formation of methyl-THF. The methyl group methyl-THF is then used in the Hcy remethylation reaction [15].
Oxidative stress is the primary consequence of the abnormal functioning of one-carbon and lipid metabolic pathways. The results indicated that HFrD induced inflammation and oxidative stress denoted as a significant decrease in serum values of oxidative stress markers (GSH and SOD) and a significant increase in 4-HNE and proinflammatory cytokines values (TNF-α, IL-6, and IL-1β). As a methionine metabolite, GSH is the most abundant non-protein sulfhydryl group in cells, which is a protective agent against oxidative stress. In addition to GSH and SOD, 4-HNE is a well-known inducer of oxidative stress and one of the main end products of lipid peroxidation. It also plays a significant role in scavenging ROS in mammals [16].
Various studies postulated that fructose consumption boosts free radical formation and inflammation response [17]. It is proposed that fructose supports the transition from NAFLD to NASH. In mild inflammation, lipids promote inflammatory liver by the formation of unusual cytokines such as IL-6, TNF-α, and IL-1 β. Cytokine formation prevents insulin signaling in hepatocytes, resulting in hyperglycemia. A key, and early, complication is the induction of hepatic VLDL synthesis or increased free fatty acids flow from adipose tissue into the liver [18]. Oxidative stress is initiated because of the excessive production of reactive oxidants and protecting antioxidants, causing interrupted redox signaling, which ultimately results in DNA damage and molecular tissue damage. Numerous liver conditions, including NAFLD, are characterized by oxidative stress, in which free radicals damage proteins, lipids, and cell membranes, leading to tissue damage [19]. Previous animal models of NAFLD have revealed a relationship between the extent of steatosis and lipid peroxidation in the liver [20]. It has been proven that reactive oxygen species have an impact on numerous processes leading to hepatic fibrosis. A number of correlated pro-oxidative mechanisms function together, including mitochondrial dysfunction. Increased FFA metabolism and lipotoxicity may be the cause of diminished mitochondrial function [19]. The influx of FFAs and accumulation of TG in the hepatocytes are the primary mechanisms by which NAFLD develops.
Moreover, the findings of this study demonstrated that HFrD-induced liver function disturbance was represented as a significant reduction in serum levels of ALB and significant increases in serum TBA levels and activities of ALT and AST enzymes. Recovery was observed in serum values of ALT and AST activities, ALB, and TBA in rats that were fed on diets supplemented with folate, methionine, and choline. AST and ALT are formed mainly in the liver and increased levels of these enzymes in the serum are directly related to liver damage progression. Combinations of serum proteins and metabolites are also used to determine the severity of certain liver alterations, for instance, TBA or bilirubin [21].
Enzymes like FAS, one of the important metabolic enzymes for lipogenesis, may contribute to the promotion of NAFLD. In this pathway, acetyl CoA is transformed into malonyl CoA by ACC, and this molecule is then transformed into long-chain saturated fatty acids by FAS. Nutritional supplements containing folate, choline, and methionine have been demonstrated to slow the enhancement of NAFLD. The current study’s findings demonstrated that the levels of GSH, SOD, 4-HNE, TNF-α, IL-6, and IL-1β in rats fed on diets supplemented with folate, methionine, and choline were significantly upregulated. The values of serum inflammatory biomarkers partly displayed the inflammatory response during disease progression. The methionine and folate-supplemented rats had the most significant improvement in oxidative stress and inflammatory biomarkers levels followed by the choline-supplemented groups. Elevated levels of antioxidant biomarkers following folic acid, methionine, and choline supplementation may suggest an increase in antioxidant defenses against free radical damage. In this research, supplemental folic acid altered oxidative status markers by reducing oxidative stress. Recent studies have suggested that folate may have preventive effects through free-radical scavenging activity. However, folic acid supplementation had positive effects on hepatic TG levels and reduced the inflammatory stimulus in mice fed a high-fat diet [22]. Previous research has shown that dietary choline might modify immune responses by upregulating mRNA expression of the anti-inflammatory cytokine IL-6 and downregulating pro-inflammatory biomarker synthesis in vertebrates [23].
In conclusion, methyl-donor supplementation can prevent the advancement of lipid accumulation in the liver tissues of animals with NAFLD. Methyl-donor supplementation resulted in major changes in OCM metabolites and decreased hepatic free fatty acid values. These effects are associated with an increased FAS and ACC activity that links C1-metabolism and β-oxidation. In conclusion, our research has shown that supplementing with methyl donors can prevent the progression of lipid accumulation in liver tissues with NAFLD.
Scientific Responsibility Statement
The authors declare that they are responsible for the article’s scientific content including study design, data collection, analysis and interpretation, writing, some of the main line, or all of the preparation and scientific review of the contents and approval of the final version of the article.
Animal and human rights statement
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. No animal or human studies were carried out by the authors for this article.
Funding: None
Conflict of interest
The authors declare no conflict of interest.
References
1. Leoni S, Tovoli F, Napoli L, Serio I, Ferri S, Bolondi L. Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis. World J Gastroenterol. 2018; 24(30):3361.
2. Zeng JD, Wu WK, Wang HY, Li XX. Serine and one-carbon metabolism, a bridge that links mTOR signaling and DNA methylation in cancer. Pharmacol Res. 2019; 149:104352.
3. Xin FZ, Zhao ZH, Zhang RN, Pan Q, Gong ZZ, Sun C, et al. Folic acid attenuates high-fat diet-induced steatohepatitis via deacetylase SIRT1-dependent restoration of PPARα. World J Gastroenterol. 2020; 26(18):2203-2.
4. Guerrero L, Paradela A, Corrales FJ. Targeted proteomics for monitoring one-carbon metabolism in liver diseases. Metabolites. 2022; 12(9):779.
5. Ouyang Y, Wu Q, Li J, Sun S, Sun S. S-adenosylmethionine: a metabolite critical to the regulation of autophagy. Cell Prolif. 2020; 53(11):e12891.
6. Li Z, Wang F, Liang B, Su Y, Sun S, Xia S, et al. Methionine metabolism in chronic liver diseases: an update on molecular mechanism and therapeutic implication. Signal Transduct Target Ther. 2020; 5(1):280.
7. Bakir MB, Salama MA, Refaat R, Ali MA, Khalifa EA, Kamel MA. Evaluating the therapeutic potential of one-carbon donors in nonalcoholic fatty liver disease. Eur J Pharmacol. 2019; 847:72-82.
8. Liu Y, Shen J, Yang X, Sun Q, Yang X. Folic acid reduced triglycerides deposition in primary chicken hepatocytes. J Agric Food Chem. 2018; 66(50):13162-72.
9. Sid V, Wu N, Sarna LK, Siow YL, House JD, O K. Folic acid supplementation during high-fat diet feeding restores AMPK activation via an AMP-LKB1-dependent mechanism. Am J Physiol Regul Integr Comp Physiol. 2015; 309(10):R1215-R25.
10. Mato JM, Alonso C, Noureddin, M, Lu SC, Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease. World J Gastroenterol. 2019; 25(24):3009.
11. Al Rajabi A, Castro GS, da Silva RP, Nelson RC, Thiesen A, Vannucchi H, et al. Choline supplementation protects against liver damage by normalizing cholesterol metabolism in Pemt/Ldlr knockout mice fed a high-fat diet. J Nutr. 2014; 144(3):252-7.
12. Brosnan ME, Brosnan JT. Formate: the neglected member of one-carbon metabolism. Annu Rev Nutr. 2016; 36:369-88.
13. Walker AK. 1-Carbon cycle metabolites methylate their way to fatty liver. Trends Endocrinol Metab. 2017; 28(1):63-72.
14. Wu S, Zhang J, Li F, Du W, Zhou X, Wan M, et al. One-carbon metabolism links nutrition intake to embryonic development via epigenetic mechanisms. Stem Cells Int. 2019; 2019:3894101.
15. Guéant JL, Oussalah A, Zgheib R, Siblini Y, Hsu SB, Namour F. Genetic, epigenetic and genomic mechanisms of methionine dependency of cancer and tumor-initiating cells: What could we learn from folate and methionine cycles. Biochimie. 2020; 173:123-8.
16. Li W, Tang R, Ma F, Ouyang S, Liu Z, Wu J. Oxidative stress and 4-hydroxy-2-nonenal (4-HNE): Implications in the pathogenesis and treatment of aging-related diseases. J Immunol Res. 2022; 2022:2233906. DOI: 10.1155/2022/2233906
17. Tappy L. Fructose-containing caloric sweeteners as a cause of obesity and metabolic disorders. J Exp Biol. 2018; 221(Pt Suppl. 1):jeb164202. DOI: 10.1242/jeb.164202.
18. Hirano T. Pathophysiology of diabetic dyslipidemia. JAT. 2018; 25(9):771-82.
19. Bovi APD, Marciano F, Mandato C, Siano MA, Savoia M, Vajro P. Oxidative stress in non-alcoholic fatty liver disease. An updated mini review. Front Med (Lausanne). 2021; 8:595371. DOI: 10.3389/fmed.2021.595371.
20. Lau JK, Zhang X, Yu J. Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances. J Pathol. 2017; 241(1):36-44.
21. Li J, Luu LDW, Wang X, Cui X, Huang X, Fu J, et al. Metabolomic analysis reveals potential biomarkers and the underlying pathogenesis involved in Mycoplasma pneumoniae pneumonia. Emerg Microbes Infect. 2022; 11(1):593-605.
22. Sid V, Shang Y, Siow YL, Hewage SM, House JD, O K. Folic acid supplementation attenuates chronic hepatic inflammation in high-fat diet fed mice. Lipids. 2018; 53(7):709-16.
23. Zhao HF, Jiang WD, Liu Y, Jiang J, Wu P, Kuang SY, et al. Dietary choline regulates antibacterial activity, inflammatory response and barrier function in the gills of grass carp (Ctenopharyngodon idella). Fish Shellfish Immunol. 2016; 52:139-50.
Download attachments: 10.4328.ACAM.21802
Huda Abdulaziz Al Doghaither. Targeting one-carbon metabolism by methyl donors for prevention of non-alcoholic fatty liver in rats. Ann Clin Anal Med 2023;14(9):830-834
Citations in Google Scholar: Google Scholar
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/
In silico investigation of the antiemetic effect of cannabidiolic acid (CBDA), the phytocannabinoid of Cannabis sativa, by molecular docking method
Meryem Albayrak 1, Sultan Mehtap Büyüker 2
1 Department of Biotechnology, 2 Department of Pharmacy Services, Üsküdar University, Istanbul, Turkey
DOI: 10.4328/ACAM.21806 Received: 2023-06-27 Accepted: 2023-08-28 Published Online: 2023-08-30 Printed: 2023-09-01 Ann Clin Anal Med 2023;14(9):835-839
Corresponding Author: Sultan Mehtap Büyüker, Department of Pharmacy Services, Üsküdar University, Istanbul, Turkey. E-mail: sultanmehtap.buyuker@uskudar.edu.tr P: +90 532 324 21 53 Corresponding Author ORCID ID: https://orcid.org/0000-0002-1344-540X
Aim: Cannabis sativa has essential secondary metabolites in the treatment of diseases. The effects of the phytocannabinoids of Cannabis sativa on emesis continue to be investigated. In this study, we aimed to investigate the antiemetic effect of cannabidiol acid, one of the phytocannabinoids of the Cannabis sativa plant, by in silico methods.
Material and Methods: In this study, the molecular properties of cannabidiolic acid obtained from the PubChem database were investigated using the SwissADME database. To examine the effects of cannabidiolic acid on vomiting, the serotonin receptor was determined as the target protein. The target protein was obtained from the protein database, and molecular insertion was performed using AutoDock Vina. The docking process was visualized using Discovery Studio Visualizer and LigPlot imaging programs.
Results: According to our clamping study, the excellent hydrogen and hydrophobic interactions shown by CBDA on the 5HT3A receptor appear to be more effective than the reference drugs used.
Discussion: The examination found that cannabidiolic acid complies with Lipinski’s rules and has better binding energy, so it is a suitable candidate for the treatment of emesis.
Keywords: In-Silico, Cannabidiolic Acid (CBDA), Molecular Docking, Emesis, Antiemetic, Cannabis Sativa
Introduction
Emesis, also known as vomiting, is usually a distasteful condition that results in the forcible ejection of stomach objects through the mouth and is distinctly connected with gastrointestinal motor activity. Therefore, vomiting can be interpreted as a protective response of the body to certain drugs, disease comorbidities, or food toxins [1]. Emesis can occur for various reasons, including illnesses such as food poisoning, motion sickness, gastroenteritis (diarrhea), intestinal obstruction, head injury, pregnancy, appendicitis, or hangover. In addition, vomiting also occurs as a side effect of various exposures: brain tumors, overexposure to ionizing radiation, high intracranial pressure cancer chemotherapy, and radiation therapy [2, 3]. Mechanisms of vomiting in the human body are quite complex. The brain’s vomiting center (VC) plays a significant role in triggering vomiting or nausea. The VC is located in an area of the human brain called the chemoreceptor trigger zone (CTZ) of the fourth ventricle [4]. In addition to the CTZ, some other regions, such as the gastrointestinal (GI) tract, higher centers in the cortex, vestibular system, and the thalamus, have also been reported in the literature to trigger vomiting [5]. Vomiting is triggered when the proteins in the VC system are stimulated. During vomiting, the stomach muscle relaxes, and Hydrochloric acid THC(HCl) secretion is prevented. Intensive backward contraction of the small intestine stimulates the stomach to cause retching and vomiting, and vomiting occurs [6]. Today, most common drugs used to treat nausea and vomiting are serotonin (5-HT3A) antagonists [7].
The search for new antiemetic drugs derived from natural sources continues. Flavonoids, cannabinoids, chalcones, glycosides, hydroxycinnamic acids, diarylheptanoids, lignans, phenylpropanoids, saponins, polysaccharides, and terpenes as new antiemetic drug candidates are some of the preferred bioactive chemicals in drug research [8].
Cannabis sativa (C.Sativa) has been used by people for over 5000 years in many fields, for example, the food, textile, and pharmaceutical industries. According to current research, the cannabis plant has been associated with more than one pharmacological activity: relieves chronic pain and muscle spasms, reduces nausea during chemotherapy, increases appetite in human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) patients, improves sleep, and reduce tics in Tourette syndrome [9, 10]. The most active class of compounds in the cannabis plant are phytocannabinoids.
Cannabinoids include compounds such as Δ⁹-tetrahydrocannabinolic acid (Δ⁹-THC), the primary psychoactive compound, and non-psychoactive cannabidiolic acid (CBDA).
The primary cannabinoids in the plant exist in an acidic form, but due to aging, heat, and exposure to ultraviolet (UV) light, Tetrahydrocannabinolic acid (THCA), the acidic precursor of both CBDA and Δ⁹-THC, gradually loses its carboxyl group over time, and cannabidiol (CBD) and Δ⁹-THC are formed [10].
There is evidence from studies that Cannabidiol (CBD) is effective in preventing nausea and vomiting. The structure of CBDA and its isolation from cannabis were first described in 1965. Numerous pharmacological effects of CBD have been reported in the literature, but there are few studies on CBDA [11]. Compared to CBD in one study, CBDA was more effective in preventing vomiting in mice and nausea in mice [12]. Consequently, CBDA is promising as a treatment for nausea and vomiting, including anticipatory nausea, for which no specific therapy is available [12].
Screening for the 5HT3A receptor and comparing its affinities with known activators/inhibitors can aid in scoring and evaluating the efficacy of cannabidiolic acid. This study aims to determine the therapeutic effect of CBDA on nausea and vomiting using in silico methods.
Material and Methods
Determination of pharmacological properties of the compound by parameter
SwissADME, a free access web tool used to help estimate ADME. The SMILES form of the CBDA molecule was taken from PubChem and entered into the SwissADME web tool, and the results were obtained.
Target protein and ligand preparation
The three-dimensional structure of the 5HT3A target proteins was taken from the RCSB PDB. 5-HT3A crystallographic structures with PDB identity 6Y5A (Resolution: 2.80 Å) were used. BIOVIA Discovery Studio 2021 program, the water molecules in the protein were deleted from the structure, and the bound ligand residues were removed from the structure. Ligands and other atoms, missing polar hydrogens, were added. Energy minimization was done to achieve stable conformation. Selected ligand (CBDA) structure PubChem (PubChem ID: 160570) was obtained from PubChem chemical compounds database (accessed 17.06.2023). The protein’s 3D structure and polarization image were obtained using the PyMOL tool.
Molecular docking
In the study, the AutoDock Vina tool (version 1.5.7) was used to investigate the molecular interaction between target proteins and the selected ligand. Before docking analysis, using the BIOVIA Discovery Studio 2021 program the structure of the enzyme was optimized by removing excess ligands and water molecules. Then all compounds were optimized for energy using the Spartan 14 (Version 1.1.4) program. Polar hydrogens were added to the protein using the AutoDock vina 1.5.7 tool, and Kollman charges were determined as partial charge of compounds calculated using Compute Gasteiger. BIOVIA Discovery was used to determine the active sites of proteins. The x, y, and z coordinates were determined to bind the proteins to the catalytic site. After protein and ligand preparation in Autodock Vina, a grid box was generated. Center points of the box were X =147.3650; Y = 128.7920; Z = 162.5790 and dimensions were X = 90; Y = 90; Z = 90 (all are in Angstrom). Finally, molecular interactions and binding types between the selected compound and target protein were investigated using the Discovery Studio and Ligplot (version 2.2.8) visualizer programs [13].
Results
3D Prediction of target protein
To better understand the 3D structure of the target protein, the 3D structure and surface polarization image of the target protein were obtained using the PyMOL tool. Surface polarization shows the charges on the protein surface. Parts shown in blue demonstrate positive charges, parts shown in red have negative charges, and parts seen in white have neutral charges. It can be seen that negative and positive charges are equally distributed on the surface of the 5HT3A protein (Figure 1).
Pharmacological properties of CBDA
Bioavailability radar results, including the chemical structure of the molecule and lipophilicity, size, polarity, solubility, saturation, and flexibility properties, were found on the SwissADME web server (Figure 2).
In addition to these results, in the water solubility parameter, according to the Estimated Solubility (ESOL) filter, CBDA is moderately soluble, GI is high, blood-brain barrier (BBB) is not permeable, there is no substrate for Pg proteins, it is an inhibitor of CYP2C9 and CYP3A4 enzymes, and it complies with the Lipinski rules in drug similarity, and there is no violation (Table 1).
Molecular-docking study of the inhibition of 5HT3A by CBDA
The hydrogen, hydrophobic, and other interactions between protein and ligands as a result of the coupling study with the 5HT3 receptor with cannabidiolic acid and reference drugs are shown in Table 2. Reference drugs and interactions of CBDA with 5HT3 are shown in Figure 3.
The docking study with CBDA and 5HT3A showed a-7.0 kcal/mol binding affinity value. This value is the same as the reference drug tropisetron. It is also very close to the binding affinity values of other reference drugs. CBDA has formed very strong hydrogen bonds with 5HT3A, Val51 (2.50Å), Glu53 (2.77Å), Asn55 (2.35Å) amino acids. Close distance between hydrogen bonds indicates strong hydrogen interactions. Dolasetron, one of the reference drugs, showed a common Val51 hydrogen interaction with CBDA. At the same time, the hydrogen interaction of dolasetron showed a hydrophobic interaction between Trp187 amino acid and cannabidiolic acid. Dolasetron shows an electrostatic interaction with Glu186 and hydrogen bonding with CBDA. In addition, Ala277 (4.04Å) and Tyr223 (5.30Å) showed hydrophobic and Lys54 (2.74Å) acceptor-acceptor interactions. Compared with other reference drugs, dolasetron showed the best interaction at-8.5 kcal/mol, and CBDA showed the most common amino acid interactions with dolasetron.
Discussion
Life arose as a result of interactions of biomolecules at the nanoscale. With the understanding of biomolecular interactions at the nano (atomistic) level, comprehensive information can be obtained from what goes wrong when a disease occurs, to which drugs should be developed to treat that disease. This understanding paved the way for the emergence and rapid development of the structural biology department. In recent years, the field of structural biology cannot keep up with the data generation rate of genetics, biochemistry or various ‘omics’ sciences, which have grown faster than it. Computational structural biology techniques have emerged to close the production rate gap between all these disciplines. Thanks to these techniques, it has been possible to quickly and reliably predict and describe the atomistic level structures of biomolecules and their interactions in the computer environment. Molecular docking allows us to examine the interactions between receptors and target ligands underlying diseases, so that the most suitable ligand for the receptor can be selected.
The SwissADME, a free web tool used in evaluating the pharmacokinetics, drug-likeness (physicochemical and ADME properties) and medicinal chemistry friendliness of small molecules [14], would be used in testing the drug-likeness of the CBDA. The physicochemical properties of the CBDA were checked using the online tool for their adaptability with Lipinski’s rule of five. Lipinski and co-workers proposed the “Rule of Five” in 1997, which was the original and most known rule-based filter for drug-likeness of a molecule, distinguishing whether a molecule can be orally absorbed well or not, following the criteria: molecular weight (MW) ≤ 500, octanol/water partition coefficient (AlogP) ≤ 5, number of hydrogen bond donors (HBD’s) ≤ 5 and number of hydrogen bond acceptors (HBAs) ≤ 10.6. According to the Rule of Five, a molecule would not be orally active if it violates two or more of the four rules [15].
CBDA were assessed for their drug-likeliness (ADME and physicochemical properties). CBDA has not violated the Lipinski rule of five, a prominent principle used in certifying the drug-likeness of a compound and this shows that it has passed the drug-likeness test as shown in Table 1. Figure 2 shows the bioavailability RADAR. The bioavailability RADAR enables a first glance at the drug-likeness of a molecule. The pink area signifies the ideal range for each property (lipophilicity: XLOGP3 between − 0.7 and + 5.0, size: MW between 150 and 500 g/mol, polarity: TPSA between 20 and 130 Å2, solubility: log S not higher than 6, saturation: fraction of carbons in the sp3 hybridization not less than 0.25 and flexibility: no more than 9 rotatable bonds) and GI absorption was also high [14].
Discovery Studio and Ligplot visualizer programs show us the interactions between the receptor-ligand at the amino acid level. Thus, the interactions of the receptor with the active site can be examined. Based on these results, the effectiveness of the reference drugs and the ligand can be compared.
The CBDA insertion study showed a binding affinity value of -7.0 kcal/mol. As a reference, the drugs showed a value close to the binding affinity of CBDA. The fact that the binding affinity values are close to each other indicates that the CBDA molecule can be a drug. It can be seen that CBDA forms very strong hydrogen bonds with the amino acids Val51 (2.50Å), Glu53 (2.77Å), and Asn55 (2.35Å) belonging to 5HT3A. In addition, close distance between the hydrogen bonds indicates that the hydrogen interactions are strong and that CBDA is well located in the protein’s active site. This shows that it has an inhibitory effect on 5HT3A. CBDA, Ala277 (4.04Å) and Tyr223 (5.30Å) hydrophobic and Lys54 (2.74Å) acceptor-acceptor interactions were activated. Hydrophobic interactions increase the likelihood of binding to other amino acids so that CBDA can exert a better inhibitory effect on the protein. Dolasetron showed the best binding affinity among the reference drugs but also showed the most common amino acid interactions with CBDA. This shows that cannabidiolic acid can inhibit protein and be a candidate for antiemetic drugs with its strong interactions with 5HT3A and better binding affinity.
These results show that it can be an inhibitor as effective as dolasetron, which is used as a drug today. When the inhibitory effects of ondansetron, granisetron, tropisetron, palosetron, dolasetron and CBDA, which are frequently used for antiemetic treatment today, are compared, CBDA interacted with more amino acids than all other reference drugs. All these results mean that CBDA can be an inhibitor that is at least as effective as the reference drugs used.
Conclusion
Considering the results of our study, it is seen that CBDA complies with Lipinski’s rules with its pharmacokinetic properties. According to our docking study, it has been examined that it has good binding energy and establishes strong amino acid interactions with the target protein. With these properties, it has been seen that it can be a therapeutic candidate for nausea and vomiting.
Scientific Responsibility Statement
The authors declare that they are responsible for the article’s scientific content including study design, data collection, analysis and interpretation, writing, some of the main line, or all of the preparation and scientific review of the contents and approval of the final version of the article.
Animal and human rights statement
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Funding: None
Conflict of interest
The authors declare no conflict of interest.
References
1. Hall J, Driscoll P. 10 Nausea, vomiting and fever. Emerg Med J. 2005;22(3):200-4.
2. Grahame-Smith DG. The multiple causes of vomiting: is there a common mechanism? Nausea and vomiting: mechanisms and treatment, Davis CJ, Lake-Bakaar GV, Grahame-Smith DG. Berlin: Springer-Verlag; 1986.p.1–8.
3. Shankar A, Roy S, Malik A, Julka PK, Rath GK. Prevention of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients. Asian Pac J Cancer Prev. 2015;16(15):6207-13.
4. Iqbal IM, Spencer R. Postoperative nausea and vomiting. Anaesthesia & Intensive Care Medicine. 2012;13(12):613-16.
5. Becker DE. Nausea, vomiting, and hiccups: a review of mechanisms and treatment. Anesth Prog. 2010;57(4):150-7.
6. Lang IM. Digestive tract motor correlates of vomiting and nausea. Can J Physiol Pharmacol. 1990;68(2):242-53.
7. Bhuia MS, Islam T, Rokonuzzman M, Shamsh Prottay AA, Akter F, Hossain MI, et al. Modulatory effects of phytol on the antiemetic property of domperidone, possibly through the D2 receptor interaction pathway: in vivo and in silico studies. 3 Biotech. 2023; 13(4):116.
8. Ahmed S, Hasan MM, Ahmed SW. Natural antiemetics: an overview. Pak J Pharm Sci. 2014;27(5 Spec no):1583-98.
9. Baron EP, Lucas P, Eades J, Hogue O. Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort. J Headache Pain. 2018;19(1):37.
10. Martinenghi LD, Jønsson R, Lund T, Jenssen H. Isolation, Purification, and Antimicrobial Characterization of Cannabidiolic Acid and Cannabidiol from Cannabis sativa L. Biomolecules. 2020;10(6):900.
11. Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol. 2008;153(2):199-215.
12. Bolognini D, Rock EM, Cluny NL, Cascio MG, Limebeer CL, Duncan M, et al. Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation. Br J Pharmacol. 2013;168(6):1456-70.
13. Laskowski RA, Swindells MB. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model. 2011;51(10):2778-86.
14. Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:42717.
15. Lawal HA, Uzairu A, Uba S. QSAR, molecular docking studies, ligand-based design and pharmacokinetic analysis on Maternal Embryonic Leucine Zipper Kinase (MELK) inhibitors as potential anti-triple-negative breast cancer (MDA-MB-231 cell line) drug compounds. Bulletin of the National Research Centre. 2021;45(1):90.
Download attachments: 10.4328.ACAM.21806
Meryem Albayrak, Sultan Mehtap Büyüker. In silico investigation of the antiemetic effect of cannabidiolic acid (CBDA), the phytocannabinoid of Cannabis sativa, by molecular docking method. Ann Clin Anal Med 2023;14(9):835-839
Citations in Google Scholar: Google Scholar
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/
Is there a relationship between systemic immune-inflammatory indices and asthma?
Fatma Esra Gunaydin 1, Huseyin Erdal 2
1 Department of Immunology and Allergy, Ordu University Training and Research Hospital, Ordu, 2 Department of Medical Genetics, Faculty of Medicine, Aksaray University, Aksaray, Turkey
DOI: 10.4328/ACAM.21807 Received: 2023-06-28 Accepted: 2023-08-07 Published Online: 2023-08-12 Printed: 2023-09-01 Ann Clin Anal Med 2023;14(9):840-843
Corresponding Author: Huseyin Erdal, Department of Medical Genetics, Faculty of Medicine, Aksaray University, Aksaray, Turkey. E-mail: herdalyfa@gmail.com P: +90 543 414 08 15 Corresponding Author ORCID ID: https://orcid.org/0000-0003-0786-5077
This study was approved by the Ethics Committee of Ordu University (Date: 2023-03-31, No: 2023/87)
Aim: Immune inflammatory response plays an important role in patients with asthma. The goal of the current study is to determine whether pan-immune inflammation value (PIV) and systemic inflammatory response index (SIRI) are effective in predicting asthma.
Material and Methods: This retrospective study included 55 patients and 55 healthy controls followed in the Allergy and Immunology Clinics of Ordu University Training and Research Hospital.
Results: Neutrophil, Monocyte, MPV and PDW were statistically significant between the groups (p<0.05). A statistically significant difference was found between SIRI, PIV and dNLR, indices between the groups (p<0.05). No statistically significant difference was detected between SII, NLR, PLR and LMR compared to the controls (p>0.05).
Discussion: We concluded that SIRI and PIV could be novel and cost-effective inflammatory indices in patients with asthma.
Keywords: Asthma, Inflammation, Systemic Inflammatory Response Index, Pan-Immune-Inflammation Value
Introduction
Asthma is a common chronic inflammatory disease with a heterogeneous spectrum that can cause shortness of breath, cough, wheezing and chest tightness [1]. Asthma affects 1-20% of the population in different countries and 300 million people worldwide [2]. In Turkey, it has been reported that the prevalence of asthma in adults ranges from 1.2 to 9.4% [3]. The main features of asthma are reversible bronchial obstruction and airway hyperresponsiveness caused by chronic airway inflammation, and systemic inflammation is part of this condition. Inflammation is a response of the immune system in many diseases [4-6]. In asthma, an inflammatory response occurs as a result of the immune response occurring more than normal to stimuli in the airway.
Oxidative stress (OS) plays a crucial role in the pathogenesis of many diseases and has not been fully elucidated [7-11]. OS occurs as a result of the deterioration of the balance between free radicals and antioxidants and plays a significant role in the pathogenesis of many diseases, including asthma [12]. It is known that there is a link between increased oxidative stress and asthma severity.
Systemic inflammatory mast cell activation occurs in patients with asthma, which is mediated by a variety of cell cytokines (e.g., eosinophilic neutrophils, macrophages, platelets, etc.) and a variety of mediators, which have been considered crucial in the development of clinical asthma [13]. For asthma, biomarkers that are easy to measure are needed to distinguish between phenotypes, determine treatment option, and predict response to treatment. In recent years, cell counts in the peripheral blood sample and combinations such as neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLO) have been accepted as indicators of systemic and ocular inflammatory conditions. There are many studies showing the systemic immune-inflammatory index such as pregnancy loss [14], sepsis [15], chronic urticaria [16] and breast cancer [17]. SIRI and PIV are new immune biomarker indices that are important in terms of immune response and systemic inflammation.
Systemic inflammation index (SII), which is a new parameter calculated by the formula of neutrophil x platelets/lymphocytes; compared to PLO and NLR, it is a much more important marker in showing inflammation and immune response. As a new inflammatory biomarker, SII has been proposed as a prognostic indicator in many different clinical settings, including asthma and autoimmune disorders [14]. Recently, Erdogan et al. found that patients with an SII value ≥895.6 had a probability of having NERD with a sensitivity of 30.56%, whereas those with a lower SII had a probability of having asthma with a sensitivity of 92.65% [18]. Peripheral blood biomarkers have been the focus of research lately, as they are inexpensive, available, and common measurements. Limited data are available on SII and asthma. In our study, while inflammation has such an important place in the pathogenesis of asthma, we aimed to determine hemogram parameters and new inflammation indices compared with the control group.
Material and Methods
This retrospective study was conducted at the Ordu University, Education and Research Hospital, Department of Immunology and Allergic Diseases Outpatient Clinic from June 2022- to March 2023. A total of 55 patients diagnosed with asthma were included in the present study. The control group consisted of age- gender matched healthy individuals. There was no significant difference between the groups in terms of age and gender. The data of the study groups were obtained from the hospital automation system. The current study was approved by the ethics committee of Ordu University (Date:31.03.2023 / No: 2023/87). The study was conducted in accordance with the Helsinki Declaration rules.
The hemogram parameters and serum C-reactive protein (CRP) levels were assessed. Neutrophil, lymphocyte, platelet and monocyte levels of groups were used in the complete blood parameters. The NLR, PLR, LMR, SII, SIRI PIV and dNLR respectively, were calculated as follows: the ratio of neutrophils to lymphocytes, platelets to lymphocytes, lymphocytes to monocytes, that of platelets x (neutrophils / lymphocytes), (neutrophils x monocytes) / lymphocytes and (neutrophils x platelets x monocytes) / lymphocytes. The neutrophil count is divided by the result of the WBC count minus the neutrophil count.
Diagnosis of asthma
The diagnosis of asthma was made using clinical history and by demonstrating objective measures of reversible airway obstruction [forced expiratory volume in one second (FEV1)< 80% and FEV1/forced vital capacity (FVC)< 70% with an improvement in FEV1 12% and 200 mL after 400 mcg of salbutamol or average daily diurnal PEF variability> 10% over two weeks) [3].
Exclusion criteria
The study exclusion criteria were as follows: exacerbation of asthma in the last month, active neoplastic processes, diagnosed active viral or bacterial infection, chronic kidney disease and elevated serum CRP/ erythrocyte sedimentation rate.
Statistical analysis
SPPS 22 was used to carry out all data analysis. Data were reported as means ± min-max. Whether the data were normally distributed or not was determined with the Kolmogorov-Smirnov test. Variables that did not show normal distribution were compared with the Mann-Whitney U test. Categorical variables were compared with the chi-square test. Statistical significance was accepted as <0.05.
Ethical Approval
Ethics Committee approval for the study was obtained.
Results
The present study consisted of 55 asthma patients with an average age of 41.8 ± 15.2 years and 55 healthy controls with an average age of 41.5± 12.5 years. There was no statistically significant difference between the groups in terms of age and gender (Table1).
Median (min-max) outcomes of the hemogram parameters and indexes between the groups are shown in Table 2.
Neutrophil, Monocyte, MPV and PDW were statistically significant between the groups (p<0.05, Table 2). However, there was no statistically significant difference between other hemogram parameters. In addition, inflammatory indices were calculated for the study groups. A statistically significant difference was found between SIRI and PIV and dNLR indices between the groups (p<0.05). Table 2). However, there was no significant difference between SII, NLR, PLR and LMR groups (p>0.05, Table 2).
Discussion
Asthma is a complex inflammatory disorder that occurs with a chronic inflammatory deterioration in the respiratory tract and its incidence is increasing, especially with urbanization [19]. Airway inflammation seen in asthma patients is continuous and the relationship between asthma severity and inflammation has not been fully clarified yet. Therefore, the evaluation of the inflammatory process in asthma and the effective management of the process are clinically very important.
In the present study, for the first time, we demonstrated NLR, PLR, LMR, SII, SIRI, and PIV indices together in patients with asthma. This study was to examine whether systemic inflammatory indices play a role in predicting the prognosis of patients with asthma. In this retrospective study, we demonstrated that SIRI, PIV and dNLR levels were higher and statistically significant in patients with asthma compared to the control group (p<0.05). Although SII and NLR levels were higher in asthma patients compared to the control group, they were not statistically significant (p>0.05). However, we indicated that PLR and LMR levels were found to be lower in the patient group compared to the control group, and there was no statistical difference between the groups. Moreover, we examined hemogram parameters and neutrophil, lymphocyte, PDW, and PCT values were found to be higher and statistically significant in the patient group compared to control subjects (p<0.05). However, WBC lymphocyte hemoglobin, CRP and platelet levels were high but not statistically significant in the patient group than in healthy subjects.
In Erdogan’s study examining systemic immune inflammation in asthma patients, he reported the probability of having nonsteroidal antiinflammatory drug (NSAID)-exacerbated respiratory disease (NERD) in patients with an SII value of ≥895.6, and a sensitivity of 92.65% in patients with a low SII value of 30.56%. In addition, N/L ratio was found as a risk factor for NERD that is affecting SII. [18]. Erdogan indicates that the presence of SII below the threshold has shown that it can be used to exclude the diagnosis of NERD. Another study conducted by Sagmen et al. showed that PLR levels were higher in asthma patients compared to the control group [20]. However, they reported that they found the NLR levels to be the same in both groups. They concluded that PLR could be valuable in asthma control and they stated that further clinical studies should be done. In a study by Thasen et al. they indicated that NLR and PLR levels were high in asthma patients with respect to the non-asthmatic healthy controls [21]. They concluded that at high inflammation, NLR and PLR are indicative of strong interdependence.
A study by Lin et al. on breast cancer patients found PIV levels to be significant [22]. They concluded that PIV was an independent predictor of breast cancer. They thought that it helps the clinicians implement targeted and individualized treatment strategies. In our study, SIRI and PIV levels we found to be significant between the study and healthy subjects. Similar studies have shown that patients with high levels of NLR, PLR and SII have a poor prognosis [23, 24]. The results obtained were different from those of our study. In the present study, NLR, PLR and SII levels were not statistically significant among the groups.
A study by Ceran et al. on Hypoxic Ischemic Encephalopathy (HIE) patients demonstrated that NLR, SII and PIV values were found statistically significant compared to the healthy subjects [25]. They hypothesized that systemic inflammatory indices may be reliable and readily available predictors of HIE risk. They also concluded that NLR was an independent factor in distinguishing between moderate and severe HIE. Similar to the studies, we found the PIV and SIRI values to be significant.
Conclusion
In conclusion, we indicated that SIRI and PIV is a new and practical inflammatory index that can be used in the evaluation of asthma patients. These indices can be an inexpensive, practical and safe indicator of the inflammatory state in patients with asthma. However, a larger patient population is needed to obtain stronger results.
Scientific Responsibility Statement
The authors declare that they are responsible for the article’s scientific content including study design, data collection, analysis and interpretation, writing, some of the main line, or all of the preparation and scientific review of the contents and approval of the final version of the article.
Animal and human rights statement
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. No animal or human studies were carried out by the authors for this article.
Funding: None
Conflict of interest
The authors declare no conflict of interest.
References
1. Hammad H, Lambrecht BN. The basic immunology of asthma. Cell. 2021;184 (6):1469-85.
2. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald JM, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31(1):143-78.
3. Tarraf H, Aydin O, Mungan D, Albader M, Mahboub B, Doble A, et al. Prevalence of asthma among the adult general population of five Middle Eastern countries: results of the SNAPSHOT program. BMC Pulm Med. 2018; 18(1):68.
4. Erdal H, Yasar E, Tuncer SC. Determination of calprotectin levels in patients with cataract surgery. Ann Clin Anal Med. 2023;14 (2):148-51.
5. Erdal H, Gunaydin FE. Are pan-immune inflammation-value, systemic inflammatory response index clinically useful to predict in patients with chronic spontaneous urticaria? Ann Clin Ann Med. 2023; DOI: 10.4328/ACAM.21799.
6. Ray A, Kolls JK. Neutrophilic Inflammation in Asthma and Association with Disease Severity. Trends Immunol. 2017;38 (12):942-54.
7. Erdal H, Ciftciler R, Tuncer SC, Ozcan O. Evaluation of dynamic thiol-disulfide homeostasis and ischemia-modified albumin levels in patients with chronic lymphocytic leukemia. J Investig Med. 2023;71 (1):62-6.
8. Erdal H, Demirtas MS, Kilicbay F, Tunc G. Evaluation of Oxidative Stress Levels and Dynamic Thiol-disulfide Balance in Patients with Retinopathy of Prematurity. Curr Eye Res. 2023;1-8. DOI: 10.1080/02713683.2023.2185569.
9. Erdal H, Turgut F. Thiol/disulfide homeostasis as a new oxidative stress marker in patients with Fabry disease. J Investig Med. 2023; DOI: 10.1177/10815589231191966.
10. Erdal H, Özcan O, Turgut FH, Neşelioğlu S, Özcan E. Evaluation of dynamic thiol-disulfide balance and ischemia modified albumin levels in patients with chronic kidney disease. MKU Tıp Dergisi. 2022;13(47): 237-42.
11. Demirtas MS, Erdal H. Evaluation of thiol disulfide balance in adolescents with vitamin B12 deficiency. Ital J Pediatr. 2023; 49(1):3.
12. Deveci, MZY, Erdal H. Determination of dynamic thiol-disulfide levels in dairy cattle with foot disease. Vet Arhiv. 2022; 92(6):657-66.
13. Lemanske RF, Jr. Inflammatory events in asthma: an expanding equation. J Allergy Clin Immunol. 2000;105(6 Pt 2):633-6.
14. Genc SO, Erdal H. Are pan-immune-inflammation value, systemic inflammatory response index and other hematologic inflammatory indexes clinically useful to predict first-trimester pregnancy loss? Ann Clin Anal Med. 2023; 14 (5):473-7.
15. Wang G, Mivefroshan A, Yaghoobpoor S, Khanzadeh S, Siri G, Rahmani F, et al. Prognostic Value of Platelet to Lymphocyte Ratio in Sepsis: A Systematic Review and Meta-analysis. Biomed Res Int. 2022; 2022:9056363.
16. Tarkowski B, Lawniczak J, Tomaszewska K, Kurowski M, Zalewska-Janowska A. Chronic Urticaria Treatment with Omalizumab-Verification of NLR, PLR, SIRI and SII as Biomarkers and Predictors of Treatment Efficacy. J Clin Med. 2023;12(7):2639.
17. Li W, Ma G, Deng Y, Chen W, Liu Z, Chen F, et al. Systemic Immune-Inflammation Index Is a Prognostic Factor for Breast Cancer Patients After Curative Resection. Front Oncol. 2021;11:570208.
18. Erdogan T. Role of systemic immune-inflammation index in asthma and NSAID-exacerbated respiratory disease. Clin Respir J. 2021;15(4):400-5.
19. Shaw DE, Sousa AR, Fowler SJ, Fleming LJ, Roberts G, Corfield J, et al. Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort. Eur Respir J. 2015; 46(5):1308-21.
20. Sagmen SB, Kıral N. The evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in asthma control. Revue Française d’Allergologie. 2020; 60(1):20-3.
21. Tahseen R, Parvez M, Kumar GS, Jahan P. A correlational study on neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in bronchial asthma. Adv Hum Biol. 2023;13(1):68-72.
22. Lin F, Zhang LP, Xie SY, Huang HY, Chen XY, Jiang TC, et al. Pan-Immune-Inflammation Value: A New Prognostic Index in Operative Breast Cancer. Front Oncol. 2022;12:830138.
23. Ethier JL, Desautels D, Templeton A, Shah PS, Amir E. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis. Breast Cancer Res. 2017;19(1):2.
24. Al Jarroudi O, El Bairi K, Abda N, Zaimi A, Jaouani L, Chibani H, et al. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer. Biomark Med. 2021;15(14):1289-98.
25. Ceran B, Alyamac Dizdar E, Beser E, Karacaglar NB, Sari FN. Diagnostic Role of Systemic Inflammatory Indices in Infants with Moderate-to-Severe Hypoxic Ischemic Encephalopathy. Am J Perinatol. 2021; DOI: 10.1055/a-1673-1616.
Download attachments: 10.4328.ACAM.21807
Fatma Esra Gunaydin, Huseyin Erdal. Is there a relationship between systemic immune-inflammatory indices and asthma? Ann Clin Anal Med 2023;14(9):840-843
Citations in Google Scholar: Google Scholar
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/
Development of the corpus callosum during normal growth
Duygu Baykal 1, Yaprak Çevirme 2, Gökhan Ocakoğlu 3, Mevlüt Özgur Taskapılıoğlu 2
1 Department of Neurosurgery, Bursa State Hospital, 2 Department of Neurosurgery, Faculty of Medicine, Uludag University, 3 Department of Biostatistics, Faculty of Medicine, Uludag University, Bursa, Turkey
DOI: 10.4328/ACAM.21812 Received: 2023-07-07 Accepted: 2023-08-14 Published Online: 2023-08-18 Printed: 2023-09-01 Ann Clin Anal Med 2023;14(9):844-848
Corresponding Author: Mevlüt Özgür Taşkapılıoğlu, Department of Biostatistics, Faculty of Medicine, Uludag University, 16059, Gorukle, Bursa, Turkey. E-mail: ozgurt@uludag.edu.tr P: +90 224 295 27 40 Corresponding Author ORCID ID: https://orcid.org/0000-0001-5472-9065
This study was approved by the Ethics Committee of Bursa Uludag University (Date: 2019-12-25, No: 2019-21/17)
Aim: Corpus callosum is the main structure communicating between the two brain hemispheres. This study aimed to investigate the differences in the corpus callosum’s and cranium’s shape during growth and assess their potential clinical implications.
Material and Methods: Cranium and corpus callosum shape data were collected from two-dimensional digital images. Generalized Procrustes analysis was used to obtain mean shapes between consecutive age groups. Shape deformation of the corpus callosum between successive age groups was evaluated using the thin-plate spline method.
Results: There were significant age-based differences were in the corpus callosum and cranium shape. The most prominent deformation was seen in the posterior midbody (a corpus callosum region), while the cranium deformation was observed in the biparietal area. There were significant differences in corpus callosum shape between 1- and 2-year age groups. The diameter of the cranium increased up to the age of 4 years; however, this increase was not uniform, especially in the biparietal areas.
Discussion: The skull’s growth and the corpus callosum’s development are not similar. The development of the corpus callosum may be a better indicator of neural development than skull enlargement.
Keywords: Corpus Callosum, Cognition, Development, Shape Analyses, Skull
Introduction
The corpus callosum is a thick bundle of nerve fibers that divides the cerebral cortex lobes into left and right hemispheres and provides connectivity between the right and left sides of the brain. It contains approximately 200 million axons symmetrically distributed to the frontal, parietal, temporal, and occipital lobes [1]. The corpus callosum transfers motor, sensory, and cognitive information between the hemispheres. Many studies have investigated the relationship of the shape of the corpus callosum with gender, race, hand dominance, behaviors, diseases, and developmental abnormalities [2,3].
Morphometrics is a field concerned with the study of variations and changes in the size and shape of organisms or their structures. It can also be defined as the quantitative analysis of a biological form [4,5]. Statistical shape analysis is a modern geometric morphometric analysis method that uses the shape of organs or organisms as input data. This entails analysis of the changes in the shape of the biological structure of interest by using anatomically significant points called landmarks. This analysis can unravel the changes in the structure’s shape linked to demographic factors, environmental factors, or disease. This quantitative analysis also enables the interpretation of shape differences and potential general or localized deformations in the target structure or organ. Many recent health-related studies have revealed that statistical shape analysis can be used as a supportive analysis type alongside the existing imaging techniques [6,7].
This study aimed to investigate the differences in the shape of the corpus callosum and cranium during the growth period in early childhood and to explore their potential clinical implications.
Material and Methods
Patient Selection
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Bursa Uludag University IRC (2019-21/17).
In this study, we retrospectively used midline sagittal magnetic resonance images and axial cranial magnetic resonance images passing through the level of the foramen of Monroe of 30 patients in the age group of 1–5 years. Previously reported normal Magnetic resonance imaging (MRI) scans were obtained from the archives of Bursa Uludag University. MRI was performed in a 3.0-Tesla MRI Device (Achieva, Philips, Best, Netherlands). Informed consent was obtained from the legal guardians of all participants, and the university ethics committee approved this retrospective study and the study protocol.
Obtaining 2D Landmarks
An expert radiologist selected the sagittal midsections that most clearly displayed the cerebral aqueduct, corpus callosum, and superior colliculus manually from the sagittal planes. The anterior-posterior commissure line and the inter-hemispheric fissure were identified and used to align the brain of all subjects to a standard position. Statistical shape analysis was performed to evaluate the corpus callosum shape using 16 homologous landmarks (Figure 1) used in previous studies [8]. We also implemented statistical shape analysis of the cranium using homologous anatomical landmarks (Figure 1) used in a previous study [3].
The descriptions of these landmarks are provided in Table 1.
Collection of Two-Dimensional Cranial Landmarks
The landmarks were chosen based on reliability, maximizing anatomical coverage, and cranial morphological descriptions. Corpus callosum and cranial data were collected from two-dimensional digital images. Standard anatomic landmarks were selected and marked on each digital image using the tpsDig2software [Rohlf F: TpsDig, ver. 2.04. Department of Ecology and Evolution, the State University of New York. Stony Brook. 2005. ]. The landmark reliability was evaluated using the intrarater reliability coefficient, calculated with a two-facet crossed design (‘landmark pairs-by-rater-by-subject,’ l x r x s) [9]. The landmarks were marked for all images by an investigator. For calculating the “G” reliability coefficient, 30 images were randomly selected and marked. The same investigator marked the same landmarks on these images two weeks after the first marks. The G coefficient calculated showed strong repeatability (G = 0.9768). Landmark reliability calculations were performed from the following link: http://biostat.home.uludag.edu.tr/landmark_reliability/G_coefficient.html
Geometric Morphometric Analysis
Differences in the shape of the corpus callosum and cranium between consecutive age groups were assessed by performing a Generalized Procrustes analysis. Box’s M procedure was used to test the equality of variance–covariance matrixes. If the variance–covariance matrixes were unequal (p<0.05), the James FJ test based on a resampling procedure was performed; otherwise, the Hotelling T2 test based on a resampling procedure was considered [1]. Procrustes’ mean shapes were calculated for thin-plate spline (TPS) analysis, derived from a mathematical model used in computer graphics and applied to morphometrics by Bookstein [10]. The primary purpose of TPS is to compare two different shapes by deforming one mean shape to the other. The points exhibiting the greatest enlargements or reductions, labeled as deformations, were established through the TPS analysis [11].
Ethical Approval
Ethics Committee approval for the study was obtained.
Results
There was no significant difference between age groups concerning gender distribution (p=0.518). The average corpus callosum shapes of the various age groups are shown in Figure 2.
In the analyzes performed between consecutive age groups, there were significant differences in the corpus callosum shapes between children in the 1-year-old and 2-year-old groups (p=0.040). However, there were no significant differences in this respect between the two-year-old and three-year-old groups, between three-year-old and four-year-old groups, and between four-year-old and five-year-old groups (p=0.129, p=0.862, and p=0.391, respectively). TPS analysis was also performed using mean corpus callosum shapes of one-year-old and two-year-old groups obtained from the Procrustes analysis. The TPS graphic shows the high level of deformations in corpus callosum shapes from one year to two years (Figure 2). The most significant deformation was observed between the age of 1 to 2 years, characterized by widening in the dark red region and narrowing in the dark blue regions.
The average cranium shapes of the age groups are presented in Figure 2. In the analyses performed between consecutive age groups, the cranium shapes differed between 1-year-old and 2-year-old groups, 2-year-old and 3-year-old groups, and 3-year-old and 4-year-old groups (p<0.001, p=0.047, and p<0.001, respectively). However, no significant differences in this respect were observed between the 4-year-old and 5-year-old groups (p=0.345).
TPS analysis was also performed using mean cranium shapes of 1-year-old and two-year-old groups obtained from the Procrustes analysis. The TPS graphic shows high deformations in the shapes of the corpus callosum at the age of one to two years (Figure 3).
Enlargement was observed in the dark red region, and narrowing in the dark blue regions, while the highest deformation was found in the transition from one year to two years old. Figure 3 shows an enlargement in the dark red region and a narrowing in the dark blue regions during the transition from 2 to 3 years of age. In addition, Figure 3 shows an enlargement in the dark red region and a narrowing in the dark blue regions as the age increases from 3 to 4 years.
Discussion
In the present study, we aimed to investigate the association between age and structural deformation of the corpus callosum and cranium. We used the landmark-based geometrical morphometric approach to evaluate these changes. Our results showed significant changes in the corpus callosum and cranium shapes with the increase in age. Further subregional analyses revealed that the most prominent deformation was in the posterior midbody, the corpus callosum region containing callosal fibers that interconnect the somatosensory cortices. The most significant deformation in the cranium was observed in the biparietal area.
The relationship between brain morphology and function has been extensively studied [12,13]. A recent MRI study has determined the central sulcus’s relations, functional body representations, and particular morphological features [14]. Sun et al. tested 252 right-handed subjects and confirmed a perfect match between the central sulcus morphological “hand knob” and the corresponding motor activation [15].
There is a more than 2-fold increase in the size of genu and splenium of the corpus callosum in the first year after birth [16]. While the growth of the genu is completed at the age of 5–6 years, the growth of the splenium and, consequently, the corpus callosum continues until the age of 10–12 years. Garel et al. reported that the genu expands more than the splenium during early development, and the splenium expands more during later development. They showed that the enlargement of the corpus callosum occurs from anterior to posterior during growth [17]. A later, longer-term expansion of the splenium compared with genu may indicate greater myelination in the splenial component [18].
Barkovich and Kjos performed an MRI study to evaluate the corpus callosum morphology in 63 patients aged < 1 year and found that it was uniformly thin without enlargements in the genu and splenium during the first postnatal year [19].
In their cross-sectional study using MRI, Giedd et al. found more age-related changes in the middle and posterior parts of the corpus callosum (body, splenium) than in the anterior parts (genu, rostrum) in individuals aged 4–18 years [20]. However, they did not evaluate the corpus callosum developments in children under < 4 years of age.
Therefore, they did not assess the period during which a maximum expansion of the corpus callosum occurs after birth.
The corpus callosum enlarges together with the growth of the cortex. In the early postnatal period, the maturation of the corpus callosum progresses with the development of myelin, especially at the splenium [21]. Myelination occurs from posterior to anterior; therefore, the primary cortical areas are connected to the isthmus and splenium. The body, genu, and rostrum are associated with more anterior associative regions [21].
Brain injury is associated with corpus callosum development and neurodevelopmental outcomes in premature infants. It reflects the severity of white matter injury and intraventricular hemorrhage [22].
Corpus callosum is related to the language functions of the splenium [6]. The splenium contains fibers projecting to primary visual cortices among additional cortical targets [5]. Because of this connectivity, splenium plays a vital role in orienting to salient information during infancy and adulthood [23]. The splenium may be a critical neurobiological region for emerging language production due to its role in maintaining visual orientation [24, 25]. The role of splenium in language has also been investigated in dyslectic adults.
In this study, we observed differences between the 1-year-old and 2-year-old groups with respect to corpus callosum shape. The rapid enlargement in the genu part of the corpus callosum during this period may be associated with infants’ acquisition of speech ability. However, it is unclear whether learning to speak causes an enlargement in these fibers or whether enlargement in the fibers enables the acquisition of speaking ability.
Many researchers have compared the changes in corpus callosum structure between males and females; however, in this study, there were no significant between-group differences concerning gender distribution [16]. Assessment of sex-based differences was beyond the scope of this study
The head circumference has been shown to correlate with brain growth and brain volume. Head circumference measurements were associated with brain tissue volumes on MRI and neurocognitive outcomes in preterm infants compared with a head circumference at term equivalent age. MRI studies have also shown decreased fractional anisotropy in the splenium in premature infants with neurodevelopmental delay. A 3-dimensional study examining the growth of the cranium identified a non-uniform growth pattern. In our study, the diameter of the cranium increased up to 4 years old, which is consistent with the literature; however, this increase was not found to be uniform, especially in the biparietal areas. This suggests that the relationship established between skull diameter and neural development in the literature may not be entirely correct and that other factors may also affect neural development.
Limitation
We did not examine the sex-based differences in this study.
Conclusion
This study found that the growth in the skull and the development in the corpus callosum are not similar and that the development in the corpus callosum may be a better indicator of neural development than skull enlargement. More extensive studies, including clinical and radiological data, are required to understand this issue better.
Scientific Responsibility Statement
The authors declare that they are responsible for the article’s scientific content including study design, data collection, analysis and interpretation, writing, some of the main line, or all of the preparation and scientific review of the contents and approval of the final version of the article.
Animal and human rights statement
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. No animal or human studies were carried out by the authors for this article.
Funding: None
Conflict of interest
The authors declare no conflict of interest.
References
1. Ercan I, Ocakoglu G, Sigirli D, Ozkaya G, Statistical shape analysis and usage in medical sciences. Turkiye Klinikleri J Biostat. 2012;4(1):27–35.
2. Bocu Y, Karabagli H, Taskapilioglu MÖ, Ocakoglu G. Statistical shape analyses of corpus callosum changes at preoperative and postoperative scaphocephaly patients. Childs Nerv Syst. 2022;38(4):773–80.
3. Ocakoglu G, Taskapilioglu MO, Kaya S, Yazici Z. Statistical shape analyses of patients with scaphocephaly after surgical remodeling. Turk Neurosurg. 2020;30(3):382–86.
4. Paul LK. Developmental malformation of the corpus callosum: a review of typical callosal development and examples of developmental disorders with callosal involvement. J Neurodev Disord. 2011;3(1):3–27.
5. Putnam MC, Steven MS, Doron KW, Riggall AC, Gazzaniga MS. Cortical projection topography of the human splenium: hemispheric asymmetry and individual differences. J Cogn Neurosci. 2010;22(8):1662–69.
6. Swanson MR, Wolff JJ, Elison JT, Gu H, Hazlett HC, Botteron K, et al. Splenium development and early spoken language in human infants. Dev Sci. 2017;20(2):10.1111/desc.12360.
7. Witelson SF. Hand and sex differences in the isthmus and genu of the human corpus callosum: a postmortem morphological study. Brain. 1989;112(3):799–835.
8. Sigirli D, Ercan I, Ozdemir ST, Taskapilioglu O, Hakyemez B, Turan OF. Shape analysis of the corpus callosum and cerebellum in female MS patients with different clinical phenotypes. Anat Rec. 2012;295(7):1202–11.
9. Dimitrov D. Reliability. In: Erford BT (editor). Assessment for Counselors. Boston: Houghton-Mifflin/Lahaska Press; 2006. p. 99–122.
10. Bookstein FL. Principal warps: thin-plate splines and the decomposition of deformations. IEEE Trans Pattern Anal Mach Intell. 1989;11(6):567–85.
11. Hammer Ø, Harper DAT, Ryan PD. PAST: paleontological statistics software package for education and data analysis. Palaeontol Electron. 2001;4:9.
12. Amiez C, Kostopoulos P, Champod AS, Petrides M. Local morphology predicts functional organization of the dorsal premotor region in the human brain. J Neurosci. 2006;26(10):2724–31.
13. Bodin C, Takerkart S, Belin P, Coulon O. Anatomo-functional correspondence in the superior temporal sulcus. Brain Struct Funct. 2018;223(1):221–32.
14. Germann J, Chakravarty MM, Collins DL, Petrides M. Tight coupling between morphological features of the central sulcus and somatomotor body representations: a combined anatomical and functional MRI study. Cereb Cortex. 2020;30(3):1843–1854.
15. Sun ZY, Pinel P, Rivière D, Moreno A, Dehaene S, Mangin JF. Linking morphological and functional variability in hand movement and silent reading. Brain Struct Funct. 2016;221(7):3361–71.
16. Vannucci RC, Barron TF, Lerro D, Antón SC, Vannucci SJ. Craniometric measures during development using MRI. NeuroImage. 2011;56(4):1855–64.
17. Garel C, Cont I, Alberti C, Josserand E, Moutard ML, Ducou le Pointe H. Biometry of the corpus callosum: MR imaging reference data. AJNR Am J Neuroradiol. 2011;32(8):1436–43.
18. Aboitiz F, Montiel J. One hundred million years of interhemispheric communication: the history of the corpus callosum. Braz J Med Biol Res. 2003;36(4):409–20.
19. Barkovich AJ, Kjos BO. Normal postnatal development of the corpus callosum as demonstrated by MR imaging. AJNR Am J Neuroradiol. 1988;9(3):487–91.
20. Giedd JN, Rumsey JM, Castellanos FX, Rajapakse JC, Kaysen D, Vaituzis AC, et al. A quantitative MRI study of the corpus callosum in children and adolescents. Brain Res Dev Brain Res. 1996;91(2):274–80.
21. Girard N, Koob M, Brunel H. Normal development. Handb Clin Neurol. 2016;136:1091–119.
22. Malavolti AM, Chau V, Brown-Lum M, Poskitt KJ, Brant R, Synnes A, et al. Association between corpus callosum development on magnetic resonance imaging and diffusion tensor imaging, and neurodevelopmental outcome in neonates born very preterm. Dev Med Child Neurol. 2017;59(4):433–40.
23. Elison JT, Paterson SJ, Wolff JJ, Reznick JS, Sasson NJ, Gu H, et al. White matter microstructure and atypical visual orienting in 7-month-olds at risk for autism. Am J Psychiatry. 2013;170(8):899–908.
24. Vouloumanos A, Curtin S. Foundational tuning: how infants’ attention to speech predicts language development. Cogn Sci. 2014;38(8):1675–86.
25. Yapıcı-Eser H, Onay A, Öztop-Çakmak Ö, Egemen E, Vanlı-Yavuz EN, Solaroğlu İ. Rare case of glioblastoma multiforme located in posterior corpus callosum presenting with depressive symptoms and visual memory deficits. BMJ Case Rep. 2016; bcr2016216505 DOI: 10.1136/bcr-2016-216505.
Download attachments: 10.4328.ACAM.21812
Duygu Baykal, Yaprak Çevirme, Gökhan Ocakoğlu, Mevlüt Özgur Taskapılıoğlu. Development of the corpus callosum during normal growth. Ann Clin Anal Med 2023;14(9):844-848
Citations in Google Scholar: Google Scholar
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/
Assessment of the patients referred to the pediatric cardiology clinic due to murmur
Ajda Mutlu Mıhçıoğlu
Department of Pediatrics, Unıversity of Health Sciences, Bakırkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey
DOI: 10.4328/ACAM.21831 Received: 2023-07-24 Accepted: 2023-08-25 Published Online: 2023-08-29 Printed: 2023-09-01 Ann Clin Anal Med 2023;14(9):849-853
Corresponding Author: Ajda Mutlu Mıhçıoğlu, Department of Pediatrics, Unıversity of Health Sciences, Bakırkoy Dr. Sadi Konuk Training and Research Hospital, 34147, Bakırköy, Istanbul, Turkey. E-mail: ajdamutlu@yahoo.com P: +90 505 648 64 68 F: +90 212 414 69 94 Corresponding Author ORCID ID: https://orcid.org/0000-0003-0143-4188
This study was approved by the Ethics Committee of Health Sciences University, Bakırköy Dr. Sadi Konuk Training and Research Hospital (Date: 2023-03-20, No: 2023-06-13)
Aim: Heart murmur is one of the most common reasons for evaluation in the pediatric cardiology clinic. The aim of this study is to evaluate the physical examination and echocardiographic findings of patients referred due to murmur.
Material and Methods: Patients admitted to the pediatric cardiology clinic due to murmur were evaluated retrospectively. The intensity of the murmurs was graded as 1-2/6, 3/6, and >3/6. The type of murmur was classified as innocent or pathological. Echocardiographic findings were classified as normal, normal for age, or pathological.
Results: Two hundred patients were included in the study. Murmur was graded 1-2/6 in 72.5% of patients, 3/6 in 7%, and>3/6 in 1%. Innocent murmur was detected in 54.5%, pathological murmur in 26% of the patients. Echocardiographic findings were normal in 54% of the presenting cases, normal for age in 15.5%, and pathological in 30.5%. Patients without murmur had normal echocardiographic findings in 64.1%, pathologic findings in 7.69%. Echocardiography was normal in the majority of the patients with a grade of 1-2/6, but was pathological in those with a grade of ≥3/6. Echocardiography was pathological in 7.69% of the patients without murmur, in 10.09% with an innocent murmur, and in 90.38% with a pathological murmur. The intensity of murmur was observed as significant (p=0.001), but the characteristics of the murmur was not observed as significant determinant in distinguishing echocardiographic findings (p=0.115).
Discussion: Echocardiographic findings are not always related to physical examination findings of murmur, therefore we suggest that auscultation alone may not be sufficient in the evaluation, and a detailed assessment with echocardiography may be more appropriate.
Keywords: Child, Echocardiography, Auscultation, Murmur
Introduction
Murmurs are sounds that are produced by turbulent blood flows in the heart and vascular structures and are transmitted to the chest wall. They have frequencies between 20 Hz and 2000 Hz [1-3]. Murmurs may be heard in approximately one-third of routine physical examinations [1]. Murmur is a cause of anxiety for parents and physicians, therefore it is one of the most frequent reasons for admission to pediatric cardiology clinics. While 75-80% of murmurs are innocent, it may sometimes be the only finding to raise suspicion of congenital heart disease. Differentiations and diagnoses of the conditions are easily made with echocardiography [4-7]. The purpose of this study is to evaluate the physical examination and echocardiographic findings of the patients referred to the pediatric cardiology clinic due to murmur.
Material and Methods
Patients presenting to the pediatric cardiology clinic due to murmur during January 2023 and February 2023 were evaluated retrospectively. Anamnesis, physical examination and echocardiographic data were obtained from records of the hospital system. Murmur intensity was classified as 1-2/6, 3/6, and >3/6. The type of murmur was classified as innocent or pathological.
Echocardiographic findings were classified as normal, normal for age, or pathological. Normal for age echocardiographic findings included physiologically normal findings, including patent foramen ovale (PFO), peripheral pulmonary stenosis (PPS), and patent ductus arteriosus (PDA).
Ethical Approval
The study was approved by the Ethics Committee of the Health Sciences University, Bakırköy Dr. Sadi Konuk Training and Research Hospital (decision number: 2023-06-13, date: 20.03.2023). Informed consent was obtained from all the patients and their parents.
Statistical Analysis
Statistical analyses and graphics were performed using SPSS 29 Statistical Software. Categorical data were presented with frequency and percentage. Continuous variables were evaluated with mean, Standard deviation, median, minimum and maximum values. The results of the evaluation with physical examination and echocardiography were compared with the McNemar test. In order to evaluate the physical examination results according to the echocardiographic findings, the rates of sensitivity, specificity, positive and negative predictive values and accuracy were calculated.
Results
Two hundred patients were included in the study. Boys represented 51% of the cases. The majority of patients consisted of children older than 49 months, the second most common group consisted of the patients aged up to three months. No murmur was detected in 19.5% of the patients referred for this reason, while 1-2/6 murmur was present in 72.5%, 3/6 in 7%, and >3/6 in 1% of the patients. Innocent murmur was detected in 54.5% and pathological murmur was detected in 26% of the patients. Echocardiographic findings were normal in 54% of the presenting cases, normal for age in 15.5%, and pathological in 30.5% of them (Table 1).
Patients without murmur had normal echocardiographic findings in 64.1%, pathological findings in 7.69%, normal for age findings in 28.21% of the patients. Patients with grade 1-2/6 murmurs had normal echocardiographic findings in 57.24%, normal for age findings in 12.41% of the patients,while 30.35% of the patients had pathological findings. Patients with grade 3/6 murmur had mostly (85.72%) pathological findings with a small percentage (14.28%) of normal for age findings. All of the patients with murmurs greater than 3/6 had pathological echocardiographic findings. Patients that are classified to have innocent murmur had normal echocardiographic findings mostly (76.15%). Further, 13.76% of the patients had echocardiographic findings that were normal for age, while 10.09% of the patients had pathological findings. Patients with pathological murmur had mostly pathological findings (90.38%), with a small percentage (9.62%) of echocardiographic findings that were normal for age (Table 2).
None of the patients with pathological murmur had normal echocardiographic findings. Pathological echocardiographic findings were present in 3 patients without murmur, in 11 patients with innocent murmur and in 47 patients with pathological murmur. Echocardiographic findings normal for age were detected in 11 patients without murmur, 15 patients with innocent murmur and 5 patients with pathological murmur (Table 2).
Pathological echocardiographic findings included mostly atrial septal defect (ASD), ventricular septal defect (VSD), PDA, mitral valve prolapse, mitral and aortic insufficiency, bicuspid aortic valve, tetralogy of Fallot and operated congenital heart diseases.
Aortic stenosis, aortic coarctation, subaortic membrane, interventricular septal hypertrophy, pulmonary insufficiency, non-compaction cardiomyopathy were also present among the patients with pathologic echocardiographic findings. It was determined that there was a significant difference between echocardiography results and physical examination results involving the intensity of murmur. The two diagnostic methods do not give similar results (p=0.001) (Table 3). When murmur intensity was used as a determinant for distinguishing echocardiographic findings, the sensitivity of the physical examination was 21.67%, the specificity was 97.86%, the positive predictive value was 81.25%, the negative predictive value was 74.46%, and the accuracy rate was 75%, odds ratio 12.63%, 95% confidence interval was 3.448-46.272. Murmur intensity was observed as a significant determinant for distinguishing echocardiographic findings.
It was determined that there were no significant differences between echocardiographic results and physical examination results in terms of characteristics of the murmur. The two diagnostic methods give similar results (p=0.115) (Table 3). When murmur characteristics were used as determinants for distinguishing echocardiographic findings, the sensitivity of the physical examination was 76.67%, specificity was 95.71%, the positive predictive value was 88.46%, the negative predictive value was 90.54%, and the accuracy rate was 90%, the odds ratio was 73.38%, 95% confidence interval was 26.638- 202.144. The characteristics of murmur were not observed as significant determinants in distinguishing echocardiographic findings (p=0.115).
Discussion
Innocent murmurs develop as a result of increased flow velocity caused by regions of different widths between the chambers of the heart and vessels or between two vessels due to tissue vibrations [1]. Heart murmur is one of the main causes of evaluation in pediatric cardiology clinics. The majority of murmurs are innocent, without accompanying structural heart disease, and can generally be differentiated from pathological murmurs through accurate history and physical examination. However, murmur differentiation requires gradual skill development [3]. Studies have described various characteristics of innocent heart murmurs. Accordingly, innocent murmurs are soft musical sounds on the left of the sternum that do not spread to other regions. They are short, systolic murmurs that show differences in characteristics with respiration or position [8]. Studies have declared that pansystolic murmurs greater than grade 3/6, accompanied with an early or mid-systolic click, the presence of abnormal S2, all diastolic murmurs should be accepted as pathological [9,10]. Consistent with this knowledge, murmur grade was 1-2/6 in the majority of the patients in our study, most of the murmurs were innocent, and echocardiography was normal in the majority of these patients. In our study, murmurs with low grade were also detected in the patients with echocardiographic findings normal for age. Echocardiographic evaluation was normal in the majority of the cases classified as innocent murmur. Patients with murmurs >3/6 do not have normal echocardiographic findings. We can suggest that in our study, echocardiographic findings were not pathologic in 92.31% of the patients without murmur, in 89.91% of the patients with innocent murmur, while it was pathological in 90.38% of the patients in the study.
Pathological murmurs can be missed with auscultation, particularly because children may be irritable during examination, and the diagnosis depends on the clinical experience of the physician [7,11]. Murmurs may not be heard exactly if conditions during examination are not appropriate for physical examination or if the physician lacks adequate clinical experience. As a result, intensity and type of murmurs that are heard may not be accurately evaluated [7]. Yıldız et al. [7] detected innocent murmurs in 92.1% of their patients, and Karacan et al. [12] in 80% of their patients. In the present study, no murmur was detected in 19.5% of the patients who were referred for this reason, while innocent murmur was present in 54.5% the participants.
Pathological murmur was present in 26% of all the patients. Pathological echocardiographic findings were detected in 30% of all the patients in our study. The American Heart Association does not recommend echocardiography in cases of murmurs of with grade 2/6 or lower intensity, which are interpreted as innocent by an experienced physician [13]. However, patients with murmurs that are thought to be innocent were examined with echocardiography in Yıldız et al.’s study [7], and different cardiac pathologies were detected. Some of these pathologies include conditions that were not expected to cause murmur and do not require follow-up, but some of them include valvular pathologies that necessitate follow-up and small atrial and ventricular septal defects and pulmonary stenosis [7]. Therefore, they suggested that murmurs that are described as innocent should also be evaluated with echocardiography. We stated 14 patients without murmur and with innocent murmur who had pathologic echocardiographic findings. These echocardiographic findings were in concordance with the previous study.
Atrial and ventricular septal defects are more commonly detected under two years of age, for this reason physical examination should be performed more carefully in these ages [7]. Children under two years of age constituted 35% of all the patients in the present study. ASD and VSD, Tetralogy of Fallot, operated congenital heart diseases were present in patients under 2 years of age. Children under 3 months of age consisted of 30 patients and pathologic findings included included VSD, ASD, interventricular septal hypertrophy.
Only half of the congenital heart diseases can be detected in the first weeks of life during routine examinations of healthy newborns. Diagnosis via physical examination is difficult since hemodynamic changes are not yet complete during this period [14]. Studies in the literature, have also reported that echocardiography definitely should be performed for the diagnosis of murmurs detected in the neonatal period [7]. Cardiac murmurs detected in patients over 12 years of age are also important because the prevalence of valvular diseases increases with age. Valve problems have been shown to be more common in patients over 5 years of age. Therefore, such problems are not expected to produce physical examination findings in the first weeks of life. Patients older than four years of age constituted 53.5% of the children in this study. Pathologic echocardiographic findings included valvular diseases in 21 patients. They were mitral insufficiency, mitral valve prolapses with mitral insufficiency, bicuspid aortic valve with aortic insufficiency and aortic stenosis and pulmonary stenosis.
Some pathological murmurs are highly determinant for some cardiac diseases, especially for VSD. Kocabaş et al. [3] detected VSD with a high incidence, according to the characteristics of the murmur. Similarly in the present study, VSD, pulmonary stenosis, and mitral valve pathologies were suspected with a high probability of pathological murmur.
Correct identification of cardiac murmurs characteristics is of very great importance. Correct recognition of innocent murmurs is important in terms of avoiding anxiety, unnecessary drug therapy, and restriction of physical activity. If pathological murmurs are misidentified as innocent, the diagnosis and management of the present congenital heart disease will be delayed. Besides, the delay in prophylaxis of infective endocarditis or surgical treatment will cause a very important problem [7]. Mahnke et al. [15] reported that 40% of research assistants identified innocent murmurs as ‘pathological’ and 21% diagnosed pathological murmurs as ‘innocent’ and concluded that auscultation experience levels were below than those required. Yıldız et al. [7] reported that echocardiographic examinations revealed pathological findings in 17.75% of patients initially regarded as having innocent murmurs, while echocardiography was normal in 7.54% of patients initially regarded as having pathological murmurs. In our study, we determined pathological echocardiographic findings in 30.35% of the patients with grade 1-2/6 murmurs and in 7.69% of the patients without murmurs. Besides, there were echocardiographic findings that were normal for age in 14.28% of the patients with grade ≥ 3/6. In addition, pathological echocardiographic findings were stated in 10.09% of the patients regarded as having innocent murmurs, while echocardiographic findings normal for age were detected in 9.62% of the patients with pathological murmurs. Yıldız et al. [7] demonstrated that physical examination is a significant determinant of echocardiographic findings with a high specificity, positive and negative predictive values and accuracy suggesting that murmurs should be also evaluated with echocardiography for evaluating possible insignificant cardiac defect that has been dismissed and should be followed up in the future. McCrindlle et al. [9] did not suggest evaluating with echocardiography if the physical examination was performed by experienced physicians. But Çimen et al. [11] declared that patients without significant murmur may have minor cardiac defects that should be evaluated during follow ups, so they suggested the necessity of echocardiography for evaluation of cardiac murmurs. We demonstrated in our study that characteristics of murmur is a not a significant determinant for echocardiographic findings. Therefore, the presence of murmur independent from its characteristics should be evaluated with echocardiography.
To our knowledge, this is the first study in the literature that examines the relation of the intensity of murmur with echocardiographic findings. We showed that murmur intensity was observed as a significant determinant for distinguishing echocardiographic findings, suggesting that high grades of murmur shows a high probability of echocardiographic findings. This finding if supported by other studies, would decrease the necessity of echocardiographic findings in lower grades of murmur and in the absence of murmur, and also will increase the requirement of echocardiographic evaluation with the presence of high grades of murmur.
Conclusion
Although the majority of murmurs were innocent and cardiac findings were normal, pathological findings were also detected in patients without murmurs or initially regarded as innocent murmurs. Pathological echocardiographic findings were detected in the majority of pathological murmurs, but findings normal for age were also observed. The intensity of murmurs is valuable in determining the need for further evaluation with echocardiography, while murmur characteristics are an independent factor to make a decision for the necessity of echocardiographic evaluation. In light of these knowledge, these findings suggest that auscultation alone may not be sufficient for the evaluation of the patients with murmur, therefore echocardiographic evaluation may be more appropriate for evaluation.
Scientific Responsibility Statement
The authors declare that they are responsible for the article’s scientific content including study design, data collection, analysis and interpretation, writing, some of the main line, or all of the preparation and scientific review of the contents and approval of the final version of the article.
Animal and human rights statement
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Funding: None
Conflict of interest
The authors declare no conflict of interest.
References
1. Ekici F, Ünal S, Dablan S, Alpan N, Şaylan Çevik B, et al. Yenidoğan yoğun bakım ünitesindeki 119 bebeğin klinik ve ekokardiyografik değerlendirmesi (Clinical and echocardiographic evaluation of 119 infants in the neonatal intensive care unit). Turkish J Pediatr Dis. 2010;4(1):22-9.
2. Frey SM, Zellweger MJ. A heart murmur – a frequent incidental finding. Ther Umsch. 2020;77(8):349-56.
3. Kocabaş A, Çetinkaya Özer S, Kardelen F, Ertup H, Akçurin G. Pediatri Asistanlarının Çocukluk Çağı Kalp Üfürümlerine Yaklaşım Becerilerinin Değerlendirilmesi (Evaluation of Pediatric Residents’ Approach Skills for Childhood Heart Murmurs). Turkish J Pediatr Dis. 2013;4:163-7.
4. Duff DF, Mcnamara DG. History and physical examination of the cardiovascular system. In: Garson A, Bricker JT, Fisher DJ, Neish SR, editors. The Science and Practice of Pediatric Cardiology. Baltimore: Williams&Wilkins; 1998.p.693-713.
5. Kostopoulou E, Dimitriou G, Karatza A. Cardiac Murmurs in Children: A Challenge For The Primary Care Physician. Curr Pediatr Rev. 2019;15(3):131-8.
6. Etoom Y, Ratnapalan S. Evaluation of children with heart murmurs. Clin Pediatr (Phila). 2014;53(2):111-7.
7. Yıldız J, Çetin İİ, Aktaş D, Arı ME, Kocabaş A. Ekici F, et al. Ekokardiyografik Değerlendirme Kardiyak Üfürüm Duyulan Tüm Çocuklarda Gerekli midir? (Is Echocardiographic Evaluation Necessary in All Children with Cardiac Murmurs?) Turkish J Pediatr Dis. 2015;3:189-94.
8. Bronzetti G, Corzani A. The seven “s” murmurs: An alliteration about innocent murmurs in cardiac auscultation. Clin Pediatr (Phila). 2010;49(7):713.
9. McCrindle BW, Shaffer KM, Kan JS, Zahka KG, Rowe SA, Kidd L. Cardinal clinical signs in the differentiation of heart murmurs in children. Arch Pediatr Adolesc Med 1996;150(2):169-74.
10. Chantepie A, Soulé N, Poinsot J, Vaillant MC, Lefort B. Heart murmurs in asymptomatic children: When should you refer? Arch Pediatr. 2016;23(1):97-104.
11. Çimen D, Oran B, Arıbaş S, Baysal T. Çocukluk çağındaki masum üfürümlerde ekokardiyografik inceleme yapalım mı? (Should we do an echocardiographic examination of innocent murmurs in childhood?) Selçuk Tıp Dergisi. 2008;24(3):131-7.
12. Karacan M, Olgun H, Orhan MF, Altay ND, Öztürk CF, Karakelleoğlu C, et al. Undiagnosed cardiac abnormalities among school-aged children. J Curr Pediatr. 2010;8:63-6.
13. Frank JE, Jacobe KM. Evaluation and management of heart murmurs in children. Am Fam Physician. 2011;84(7):793-800.
14. Ahmadipour S, Mohsenzadeh A, Soleimaninejad M. Echocardiographic Evaluation in Neonates with Heart Murmurs. J Pediatr Intensive Care. 2018;7(2):81-5.
15. Mahnke CB, Nowalk A, Hofkosh D, Zuberbuhler JR, Law YM. Comparison of two educational interventions on pediatric resident auscultation skills. Pediatrics. 2004;113(5): 1331-5.
Download attachments: 10.4328.ACAM.21831
Ajda Mutlu Mıhçıoğlu. Assessment of the patients referred to the pediatric cardiology clinic due to murmur. Ann Clin Anal Med 2023;14(9):849-853
Citations in Google Scholar: Google Scholar
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/
Validation of the Japan score in patients with upper gastrointestinal system bleeding and comparison with other scores
Abuzer Özkan 1, Kadir Özsivri 1, Serdar Özdemir 2, Abuzer Coşkun 1
1 Department of Emergency Medicine, University of Health Sciences Bağcılar Training and Research Hospital, 2 Department of Emergency Medicine, Health of Sciences University, Ümraniye Training and Research Hospital, Istanbul, Turkey
DOI: 10.4328/ACAM.21834 Received: 2023-07-27 Accepted: 2023-08-28 Published Online: 2023-08-30 Printed: 2023-09-01 Ann Clin Anal Med 2023;14(9):854-858
Corresponding Author: Abuzer Özkan, Department of Emergency Medicine, Health of Sciences University, Bağcılar Training and Research Hospital, Istanbul, Turkey. E-mail: ebuzerozkan@gmail.com P: +90 505 615 55 50 Corresponding Author ORCID ID: https://orcid.org/0000-0003-4284-0086
This study was approved by the Ethics Committee of Umraniye Training and Research Hospital (Date: 2022-08-11, No: 258)
Aim: Upper gastrointestinal bleeding is a life-threatening emergency. Endoscopic intervention facilities are not available in all hospitals, and the number of personnel performing this procedure is insufficient to provide 24-hour service. Scales are being developed to predict endoscopic intervention in AUGB. Japan score is one of them.
Material and Methods: The study was designed prospectively. It was performed between 02-02-2023 and 02-06-2023. The study was carried out on patients who were admitted to the emergency department with the suspicion of upper gastrointestinal bleeding and were diagnosed with non-variceal upper GI bleeding after endoscopic examination.
Results: A total of 65 patients were included in the study. The median age was 61.0 years (44.0, 78.0); 46 were men (71%). Among the scores, Japan Score was the strongest predictor of the need for Endoscopic intervention (AUC 0.750).
Discussion: The Japan score, which is simpler to use and has a stronger predictive ability, can be used in this patient group compared to the relatively older scorings used to predict endoscopic intervention in UGIB.
Keywords: Upper Gastrointestinal Bleeding, Scores, Japan Score, Endoscopy, Glasgow Blatchford Score
Introduction
Acute abdominal pathologies are important in emergency practice because they are life-threatening. Acute gastrointestinal bleeding constitutes 6-9.7% of acute abdominal pathologies presenting to the emergency department [1,2]. The ligament of Treitz anatomically defines upper gastrointestinal bleeding (UGIB) [3]. Non-steroidal anti-inflammatory drug use, Helicobacter pylori and ulcerative diseases are the most common causes of UGIB [3]. Hospitalization rates are relatively high and 30-day mortality ranges from 9 % to 14% [4]. When patients are admitted to the hospital, there are signs and symptoms such as melena, hematochezia, coffee grounds vomiting, and syncope [5].
The reason why UGIB is life-threatening is the ongoing bleeding or the risk of re-bleeding. Endoscopic interventions are the primary treatment modality in patients with ongoing bleeding or a high probability of re-bleeding [6]. Endoscopic intervention facilities are not available in all hospitals and the number of qualified personnel performing this procedure is insufficient to provide 24-hour service. These conditions raise the question of what the timing of endoscopic intervention should be in all patients with UGIB. Scorings have been developed for the planning of endoscopic intervention in UGIB [7]. Glasgow Blackford (GBS), Pre-Rockall, MAPS and AIMS65 are the most commonly used [8,9]. Efforts to develop new scores are still ongoing. H3B2 and Japan score are some of them [10,11].
While developing the scoring, the studied patient groups differ. There are many different variables such as eating habits, age, disease susceptibility in the region, genetic risk factors, sociocultural level. The generalizability of a score developed in any patient group may be limited to similar populations. Validation of scoring is done for each country and patient population. In this study, we wanted to confirm the Japan score, which was studied in the Japan UGIB patient group and claimed to be successful, in the Turkish patient group.
Material and Methods
The study was designed prospectively. It was performed in Umraniye Training and Research Hospital between 02-02-2023 and 02-06-2023. Patients presenting to the emergency department with non-variceal UGIB were included. Patients who did not undergo endoscopic evaluation and refused to participate in the study were excluded. Endoscopic examinations of all patients were performed within the first 6 hours or within 12 hours at the latest. The Forrest classification was used for reporting endoscopic evaluations of all patients. Patients were divided into two groups: requiring intervention and not requiring intervention. According to the Forrest classification, Ia, 1b and IIa were the groups that required endoscopic intervention. Other Forrest classes were included in the group not requiring endoscopic intervention. The amount of erythrocyte suspension administered in the first 24 hours was recorded in units. Blood transfusion was not considered an interventional procedure. Patient age, gender, SpO2, diastolic and systolic blood pressure, fever, respiratory rate, pulse rate, melena, coffee grounds vomiting, presence of hematemesis or syncope, hemogram values, blood urea nitrogen, albumin, estimated glomerular filtration rate (eGFR), international normalized rate (INR), comorbid diseases, Forrest category, discharge, service, intensive care hospitalization and in-hospital death status were recorded. NEWS-L, Pre-Rockall, AIMS65, GBS, and Japan scores were calculated at admission for all patients. Parameters included in the Japan score are Systolic blood pressure <100 mmhg 2 points, Syncope 2 points, Hematemesis 3 points, Hemoglobin <10 g/dl 1 point, Blood Urea Nitrogen (mg/dl) ≥22.4 2 points, eGFR ≤60 mL/min per 1.73 m2 -2 points, antiplatelet agents -2 points. Ethical approval was obtained from the local ethics committee with number 258 on 2022-08-11.
Statistical analysis
Ordinal and Continuous data are shown with median and 25th and 75th quartiles. Categorical variables were expressed as percentages. Ordinal variables were calculated with the Mann-Whitney U test and categorical variables with the chi-square test or Fisher’s exact test. The power of the scores to predict the need for endoscopic intervention was evaluated with the receiver operating characteristic (ROC) test. The significant upper limit for the p-value was determined as 05%. For statistical calculations, the Jamovi (Version 1.6.21.0; The Jamovi Project, 2020; R Core Team, 2019) statistical program was used.
Ethical Approval
Ethics Committee approval for the study was obtained.
Results
A total of 65 patients were included in the study. The median age was 61 years (25th and 75th quartiles: 44-78); 46 (71%) were men. The most common disease was chronic renal failure with 60 (92.3%) individuals; 49 patients (75.4%) had a history of gastrointestinal bleeding. Comorbidity rates were not different in the two groups. The hemoglobin value was 8.2 (6.7-11.5) in the group requiring intervention and 9.5 (7.6 -11.6) in the group not requiring intervention, but this did not make a significant difference (p=0.380). There was no significant difference in INR values either (p=0.172). While there was no significant difference in the vital parameters of systolic blood pressure and respiratory rate, diastolic blood pressure was different between the groups (p=0.110, 0.308, 0.030, respectively). The most common complaints were hematochezia in 60 (92.3%) and melena in 45 (69.2%) patients. Erythrocyte suspension transfusion was administered to 44 (67.7%) individuals. There was no significant difference between the groups in the need for blood transfusion (p= 0.990). The Japan score was significantly different between the groups with and without the need for endoscopic intervention (p=0.018). There was no significant difference between groups in terms of AIMS65, Glasgow-Blatchford Score, Pre-Rockall Score and NEWS-L scores. Baseline characteristics of the groups requiring intervention and not requiring intervention are shown in Table 1. Among the scores, Japan Score was the strongest predictor of the need for Endoscopic intervention (AUC 0.750 Sensitivity 75%, specificity 64.91%). The highest value in the ROC curves was also in the Japan score (Figure 1). The area under the receiver operating characteristic curve values is presented in Table 2. When the threshold value of the Japan score was taken as 5 in the odds ratio calculations, the result was 5.55 (1.02-30.8). This value was better than the results found in other scorings (Table 3).
Discussion
In this study, we evaluated the success of the Japan score in predicting the need for endoscopic intervention in Turkish UGIB patients. This is a validation study. We also compared it with the commonly used Pre-Rockall, Glasgow Blackfort, AIMS65 and NEWS-L scores. The Japan score successfully predicted the need for endoscopic intervention and we found it to be a stronger guide than other scores. To the best of our knowledge, this study is the first validation study of the Japan score on Turkish patients.
UGIB is a disease with high mortality, morbidity, and cost. It has an important place among acute abdominal pathologies [1]. According to the hemodynamic status of patients, endoscopic imaging is recommended within the first 24 hours [12]. It has been shown that early endoscopic imaging can be beneficial for patients [13]. Determining the need for an interventional procedure without endoscopic imaging will both prevent unnecessary procedures for patients and reduce costs [14]. The most effective method against this problem is scoring systems using patient data. In addition to scores such as Pre-Rockall, Glasgow Blackfort, AIMS65, new scores such as H3B2 and Japan score have appeared in the literature [15]. Poor prognosis and evaluation of the possibility of re-bleeding reveal the necessity of early prediction in this patient group. Therefore, new score studies are frequently tried.
Lino et al. reported that while the Japan scoring system demonstrated success in predicting the effectiveness of interventional treatments, the study was limited by a small patient cohort and the exclusive focus on Japanese participants. Choi et al. in their study showed that the Japan score was not successful in South Korean patients [16]. John et al. on the other hand, in a study conducted on 1048 patients from South Korea, the Japan score was found to be more successful than other scores in predicting the need for interventional procedures. [17] Similarly, in our patient group, the Japan score was successful in predicting endoscopic intervention. This score includes effective indicators of hemodynamic status of patients such as systolic blood pressure, hemoglobin and blood urea nitrogen. In addition, it includes indicators of UGIB severity such as Hematemesis and Syncope [10] Several studies have shown that these parameters are associated with mortality and poor outcome in UGIB. In the Japan score, the parameters are evaluated from 1 to 3 points.. In AIMS65, each parameter is calculated with only 1 point. While the Japan score has 5 parameters, GBS has 9 parameters and Pre-Rockall has only 3 parameters. According to Cazacu et al., GBS and RS are difficult to use in emergency departments due to their complexity and low accuracy [15]. We think that the use of the Japan score will become widespread due to its advantages such as stronger prediction and simple use.
Although the Japan score is in an advantageous position, there are some problems that cannot be overcome. For example, syncope is a condition that is difficult to understand by patients and their relatives. Relatives of the patient may describe the patient’s worsening as syncope. Another problem is low blood count, which is a common situation among young women in some countries [18]. A patient with a chronic low hemogram will get a meaningless score from this parameter and the risk level will be high. In addition, a handicap is that patients can get points on this parameter even if they use their drugs irregularly in the questioning of antiplatelet use.
In our study, we evaluated the Pre-Rockall, Glasgow Blackfort, AIMS65 and NEWS-L scores as well as the validation of the Japan score. Similarly, there are studies in the literature evaluating the mentioned scores. For example, in a retrospective cohort study by Kim et al. in which 530 patients with UGIB were included, the NEWS-L score was compared with the Pre-Rockall, Glasgow-Blatchford, and AIMS65 scores in patients with upper gastrointestinal bleeding [19]. In the composite outcome group of the study, 59 (in-hospital death in 19 patients, intensive care unit admission in 13 patients, and ≥5 units of ES replacement within 24 hours in 40 patients) were enrolled. For the composite outcome, the AUC value of the NEWS-L score was found to be the highest among the risk scores (AUC: 0.760). This value is significantly higher than that of the pre-Rockall score (AUC: 0.660). However, there was no significant difference when compared with the AUC value of the Glasgow-Blatchford score (AUC: 0.700) and that of the AIMS65 score (AUC: 0.760). The NEWS-L score showed better discriminant performance than the pre-Rockall score, discriminant performance comparable to GBS and AIMS65, and it has been shown that the NEWS-L score can be used to identify low-risk patients among patients with UGIB [19]. Although no significant difference was found in the diagnostic test performances of the scorings in the current study, the probability of type 2 error is high due to the limited sample size of the study.
Limitation
There were some limitations in our study. The first is that it was carried out in a single center. Second limitation is the limited sample size. Another factor limiting the generalizability of the results of our study is that only patients who underwent endoscopic evaluation were included. This could be interpreted that clinicians do not perform endoscopic evaluation for patients they consider to be at low risk for UGIB. This may have led to the exclusion of low-risk patients from our study.
Conclusion
The Japan score is as successful in the Turkish patient population as it is in the Japanese and South Korean patients. The Japan score, which is easier to use and has a stronger predictive ability, can be used in this patient group compared to the relatively older scorings used to predict endoscopic intervention in UGIB.
Scientific Responsibility Statement
The authors declare that they are responsible for the article’s scientific content including study design, data collection, analysis and interpretation, writing, some of the main line, or all of the preparation and scientific review of the contents and approval of the final version of the article.
Animal and human rights statement
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Funding: None
Conflict of interest
The authors declare no conflict of interest.
References
1. Akça HŞ, Özdemir S, Algin A, Kar E, Altunok İ. Evaluation of the efficacy of the clinical frailty scale in the prediction of prognosis in geriatric patients presenting to the emergency department with acute abdominal pathologies: a prospective study. Kocatepe Medical Journal. 2023;24(1):36-42.
2. Akça HŞ, Algin A, Özdemir S, Yilmaz B, Altunok İ. Evaluation of the relationship of hemogram parameters with prognosis in older adults with acute abdominal pathologies. Journal of Health Sciences and Medicine. 2022;5(2):385-92.
3. Dolek UC, Ozdemir S, Babayeva K, Gol M. Leech Application-related Upper Gastrointestinal Bleeding: A Case Report. Bull Emerg Trauma. 2023;11(1):47-50.
4. Hreinsson JP, Kalaitzakis E, Gudmundsson S, Björnsson ES. Upper gastrointestinal bleeding: incidence, etiology and outcomes in a population-based setting. Scand J Gastroenterol. 2013;48(4):439-47.
5. Kamboj AK, Hoversten P, Leggett CL. Upper Gastrointestinal Bleeding: Etiologies and Management. Mayo Clinic Proceedings. 2019;94(4):697-703.
6. Yahya H, Umar H, Shekari BT, Sani K. Endoscopy for Upper Gastrointestinal Bleeding in a Tertiary Hospital in Kaduna, North-West Nigeria: Experience and Findings. Ann Afr Med. 2022;21(3):262-8.
7. Alimoğlu F, Özkan A, Çalık M. Evaluation of the shock index and different scores in predicting the mortality in upper gastrointestinal bleeding. J Clin Med Kaz. 2023;20(3):32-7.
8. Kılıç M, Ak R, Hökenek UD, Alışkan H. Use of the AIMS65 and pre-endoscopy Rockall scores in the prediction of mortality in patients with the upper gastrointestinal bleeding. Ulus Travma Acil Cerrahi Derg. 2023;29(1):100-4.
9. Taslidere B, Sonmez E, Özcan AB, Mehmetaj L, Keskin EB, Gulen B. Comparison of the quick SOFA score with Glasgow-Blatchford and Rockall scores in predicting severity in patients with upper gastrointestinal bleeding. Am J Emerg Med. 2021;45:29-36.
10. Sasaki Y, Abe T, Kawamura N, Keitoku T, Shibata I, Ohno S, et al. Prediction of the need for emergency endoscopic treatment for upper gastrointestinal bleeding and new score model: a retrospective study. BMC Gastroenterol. 2022;22(1):337.
11. Iino C, Mikami T, Igarashi T, Aihara T, Ishii K, Sakamoto J, et al. Evaluation of scoring models for identifying the need for therapeutic intervention of upper gastrointestinal bleeding: A new prediction score model for Japanese patients. Dig Endosc. 2016;28(7):714-21.
12. Kim JS, Kim B-W, Kim DH, Park CH, Lee H, Joo MK, et al. Guidelines for Nonvariceal Upper Gastrointestinal Bleeding. Gut Liver. 2020;14(5):560-70.
13. Guo CLT, Wong SH, Lau LHS, Lui RNS, Mak JWY, Tang RSY, et al. Timing of endoscopy for acute upper gastrointestinal bleeding: a territory-wide cohort study. Gut. 2022;71(8):1544-50.
14. Cryer BL, Wilcox CM, Henk HJ, Zlateva G, Chen L, Zarotsky V. The economics of upper gastrointestinal bleeding in a US managed-care setting: a retrospective, claims-based analysis. J Med Econ. 2010;13(1):70-7.
15. Cazacu SM, Alexandru DO, Statie R-C, Iordache S, Ungureanu BS, Iovănescu VF, et al. The Accuracy of Pre-Endoscopic Scores for Mortality Prediction in Patients with Upper GI Bleeding and No Endoscopy Performed. Diagnostics. 2023;13(6):1188.
16. Choi SW, Moon HS, Kwon IS, Sakong H, Kang SH, Sung JK, et al. Validation and Comparison of the Japanese Score and Other Scores in Patients with Nonvariceal Upper Gastrointestinal Bleeding: A Retrospective Study. Digestive Diseases. 2023;41(1):66-73.
17. Jeon HJ, Moon HS, Kwon IS, Kang SH, Sung JK, Jeong HY. Which scoring system should be used for non-variceal upper gastrointestinal bleeding? Old or new? Journal of Gastroenterology and Hepatology. 2021;36(10):2819-27.
18. Jadhav S, Khaparde S. Study of the red cell indices, hemogram and platelet variations in anaemic (<10gm%) patients by automatic cell counter in a tertiary care centre, Ahmednagar, Maharashtra, India. International Journal of Research in Medical Sciences. 2022;5:1582-7.
19. Kim D, Jo S, Lee JB, Jin Y, Jeong T, Yoon J, et al. Comparison of the National Early Warning Score+Lactate score with the pre-endoscopic Rockall, Glasgow-Blatchford, and AIMS65 scores in patients with upper gastrointestinal bleeding. Clin Exp Emerg Med. 2018;5(4):219-29.
Download attachments: 10.4328.ACAM.21834
Abuzer Özkan, Kadir Özsivri, Serdar Özdemir, Abuzer Coşkun. Validation of the Japan score in patients with upper gastrointestinal system bleeding and comparison with other scores. Ann Clin Anal Med 2023;14(9):854-858
Citations in Google Scholar: Google Scholar
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/
Factors affecting mortality in patients with tuberculosis and the impact of the pandemic on patient follow-up
Derya Korkmaz 1, Pınar Ersoy 2
1 Department of Infectious Disease and Clinical Microbiology, Faculty of Medicine, Afyonkarahisar Health Science University, 2 Department of Public Health, Provincial Directorate of Health, Afyonkarahisar, Turkey
DOI: 10.4328/ACAM.21835 Received: 2023-07-30 Accepted: 2023-08-30 Published Online: 2023-08-30 Printed: 2023-09-01 Ann Clin Anal Med 2023;14(9):859-863
Corresponding Author: Derya Korkmaz, Department of Infectious Disease and Clinical Microbiology, Faculty of Medicine, Afyonkarahisar Health Science University, 03200, Afyonkarahisar, Turkey. E-mail: drderya@ymail.com P: +90 506 278 84 68 Corresponding Author ORCID ID: https://orcid.org/0000-0001-7236-2164
This study was approved by the Clinical Research Ethics Committee of Health Sciences University (Date: 2022-08-05, No: 2022/394)
Aim: Tuberculosis (TB) remains one of the leading causes of mortality worldwide. In this study, we aimed to evaluate the patients who were followed up with a diagnosis of TB in the last five years, examine the factors associated with mortality in these patients, and investigate the effect of the pandemic on patient follow-up.
Material and Methods: The data of the patients who were followed up at the Tuberculosis Dispensary between June 1, 2017, and June 1, 2022, with a diagnosis of TB were retrospectively analyzed.
Results: The study included 395 patients with a mean age of 49.6±20.2 years who were followed up with a diagnosis of TB for five years. Of the patients, 208 (52.7%) were male and 187 (47.3%) were female. Pulmonary involvement was found in 160 (40.5%) and non-pulmonary involvement in 212 (53.7%) patients. Follow-up of 11.1% of patients resulted in death. The mean age of the deceased (65.1±16.9) was significantly higher (p<0.001), and there was no significant difference in mortality between both sexes (p=0.957). While the number of patients diagnosed before the pandemic was 219 (55.4%), it was 176 (44.6%) during the pandemic period and there was no difference between the two periods in terms of mortality.
Discussion: Patients over 61 years of age and those with pulmonary + non-pulmonary or pulmonary involvement had significantly higher mortality; therefore, a great deal of care should be taken to avoid delays in diagnosis and treatment, particularly for elderly patients. During the pandemic, the number of patients diagnosed has decreased due to disruptions in health services, so the number of cases and deaths due to TB may increase in the coming years. It is of great importance to take effective measures for disease control and to raise awareness on this issue.
Keywords: Tuberculosis, Pandemic, Mortality, Treatment
Introduction
Tuberculosis (TB) has been a major cause of illness and death in human society since ancient times. TB dates back to approximately 3.3 million years ago. After reaching epidemic levels in Europe and North America in the eighteenth and nineteenth centuries, TB declined in developed countries in the twentieth century, but continues to be a serious threat in low-middle-income and developing countries, particularly due to the emergence of drug-resistant strains and the increasing association with human immunodeficiency virus (HIV) [1,2].
TB is an infectious disease caused by Mycobacterium tuberculosis, a gram-positive, aerobic, non-spore bacillus, most commonly affecting the lungs. The causative microorganism is airborne and reaches the lungs through inhalation of bacilli spread by coughing, sneezing, and talking of an infected person. Immediate diagnosis and initiation of effective treatment are vital in terms of prevention of transmission and control of the disease [3]. However, since common clinical manifestations of TB such as cough, fever, malaise, and weight loss are also seen in many other diseases, there may be delays in diagnosis and treatment.
According to the World Health Organization (WHO), TB is the largest cause of death from a single infectious agent and the 13th leading cause of death worldwide. In 2020, TB ranked second only to COVID-19 as a cause of death from a single infectious agent. According to the estimate in the “2022 Global Tuberculosis Report”, 10.6 million people contracted TB and 1.6 million people died from TB in 2021 (including 187 000 people who were HIV positive), an increase of 4.5% compared to 2020. The burden of drug-resistant tuberculosis (DR-TB) also increased by 3% between 2020 and 2021, with 450 000 new cases of rifampicin-resistant TB (RR-TB) in 2021. For the first time in many years, an increase in the number of people infected with TB and DR-TB has been reported. As with many other healthcare services, TB services have been disrupted by the COVID-19 pandemic, but its impact on the fight against TB has been particularly severe. Ongoing conflicts in Eastern Europe, Africa, and the Middle East have made poor populations more vulnerable (Available at: https://www.who.int/publications/i/item/9789240037021).
Globally, there is concern about increases in the number of patients and TB-related deaths compared to previous years as a result of the disruption of healthcare services due to the pandemic. Turkey has been receiving large numbers of migrants from these regions in recent years due to the wars in its geography. Immigrants who have not been able to access healthcare services sufficiently due to war, poverty, and the pandemic are a high-risk group in terms of TB transmission. As a result of this risky migration wave, the number of cases and deaths in the country is likely to increase. Raising awareness on this issue, especially in primary health care facilities, knowing the characteristics of the disease, preventing delays in diagnosis and treatment, and controlling the spread of the disease will be useful. In this study, we aimed to evaluate the TB patients diagnosed and followed up in the last five years in our province, to examine the factors affecting mortality and the effects of the pandemic on patient follow-up.
Material and Methods
In this cross-sectional study, we retrospectively analyzed the records of patients who were followed up with a diagnosis of TB in the Afyonkarahisar Tuberculosis Dispensary between June 1, 2017, and June 1, 2022. The pandemic period was considered to be 2020, 2021, and 2022, while the pre-pandemic period was considered to be 2019, 2018, and 2017. Demographic characteristics of the patients, sites of TB involvement, diagnostic methods, treatment modalities, treatment durations, treatment outcomes, TB incidence, and distribution of patients according to age and sex were analyzed. Patients under the age of 18 years were considered to be in the pediatric age group.
Statistical Analysis
Statistical analysis of the data was conducted via SPSS version 22 software. Number, percentage, mean, standard deviation, minimum and maximum values, and independent sample t-tests were used to analyze the research data in the computer environment.
In the bivariate analysis, a multivariate logistic regression model was established with the variables of age and site of TB involvement, which showed statistically significant differences in mortality. The cut-off value for significance was p<0.05.
Ethics Committee Approval
The study was approved by the Health Sciences University Clinical Research Ethics Committee (Decision No: 2022/394 and dated 05-08-2022).
Results
In the study, 395 TB patients who were followed up between June 2017 and June 2022 and whose records could be accessed in Afyonkarahisar Tuberculosis Dispensary were evaluated. Of the patients, 208 (52.7%) were male and 187 (47.3%) were female with a mean age of 49.6±20.2 years. Three hundred and seventy-six (95.2%) patients were newly diagnosed with TB, while 19 (4.8%) patients had a relapse. Thirty-two (8.1%) patients were in the pediatric age group, and none of them developed mortality. HIV positivity was detected in only one patient (0.3%). Of the patients, 363 (91.9%) were citizens of the Republic of Turkey, and 32 (8.1%) were immigrants (3.8% from Afghanistan, 3.0% from Syria, and 1.3% other immigrants). Patients with pulmonary involvement accounted for 160 (40.5%) patients, while patients with non-pulmonary involvement made up the majority (212, 53.7%). Pulmonary + non-pulmonary involvement was present in 12% of patients. Socio-demographic characteristics and sites of involvement are presented in Table 1.
The diagnosis was most commonly made by histopathologic examination (209, 52.9%). In addition, 102 (25.8%) were diagnosed due to smear positivity and 28 (7.1%) due to culture positivity, while 57 (14.4%) were diagnosed clinically and radiologically. In 15 (3.8%) patients, other diagnostic methods such as the Quantiferon TB-Gold test and polymerase chain reaction (PCR) were used for diagnosis.
While first-line drug therapy (isoniazid, rifampicin, pyrazinamide, ethambutol) was given to 374 (94.7%) patients in the treatment, second-line drug treatments were given to 15 (3.8%) patients due to the development of side effects (n=6, 1.5%), multi-drug resistance (n=3, 0.7%) and insufficient pyrazinamide stock status (n=6, 1.5%). The clinical follow-up of 5 (1.2%) of 6 (1.5%) patients who refused to receive treatment resulted in death. It was determined that 69.4% of the patients in whom treatment was initiated completed the treatment, 15.7% were cured, and 11.1% died during the follow-up period. Of the deaths, 89.1% (41 people) occurred within the first 6 months after diagnosis, and the mean age of those who died (65.1±16.9) was significantly higher than that of survivors (47.7±19.7) (p <0.001). When mortality rates were compared, no significant difference was found between the male and female gender (p=0.957). Characteristics of the patients according to mortality status are presented in Table 2. The results of the multivariate analysis revealed that the site of TB involvement and age affected mortality. While mortality was significantly higher in people aged 61 and above compared to those aged 0-40, mortality was significantly higher in pulmonary + non-pulmonary TB or pulmonary TB compared to non-pulmonary TB (Table 3).
Among the extrapulmonary sites involved, extrathoracic lymphadenopathy (LAP) (32.3%) and pleural involvement (16.6%) ranked first and second, respectively, while intrathoracic lymphadenopathy (9.3%) was the third most prevalent. In addition, 17 (7.3%) of the patients had gastrointestinal, 15 (6.4%) vertebral, 15 (6.4%) skin, 14 (6%) genitourinary, 8 (3.4%) nonvertebral bone joint involvement, 6 (2.5%) patients had TB meningitis. While the incidence of TB in our province was 11.0 per 100,000 in 2018, it increased to 13.6 per 100,000 in 2019, and it was observed that the incidence decreased significantly in 2020 and 2021 (Figure 1). TB was more common in older age and in males (Figure 2). The highest number of patients and deaths occurred in 2019 (Figure 3).
During the pandemic, 176 (44.6%) patients were diagnosed with TB compared to 219 (55.4%) before the pandemic. Meanwhile, the number of patients who died was 26 (11.9%) before the pandemic and 18 (10.2%) during the pandemic. Mortality rates during the pandemic period were not significantly different from those during the pre-pandemic period (p=0.606).
Discussion
In this study, we analyzed the data and mortality status of 395 patients who were followed up with a diagnosis of TB between June 2017 and June 2022 in our province. The mean age in the study was similar to the literature data. WHO reports that the majority of TB cases (70%) occur between the ages of 15-54. In similar studies conducted in Turkey, it was observed that tuberculosis was detected more frequently in middle-aged people. [4,5]. It is well-documented that TB is more common in males than in females in Turkey as well as in the world [6]. In this study, similar to the literature data, the proportion of males was higher.
Effective disease management is one of the critical components of TB control. TB patients are reported within 24 hours after diagnosis and patients are referred to the local TB Dispensary for follow-up and treatment, where treatment, follow-up, vaccination, contact screening, education, and counseling services are provided free of charge. The Directly Observed Therapy (DOT) strategy, recommended by the World Health Organization to increase treatment success and survival, started to be implemented in health institutions in Turkey in 2006. TB mortality is a significant indicator to assess the effectiveness of TB control programs and to quantify the burden of TB. Investigating risk factors associated with mortality in TB is essential to improve survival. WHO defines TB-related deaths as the number of TB patients who die during treatment, regardless of the actual cause of death. Despite differences across countries, various studies evaluating risk factors for mortality during TB treatment have suggested that factors such as age, sex, comorbidities, and HIV infection may be associated with mortality [7,8]. In Turkey, several studies have been conducted on the characteristics of TB-related mortality and associated risk factors.
In the present study, no significant difference was found between male and female sex in terms of mortality (p=0.957). Although the role of sex in mortality varies across studies, male sex has been defined as an independent risk factor for TB-related mortality in some studies [9]. On the other hand, in many studies, no significant difference has been found between surviving and deceased patients in terms of sex [10]. In a study investigating the factors associated with mortality in TB patients in Turkey, 382 patients with a median age of 54.0 years (34.0-67.0) were examined. 62% of the study group were males and male patients were found to be more common in the deceased patient group. It was also found that while treatment was successful in 90.6% of patients, 51.6% of those with a mortal course were over 70 years of age, and pulmonary TB was significantly more common in patients who died [11]. The results of the study, which found that mortality in pulmonary TB or pulmonary + non-pulmonary TB is higher compared to non-pulmonary TB, are consistent with the literature in this regard.
The most common mortality occurred in patients over 61 years of age, whereas the pediatric population had no mortality, and there was no significant difference between immigrant and Turkish patients in terms of mortality. In numerous studies, advancing age has been reported as a risk factor for mortality in TB patients [8,12]. High mortality in elderly patients may be due to comorbidities that increase with advancing age and factors such as weakened immune system responses, lack of awareness, association of symptoms with old age, and delayed hospital admissions. Therefore, TB screening in the elderly should be performed without delay whenever possible for early detection, diagnosis, and treatment.
There was a significant decrease in TB incidence during the pandemic period compared to the pre-pandemic period. However, there was no significant difference between the two periods in terms of mortality. In 2020, the COVID-19 pandemic significantly disrupted essential healthcare services, including the follow-up and treatment of TB patients. While the negative consequences of this especially on the poor and disadvantaged populations were felt more severely, reports of tuberculosis people decreased by 18% in 2020 compared to the previous year, and the number of estimated TB deaths increased for the first time in 9 years [13]. According to the Global Tuberculosis Report 2022, which covers more than 99% of the world’s population and presents data reported from 202 countries and regions, the COVID-19 pandemic adversely affected the diagnosis and care of TB, which increased the burden of the disease and caused the slowdown, interruption and even reversal of the progress made in the fight against TB until 2019. However, during the pandemic, the use of masks and adherence to social distancing measures contributed to a reduction in community transmission of TB. Due to the restrictions applied from time to time, lock-down measures, health policies giving priority to the fight against COVID-19, and using financial and human resources more in this area, and people refraining from applying to health institutions that are considered to be risky in terms of COVID-19 transmission, health services for the diagnosis and treatment of TB could not reach many people. Ultimately, newly diagnosed TB cases fell from 7.1 million in 2019 to 5.8 million in 2020. In 2021, this figure increased to 6.4 million but remained below pre-pandemic numbers [14]. Based on a similar study conducted in Turkey, it was found that TB incidence decreased significantly during the pandemic period [4]. The fact that the number of cases detected in our study decreased compared to the pre-pandemic period, as is the case worldwide, suggests that there is an increase in undiagnosed and untreated TB cases, which may lead to the spread of the infection in the community and an increase in deaths in the coming years. In order to correct this pessimistic picture and continue towards the global TB control targets, public health policies should be reconsidered as soon as possible and financial funds should be allocated to effectively fight TB. Furthermore, new and effective health service models should be developed to ensure uninterrupted access to health services, particularly for populations at-risk, and prompt diagnosis and treatment of TB.
Conclusion
In conclusion, since age 61 years or older and pulmonary or pulmonary + non-pulmonary involvement are associated with mortality, the diagnosis and treatment of these patients should not be delayed, and diagnostic tests should be performed immediately in case of clinical suspicion, especially in elderly patients, and effective treatment should be started. The number of TB patients diagnosed during the pandemic period has decreased compared to the pre-pandemic period. Since this situation will hinder the control of the disease, patients who cannot be detected in this period may spread the infection in the community and may cause an increase in the number of patients and deaths in the next few years.
Limitations
The retrospective study design is the most important limitation of this study. Data such as socioeconomic status, comorbidities, dietary habits, and admission symptoms of the patients could not be obtained. Prospective studies that take all these factors into account are needed to reach a more definitive conclusion.
Scientific Responsibility Statement
The authors declare that they are responsible for the article’s scientific content including study design, data collection, analysis and interpretation, writing, some of the main line, or all of the preparation and scientific review of the contents and approval of the final version of the article.
Animal and human rights statement
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Funding: None
Conflict of interest
The authors declare no conflict of interest.
References
1. Natarajan A, Beena PM, Devnikar AV, Mali S. A systemic review on tuberculosis. Indian J Tuberc. 2020;67(3):295-311.
2. Pezzella AT. History of Pulmonary Tuberculosis. Thorac Surg Clin. 2019;29(1):1-17.
3. Kara ŞA, Aslan D. Küreselleşen Dünyada Tüberküloz : Halk Sağlığı Bakış Açısıyla Güncel Durum Değerlendirmeleri (Tuberculosis in a Globalizing World: Current Situation Assessments from a Public Health Perspective). Sağlık ve Toplum/ Health and Society. 2021;31(1):3-22.
4. Ozdemir S, Oztomurcuk D, Oruc MA. Impact of the COVID-19 pandemic on tuberculosis patients and tuberculosis control programs in Turkey, review and analysis. Arch Public Heal. 2022;80(1):252.
5. Yakupogullari Y, Ermis H, Kazgan Z, Otlu B, Bayındır Y, Gulbas G, et al. Diagnostic and treatment outcomes of patients with pulmonary tuberculosis in the first year of COVID-19 pandemic. East Mediterr Health J. 2022;28(9):682-9.
6. Yılmaz S, Daharlı EK. Evaluation of tuberculosis cases followed in Erzurum tuberculosis dispensary between 2012-2018. Turk J Public Health. 2021;19(2):106-15.
7. Birlie A, Tesfaw G, Dejene T, Woldemichael K. Time to death and associated factors among tuberculosis patients in dangila woreda, northwest Ethiopia. PLoS One. 2015;10(12):e0144244.
8. Kwon YS, Kim YH, Song JU, Jeon K, Song J, Ryu YJ, et al. Risk factors for death during pulmonary tuberculosis treatment in Korea: A multicenter retrospective cohort study. J Korean Med Sci. 2014;29(9):1226-31.
9. Xie Y, Han J, Yu W, Wu J, Li X, Chen H. Survival Analysis of Risk Factors for Mortality in a Cohort of Patients with Tuberculosis. Can Respir J. 2020;2020:1654653.
10. Tolosie K, Sharma MK. Application of Cox Proportional Hazards Model in Case of Tuberculosis Patients in Selected Addis Ababa Health Centres, Ethiopia. Tuberc Res Treat. 2014;2014:536976.
11. Oruç MA, Ozdemir S, Oztomurcuk D. Characteristics of tuberculosis-related deaths and risk factors: a retrospective cohort study in Samsun province of Turkey. Postgrad Med. 2022;134(2):217-23.
12. Djouma FN, Noubom M, Ngomba AV, Donfack H, Kouomboua PSM, Saah MAF. Determinants of death among tuberculosis patients in a semi urban diagnostic and treatment centre of Bafoussam, West Cameroon: A retrospective case-control study. Pan Afr Med J. 2015;22:253.
13. Chakaya J, Petersen E, Nantanda R, Mungai BN, Migliori GB, Amanullah F, et al. The WHO Global Tuberculosis 2021 Report – not so good news and turning the tide back to End TB. Int J Infect Dis. 2022;124(1):26-9.
14. Bagcchi S. WHO’s Global Tuberculosis Report 2022. The Lancet Microbe. 2023;4(1):e20.
Download attachments: 10.4328.ACAM.21835
Derya Korkmaz, Pınar Ersoy. Factors affecting mortality in patients with tuberculosis and the impact of the pandemic on patient follow-up. Ann Clin Anal Med 2023;14(9):859-863
Citations in Google Scholar: Google Scholar
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/